GT,Diagnosis 1,ERN Category
['Vitamin B12-unresponsive methylmalonic acidemia'],"1. Methylmalonic acidemia: Hallmark symptoms of death in infancy/childhood, metabolic acidosis, and diagnostic finding of decreased methylmalonyl-CoA mutase activity. Other typical symptoms that were not reported include poor feeding, vomiting, lethargy, and developmental delay.

2. Propionic acidemia: Can also present with death in infancy, metabolic acidosis, and potentially decreased methylmalonyl-CoA mutase activity. However, methylmalonic acidemia is more likely given the specific enzyme deficiency noted.

3. Disorders of cobalamin metabolism (e.g. cblA, cblB, cblC, cblD): Defects in cobalamin (vitamin B12) metabolism can impair methylmalonyl-CoA mutase activity and cause a similar clinical picture as methylmalonic acidemia. Additional findings may include megaloblastic anemia, hyperhomocysteinemia, and methylmalonic aciduria.

4. MELAS syndrome (mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes): This mitochondrial disorder can present in childhood with metabolic acidosis and early death, but would typically have additional neurologic symptoms like seizures, stroke-like episodes, and muscle weakness. Methylmalonic acidemia is much more likely in this case.

5. Pyruvate dehydrogenase deficiency: Another metabolic disorder that can present with lactic acidosis and early childhood death. However, patients typically have severe neurologic dysfunction, seizures, and structural brain abnormalities. Less likely than methylmalonic acidemia given this patient's presentation and diagnostic studies.",Hereditary metabolic disorders
['Succinic semialdehyde dehydrogenase deficiency'],"1. Glycine Encephalopathy (Nonketotic Hyperglycinemia): Characterized by hypotonia, developmental delay, and respiratory difficulties. Elevated glycine would be expected. No mention of seizures which are common.

2. Canavan Disease: A leukodystrophy causing hypotonia, motor delay, macrocephaly, and death in infancy. Key features of macrocephaly and leukodystrophy on MRI are lacking.

3. Spinal Muscular Atrophy (SMA) Type 1: Causes profound hypotonia, weakness, motor delay, and respiratory failure in infancy. Does not explain elevated carboxylic acid.

4. Pompe Disease (Glycogen Storage Disease Type II): Leads to hypotonia, cardiomegaly, hepatomegaly, and respiratory insufficiency. Patient is not reported to have heart or liver enlargement. 

5. Glutaric Acidemia Type 1: Causes motor delay, hypotonia, and dystonia with risk of metabolic crises. Elevated glutaric acid would be expected. Typical brain findings of fronto-temporal atrophy are not mentioned.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia type I: Characterized by hypertyrosinemia, liver dysfunction, renal tubular dysfunction, and neurologic crises. Can lead to death in infancy if untreated. Patient's hypertyrosinemia is consistent, but liver and kidney involvement are not mentioned.

2. Phenylketonuria (PKU): Causes hyperphenylalaninemia and severe intellectual disability if untreated. Screened for at birth in many countries. Patient has hyperphenylalaninemia but no mention of developmental delay or intellectual disability, which are key features.

3. Maple syrup urine disease: Disorder of branched-chain amino acid metabolism causing poor feeding, vomiting, lethargy, and maple syrup odor to urine. Can be fatal in the neonatal period if untreated. Elevated branched-chain amino acids are not reported in this patient.

4. Homocystinuria: Defect in methionine metabolism leading to elevated homocysteine and methionine. Can cause developmental delay, eye problems, skeletal abnormalities, and thromboembolism. Patient's symptoms do not clearly fit this diagnosis.

5. Urea cycle disorder: Defects in the urea cycle lead to hyperammonemia, which can cause lethargy, poor feeding, vomiting, coma, and death. Typical presentation is in the neonatal period. Hyperammonemia is not reported in this patient.",Hereditary metabolic disorders
['PMM2-CDG'],"1. Congenital disorder of glycosylation (CDG): Presents with failure to thrive, cerebellar hypoplasia, lipodystrophy, and high infant mortality. Key features not reported include inverted nipples, abnormal fat pads, and liver dysfunction.

2. Zellweger spectrum disorder: Caused by peroxisome dysfunction. Consistent with cerebellar dysfunction, failure to thrive, and early death. Additional symptoms may include hearing loss, vision abnormalities, liver cysts and distinctive facial features.

3. Pontocerebellar hypoplasia (PCH): Matches cerebellar atrophy/agenesis and motor delay. Can be associated with failure to thrive and early mortality depending on subtype. Seizures, microcephaly and breathing abnormalities are other key features.

4. Congenital myopathy: The reported muscle abnormalities and motor delay fit this diagnosis. Failure to thrive and infant mortality can occur in severe cases. Symptoms not mentioned include hypotonia, high-arched palate, and contractures.

5. Donnai-Barrow syndrome: Rare disorder that can present with diaphragmatic hernia, cerebellar malformation, failure to thrive and motor delay. Other characteristic features include sensorineural hearing loss, vision problems, and distinctive facial features.",Hereditary metabolic disorders
['Maple syrup urine disease'],"1. Maple syrup urine disease: Characterized by intellectual disability, feeding difficulties, hypotonia, opisthotonus, and elevated branched-chain amino acids (leucine, isoleucine, valine). Can be life-threatening in infancy and early childhood.

2. Glutaric aciduria type 1: Features include intellectual disability, motor delay, hypotonia, dystonia, athetosis, and elevated urinary organic acids. Onset often in infancy with risk of metabolic crises.

3. Propionic acidemia: Can present with intellectual disability, hypotonia, feeding difficulties, and elevated urinary organic acids. Typically presents in the neonatal period with risk of life-threatening complications.  

4. Menkes disease: X-linked disorder of copper metabolism causing intellectual disability, hypotonia, feeding difficulties, seizures, and connective tissue abnormalities. Mortality often in early childhood.

5. Zellweger spectrum disorder: Peroxisomal biogenesis disorders characterized by intellectual disability, hypotonia, feeding difficulties, liver dysfunction, and skeletal abnormalities. Severe forms are often fatal in infancy or early childhood.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Phenylketonuria (PKU): Hyperphenylalaninemia, skin rash, developmental delay, early death. Key missing symptom is musty body odor.

2. Tyrosinemia type I: Hypertyrosinemia, gastrointestinal issues, developmental problems, early mortality. Lacking report of liver and kidney dysfunction.

3. Severe combined immunodeficiency (SCID): Recurrent infections, diarrhea, failure to thrive, early death. No mention of lymphopenia.

4. Netherton syndrome: Erythematous skin rash, immune dysfunction, failure to thrive, recurrent infections. Hair shaft abnormalities not reported. 

5. Propionic acidemia: Gastrointestinal issues, developmental delay, early mortality. Typically presents with metabolic acidosis and hyperammonemia.",Hereditary metabolic disorders
['Biotinidase deficiency'],"1. Mitochondrial disorder: The increased lactate in blood and CSF, along with neurological symptoms and multi-organ involvement (skin, brain) can be seen in mitochondrial diseases. Some forms like Leigh syndrome can cause infant death.

2. Netherton syndrome: This autosomal recessive disorder causes an ichthyosiform erythroderma (scaly red skin), hair shaft abnormalities, immune dysregulation, failure to thrive and recurrent infections. It can rarely be fatal in infancy. The patient's eczematoid rash and alopecia fit, but additional findings like bamboo hair would support the diagnosis.

3. Autoimmune polyglandular syndrome: A collection of autoimmune disorders that can manifest with dermatological symptoms like alopecia and vitiligo, as well as endocrine abnormalities. Type 1 can appear in infancy. The patient is missing classic features like mucocutaneous candidiasis and hypoparathyroidism.

4. Ectodermal dysplasia: A group of disorders affecting derivates of the ectoderm, which can cause abnormalities of the skin, hair, nails, teeth and sweat glands. The skin rash and alopecia fit, but the patient lacks other classic symptoms like missing teeth or decreased sweating. Can rarely be fatal in infancy due to infections.

5. Menkes disease: An X-linked recessive disorder of copper metabolism, which can cause neurodegeneration, seizures, hypotonia, failure to thrive, and kinky hair. Rarely, it can present with skin laxity and wrinkling. The patient's neurological symptoms and infant death could fit, but additional findings like seizures and kinky hair are absent.",Hereditary metabolic disorders
['PMM2-CDG'],"1. Zellweger spectrum disorder: Symptoms consistent with this peroxisomal biogenesis disorder include intellectual disability, vision and hearing loss, liver dysfunction, and distinctive facial features. Additional symptoms may include epilepsy, kidney cysts, and skeletal abnormalities.

2. Aicardi-Gouti√®res syndrome: This inflammatory disease is characterized by intellectual disability, abnormal neurological findings, liver dysfunction, thrombocytopenia, and skin lesions. Cerebellar atrophy is a key feature. Lipodystrophy is not typically seen.

3. Congenital disorders of glycosylation: This group of disorders can present with intellectual disability, cerebellar atrophy, retinal dystrophy, liver dysfunction, abnormal fat distribution, and dysmorphic features. Symptoms vary depending on the specific gene mutation.

4. Niemann-Pick disease type C: Hallmarks include intellectual decline, cerebellar ataxia, vertical gaze palsy, and hepatosplenomegaly. Retinal degeneration and thrombocytopenia can occur. Facial dysmorphism is not a major feature.

5. Infantile Refsum disease: Part of the Zellweger spectrum, this disorder causes retinal dystrophy, sensorineural hearing loss, developmental delays, liver dysfunction, and facial dysmorphism. Cerebellar atrophy is less common than in some of the other conditions listed.",Hereditary metabolic disorders
['Glutaryl-CoA dehydrogenase deficiency'],"1. Glutaric acidemia type 1: Consistent with glutaric aciduria, macrocephaly, dystonia, dyskinesia, and risk of metabolic crisis and early death. Additional symptoms can include subdural hematoma and dehydration.

2. Pyruvate dehydrogenase deficiency: Hypotonia, lethargy, poor feeding, and lactic acidosis are common. Dysmorphic features may be present. Can be fatal in infancy.

3. Zellweger syndrome (a peroxisomal biogenesis disorder): Presents with hypotonia, poor feeding, distinctive facial features, and hepatic dysfunction. Seizures and bony abnormalities are also seen.

4. Molybdenum cofactor deficiency: Characterized by neonatal seizures, hypotonia, and dysmorphic facial features. Feeding difficulties and high risk of early death are typical. 

5. Menkes disease: Key features include hypotonia, seizures, failure to thrive, and kinky, sparse hair. Hypothermia and bladder diverticula may occur. Usually fatal in early childhood.",Hereditary metabolic disorders
['Isovaleric acidemia'],"1. Propionic acidemia: Consistent with hyperammonemia, lethargy, feeding problems, and risk of infant death. May also have ketoacidosis and hypoglycemia.

2. Methylmalonic acidemia: Also features hyperammonemia, lethargy, poor feeding, and high mortality. Megaloblastic anemia and neutropenia may be present.  

3. Urea cycle disorders (e.g. OTC deficiency, CPS deficiency): The hyperammonemia, lethargy, and childhood mortality fit. Additional symptoms may include vomiting, seizures, and cerebral edema.

4. Non-ketotic hyperglycinemia: Matches the abnormal glycine levels, lethargy, and infant death. Seizures and severe hypotonia are often seen.

5. Carnitine uptake defect: The abnormal carnitine levels, drowsiness and early death are consistent. Typically also causes cardiomyopathy and hypoglycemia.",Hereditary metabolic disorders
['PMM2-CDG'],"1. Joubert syndrome: Characterized by cerebellar vermis hypoplasia, hypotonia, ataxia, developmental delays, and eye movement abnormalities. Matches the patient's cerebellar findings, hypotonia, ataxia, and eye signs, but this patient has more severe features.

2. Walker-Warburg syndrome: Includes brain malformations (lissencephaly, cerebellar abnormalities), eye anomalies, intellectual disability, seizures, and hypotonia. Fits with microcephaly, cerebellar issues, eye findings, intellectual disability and hypotonia. Patient is missing lissencephaly and seizures.

3. Pontocerebellar hypoplasia: Presents with microcephaly, severe developmental delays, hypotonia, and cerebellar hypoplasia/atrophy. Matches microcephaly, cerebellar atrophy, motor delay, intellectual disability, and hypotonia. Additional spinal cord involvement is often seen.

4. Trisomy 13: Features intellectual disability, microcephaly, hypotonia, eye defects, and brain malformations. Consistent with microcephaly, intellectual disability, hypotonia, and eye movement disorders. Other typical findings (cleft lip/palate, polydactyly, heart defects) not reported.

5. Zellweger spectrum disorder: Includes cerebellar hypoplasia, hypotonia, seizures, vision/hearing impairment, and early death. Matches cerebellar abnormality, hypotonia, encephalopathy, and death in infancy. Typical liver dysfunction and facial features not mentioned.",Hereditary metabolic disorders
"['Methylmalonic acidemia with homocystinuria, type cblC']","1. Methylmalonic acidemia: Consistent with methylmalonic aciduria, hyperammonemia, metabolic/developmental abnormalities, and high mortality. May not fully explain the eye findings.

2. Homocystinuria: Accounts for the hyperhomocystinemia, eye abnormalities, developmental delay, and possible cardiac defect. Other metabolic abnormalities would need further explanation.

3. Propionic acidemia: Could cause hyperammonemia, cardiomyopathy, metabolic abnormalities, and developmental issues. Specific organic acid profile would need to be confirmed.  

4. 3-Hydroxy-3-methylglutaryl-CoA lyase deficiency: Presents with hyperammonemia, hypotonia, cardiomyopathy, and abnormal organic acids. Could be consistent if methylmalonic aciduria is present.

5. Multiple acyl-CoA dehydrogenase deficiency (glutaric aciduria type 2): Can feature hypotonia, cardiomyopathy, metabolic acidosis, and low carnitine. Would expect additional organic acid abnormalities.",Hereditary metabolic disorders
['Medium chain acyl-CoA dehydrogenase deficiency'],"1. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: Presents with hypoglycemia, vomiting, and lethargy in infancy. Can cause sudden death. Abnormal carnitine and elevated liver enzymes are consistent. Lacks some features like developmental delay and seizures.

2. Ornithine transcarbamylase (OTC) deficiency: Can present in infancy with vomiting, lethargy, and elevated liver enzymes due to hyperammonemia. Hypoglycemia is possible but less common. Typically also have respiratory alkalosis and altered mental status.

3. Galactosemia: Classically presents with vomiting, diarrhea, jaundice, hepatomegaly, and lethargy after exposure to milk. Liver dysfunction is common. Hypoglycemia and death can occur if untreated. Cataracts would also be expected.

4. Hereditary fructose intolerance: Symptoms of vomiting, diarrhea, lethargy, and liver dysfunction appear after fructose exposure. Hypoglycemia is a key feature. Additional symptoms may include seizures, kidney dysfunction, and coagulopathy.

5. Fatty acid oxidation disorder (other than MCAD): Encompasses a group of disorders with overlapping symptoms. Hypoglycemia, liver dysfunction, and abnormal carnitine are characteristic. Rhabdomyolysis and cardiomyopathy are often seen but not reported here.",Hereditary metabolic disorders
['Succinic semialdehyde dehydrogenase deficiency'],"1. Propionic acidemia: Consistent with neonatal presentation of coma, respiratory acidosis, hyperkalemia, elevated urinary carboxylic acid. Can also cause hyponatremia.

2. Methylmalonic acidemia: Also fits with neonatal coma, respiratory acidosis, hyperkalemia, hyponatremia, and elevated urinary carboxylic acid. 

3. Isovaleric acidemia: Another organic acidemia that can present in neonates with coma, acidosis, hyperkalemia, and elevated carboxylic acid, but hyponatremia is less common.

4. Glutaric acidemia type 2: Can cause neonatal coma, acidosis, hyperkalemia, hyponatremia, and elevated urinary carboxylic acids. Hypoglycemia is often present as well.

5. Urea cycle disorder (e.g. OTC deficiency): The hyperammonemia in urea cycle disorders can lead to neonatal coma and respiratory alkalosis progressing to acidosis. Hyponatremia can occur, but hyperkalemia and elevated carboxylic acid are less typical.",Hereditary metabolic disorders
['Homocystinuria due to cystathionine beta-synthase deficiency'],"1. Homocystinuria: Ectopia lentis, intellectual disability, long limbs, hyperhomocystinemia and hypermethioninemia are characteristic. Thromboembolism and osteoporosis were not mentioned.

2. Marfan syndrome: Ectopia lentis, long limbs, and intellectual disability can occur. Lacking aortic root dilation, scoliosis, and pectus deformity.

3. Sulfite oxidase deficiency: Intellectual disability, ectopia lentis, elevated methionine, and early death are consistent. Seizures, movement disorders, and brain atrophy are additional features.

4. Congenital disorders of glycosylation: Can present with multisystem issues including eye abnormalities, developmental delay, failure to thrive, and early mortality. Inverted nipples and abnormal fat pads are common features not reported here.

5. Stickler syndrome: Ocular findings and skeletal changes fit this diagnosis. midface hypoplasia, hearing loss, and joint problems are often seen as well. Intellectual disability would be atypical.",Hereditary metabolic disorders
[],"1. Leigh syndrome: Consistent with seizures, feeding difficulties, and early mortality. Key features not mentioned include developmental regression, muscle weakness, and lactic acidosis.

2. Zellweger syndrome: Matches facial dysmorphism, seizures, and neonatal/infant death. Other common symptoms include severe hypotonia, liver dysfunction, and vision/hearing impairment.  

3. Pyruvate dehydrogenase deficiency: Explains seizures, hypoglycemia, lactic acidosis, and early death. Developmental delay is another key feature.

4. Tay-Sachs disease: Fits with seizures, developmental regression, vision loss, and death in early childhood. Cherry-red spot on retinal exam is a hallmark sign.

5. Mucopolysaccharidosis type 1: Coarse facial features, sparse hair, frequent respiratory infections, and developmental delays are typical. Corneal clouding and skeletal abnormalities are also common.",Hereditary metabolic disorders
['Propionic acidemia'],"1. Propionic acidemia: Symptoms consistent with this diagnosis include intellectual disability, seizures, anemia, hyperammonemia, hepatomegaly, and death in infancy or childhood. Key features not mentioned include vomiting, lethargy, ketoacidosis, and odd odor.

2. Methylmalonic acidemia: Overlapping symptoms include intellectual disability, seizures, anemia, hepatomegaly, and death in infancy/childhood. Additional signs can include vomiting, dehydration, respiratory distress, and kidney problems.

3. Glycine encephalopathy (nonketotic hyperglycinemia): The patient's hyperglycinemia, intellectual disability, seizures, and early death fit with this condition. Other features may include hypotonia, apnea, and brain malformations.

4. Ornithine transcarbamylase deficiency: Hyperammonemia, intellectual disability, seizures, and death in infancy/childhood match this urea cycle disorder. Protein aversion and episodic vomiting are also common.

5. Glutaric acidemia type 1: While less likely, some consistent symptoms include intellectual disability, motor delay, seizures, and death in infancy/childhood. However, the patient lacks other classic signs like macrocephaly, dystonia, and basal ganglia degeneration.",Hereditary metabolic disorders
['Vitamin B12-unresponsive methylmalonic acidemia'],"1. Methylmalonic acidemia: Generalized hypotonia, metabolic acidosis, decreased methylmalonyl-CoA mutase activity, methylmalonic aciduria, thrombocytopenia, leukopenia, feeding difficulties, apnea, neonatal death. Key symptom not reported: Hyperammonemia.

2. Propionic acidemia: Generalized hypotonia, metabolic acidosis, thrombocytopenia, leukopenia, feeding difficulties, apnea, neonatal death. Key symptoms not reported: Hyperammonemia, ketoacidosis, hypoglycemia.

3. Severe combined immunodeficiency (SCID): Thrombocytopenia, leukopenia, feeding difficulties, death in infancy. Key symptoms not reported: Recurrent/opportunistic infections, failure to thrive, absent lymphoid tissue.

4. Zellweger syndrome (a peroxisomal disorder): Generalized hypotonia, abnormal nervous system physiology, feeding difficulties, apnea, neonatal death. Key symptoms not reported: Distinctive facial features, hepatomegaly, vision/hearing impairment.

5. Molybdenum cofactor deficiency: Generalized hypotonia, metabolic acidosis, feeding difficulties, apnea, neonatal death. Key symptom not reported: Seizures.",Hereditary metabolic disorders
['Systemic primary carnitine deficiency'],"1. Fatty acid oxidation disorder: Consistent with hypoglycemia, sudden death, decreased carnitine, and abnormal amino acids. May not explain the elevated alkaline phosphatase.

2. Organic acidemia (e.g. propionic acidemia, methylmalonic acidemia): Matches the symptoms of vomiting, hypoglycemia, coma, and abnormal amino acids. Elevated lactate and ketones may also be present but were not reported.

3. Urea cycle disorder: Could cause the vomiting, altered mental status, hypoglycemia, and abnormal amino acids. Typically presents with hyperammonemia which was not mentioned.

4. Mitochondrial disorder: The combination of hypoglycemia, elevated lactate dehydrogenase, and multi-system involvement could fit with a mitochondrial disease. Other symptoms may include muscle weakness, seizures, or organ dysfunction.

5. Glycogen storage disease: Certain types can present with hypoglycemia, elevated liver enzymes, and lactic acidosis. Hepatomegaly is often present but was not noted in this case. Abnormal amino acids would be less typical.",Hereditary metabolic disorders
['3-methylcrotonyl-CoA carboxylase deficiency'],"1. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: Lethargy, drowsiness, poor coordination, clumsiness, decreased plasma free carnitine. Can cause sudden death in infancy or childhood, especially with illness or fasting.

2. Very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency: Lethargy, drowsiness, poor coordination, decreased plasma free carnitine, feeding difficulties. Can present with cardiomyopathy or liver dysfunction.

3. Multiple acyl-CoA dehydrogenase deficiency (MADD) or glutaric aciduria type 2: Lethargy, drowsiness, poor coordination, decreased carnitine. Can have severe neonatal presentation with metabolic acidosis, hypoglycemia, and early death.

4. Mitochondrial disorder (e.g. Leigh syndrome, MELAS): Lethargy, drowsiness, poor coordination, neurological symptoms. Family history of early death is consistent. Lactate and pyruvate levels would likely be elevated.

5. Tay-Sachs disease: Lethargy, decreased coordination, neurological deterioration, death in childhood. Lacking hepatomegaly, cherry-red spot, and seizures typical of this condition.",Hereditary metabolic disorders
[],"1. Ethylmalonic encephalopathy: Characterized by delayed development, dysarthria, spasticity, seizures, ethylmalonic aciduria, and recurrent infections. Key features not reported include acrocyanosis, petechiae, chronic diarrhea.

2. MELAS syndrome (Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes): Explains developmental delays, spasticity, hyperreflexia, and COX-negative fibers. Other common symptoms include seizures, headaches, vomiting, hearing loss, diabetes.

3. Nonketotic hyperglycinemia: Presents with hypotonia, seizures, spasticity, and developmental delays. Elevated CSF and plasma glycine levels are diagnostic. Absence of seizures in this patient makes it less likely.

4. Cerebral folate deficiency: Can cause delayed development, spasticity, dysarthria, seizures, and recurrent infections. Low CSF levels of 5-methyltetrahydrofolate are diagnostic. Hypothyroidism is not typically seen.

5. Infantile spasm syndrome (West syndrome): Characterized by developmental delay, spastic quadriplegia, and clustered flexor spasms. EEG shows hypsarrhythmia. Hypothyroidism and metabolic abnormalities are not typical features.",Hereditary metabolic disorders
['Medium chain acyl-CoA dehydrogenase deficiency'],"1. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: Consistent with neonatal death, abnormal carnitine levels. May not explain prenatal abnormalities.

2. Carnitine palmitoyltransferase I (CPT I) deficiency: Matches abnormal carnitine concentration, neonatal death. Other symptoms can include hypoketotic hypoglycemia and liver problems.

3. Trisomy 18 (Edwards syndrome): Associated with prenatal abnormalities, high infant mortality. Additional symptoms often include growth deficiency, microcephaly, clenched fists.

4. Zellweger spectrum disorders: Consistent with abnormal prenatal development, neonatal issues, early death. May also have distinct facial features, seizures, liver dysfunction.

5. Smith-Lemli-Opitz syndrome: Matches prenatal abnormalities, possible neonatal complications. Other features can include microcephaly, cleft palate, syndactyly of the 2nd and 3rd toes.",Hereditary metabolic disorders
['Glutaryl-CoA dehydrogenase deficiency'],"1. Glutaric acidemia type 1: Characterized by macrocephaly, dystonia, dyskinesia, and episodes of metabolic decompensation triggered by illness. Glutaric aciduria and low plasma carnitine are hallmark lab findings. Can lead to death in infancy or childhood if untreated.

2. Canavan disease: A leukodystrophy causing macrocephaly, hypotonia, and developmental regression. Fever and metabolic acidosis can occur during acute decompensation episodes. Elevated N-acetylaspartic acid is a key diagnostic finding. Usually fatal in childhood.

3. Leigh syndrome: A mitochondrial disorder presenting with hypotonia, dystonia, developmental regression, and episodes of vomiting, dyspnea, and lethargy. Metabolic acidosis and fever are common. Symmetric brain lesions are seen on MRI. Prognosis is poor.

4. Tay-Sachs disease: Causes hypotonia, dyskinesia, exaggerated startle response, and developmental regression starting around 6 months old. Cherry-red spot on eye exam. Hexosaminidase A deficiency on enzyme testing. Usually fatal by age 4.

5. Alexander disease: Leukodystrophy characterized by macrocephaly, hypotonia, seizures, and developmental delays. Fever and vomiting can occur with illness. Protein deposits (Rosenthal fibers) in astrocytes. Can be fatal in infancy with severe neonatal form.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia type I: Characterized by hypertyrosinemia, this disorder causes severe liver disease, renal dysfunction, and neurological problems. Can be fatal in infancy or early childhood without treatment.

2. Phenylketonuria (PKU): Causes hyperphenylalaninemia and, if untreated, leads to intellectual disability, seizures, and behavioral problems. Rarely fatal in infancy but does cause neonatal issues and death in childhood/adolescence if untreated.  

3. Maple syrup urine disease: Disrupts metabolism of certain amino acids, leading to a toxic buildup. Presents in the neonatal period with poor feeding, vomiting, lethargy, and a characteristic sweet odor to the urine. Can rapidly progress to coma and death if untreated.

4. Zellweger spectrum disorders: Includes Zellweger syndrome, neonatal adrenoleukodystrophy, and infantile Refsum disease. Symptoms begin in infancy and include poor muscle tone, seizures, hearing and vision loss, and skeletal abnormalities. Often fatal in infancy or childhood.

5. Niemann-Pick disease type A: Causes enlargement of the liver and spleen (hepatosplenomegaly), failure to thrive, and progressive neurological deterioration. Symptoms appear around 3-6 months of age and progress rapidly, with death usually occurring by 2-3 years of age.",Hereditary metabolic disorders
['L-2-hydroxyglutaric aciduria'],"1. Krabbe disease: Matches the patient's developmental delays, intellectual disability, motor difficulties, hyperreflexia, and abnormal white matter. Key features not mentioned include vision loss, irritability, and peripheral neuropathy.

2. Metachromatic leukodystrophy: Explains the speech delays, cognitive impairment, gait abnormalities, hyperreflexia, and leukodystrophy on imaging. Additional symptoms can include behavior changes, seizures, and incontinence.

3. Canavan disease: Accounts for the developmental delays, intellectual disability, motor problems, early death, and abnormal cerebral white matter. Macrocephaly is a key feature not reported.

4. Alexander disease: The patient's speech and motor delays, intellectual impairment, hyperreflexia, and leukodystrophy fit. Seizures, macrocephaly, and autonomic dysfunction are other classic signs.

5. Pelizaeus-Merzbacher disease: Matches the delayed development, cognitive issues, motor dysfunction, hyperreflexia, and abnormal white matter. Nystagmus and ataxia are additional characteristic findings.",Hereditary metabolic disorders
['Maple syrup urine disease'],"1. Maple syrup urine disease (MSUD): Characterized by elevated branched-chain amino acids (valine, leucine, isoleucine), neurological symptoms like hypotonia and spasticity, hypoglycemia, and high mortality in untreated cases. The patient's apathy and obesity are also consistent with MSUD.

2. Isovaleric acidemia (IVA): Can present with hypotonia, developmental delays, hypoglycemia, and high mortality. Leucine levels may be mildly elevated. The patient did not have the characteristic ""sweaty feet"" odor often found in IVA.

3. Propionic acidemia: Features can include hypotonia, developmental delays, hypoglycemia, and early mortality. Hyperammonemia is common but was not reported in this patient.

4. 3-Methylcrotonyl-CoA carboxylase (3-MCC) deficiency: Can cause hypotonia, developmental delays, and hypoglycemia. Leucine levels may be slightly high. However, 3-MCC deficiency is usually not fatal in infancy or early adulthood.

5. Glutaric aciduria type II: Characterized by hypotonia, hypoglycemia, and high mortality. Organic acid levels are usually elevated, which was not reported here. Branched-chain amino acids are typically normal or only mildly increased in this disorder.",Hereditary metabolic disorders
['Classic galactosemia'],"1. Galactosemia: Explains the hypergalactosemia, liver dysfunction (increased bilirubin), aminoaciduria, and risk of early death. Speech delays and intellectual disability are common. Key symptom not reported: cataracts.

2. Tyrosinemia type I: Accounts for the elevated tyrosine, liver problems, and risk of early death. Can cause intellectual disability and developmental delays. Not specifically mentioned: renal tubular dysfunction, peripheral neuropathy.

3. Phenylketonuria (PKU): Characterized by high phenylalanine levels which can present as hyperalaninemia. Untreated PKU causes severe intellectual disability, developmental delays, and seizures. Missing symptom: musty body odor.

4. Fructose intolerance: A disorder of fructose metabolism that can present with liver dysfunction, aminoaciduria, and early mortality. Developmental delays are possible. Lacking symptom: aversion to sweets and fruits.

5. Niemann-Pick disease type C: A lysosomal storage disorder that can feature developmental delays, intellectual decline, liver dysfunction, and childhood death. Vertical gaze palsy is a hallmark sign not mentioned here.",Hereditary metabolic disorders
['3-hydroxy-3-methylglutaric aciduria'],"1. Propionic acidemia: Characterized by hyperammonemia, metabolic acidosis, and elevated 3-methylglutaric acid. Can present in infancy with poor feeding, vomiting, and lethargy progressing to coma. Glycine is often elevated.

2. Methylmalonic acidemia: Similar presentation to propionic acidemia with the added finding of methylmalonic acid in the urine. Can cause severe metabolic decompensation and death in infancy.

3. Isovaleric acidemia: Another organic acidemia that can present in the neonatal period with vomiting, acidosis, and hyperammonemia. Would expect to see isovalerylglycine in urine.

4. Glutaric acidemia type 2: A disorder of fatty acid oxidation and amino acid catabolism. Characterized by metabolic acidosis, hypoglycemia, dicarboxylic aciduria, and often death in infancy if untreated. 

5. Glycine encephalopathy: Most commonly presents in infancy with hypotonia, seizures, and apnea due to buildup of glycine. High levels of glycine are seen in plasma and CSF. Urine organic acids may show dicarboxylic aciduria.",Hereditary metabolic disorders
['Homocystinuria due to cystathionine beta-synthase deficiency'],"1. Cystathionine beta-synthase deficiency (Classical homocystinuria): Characterized by hyperhomocystinemia, neurologic abnormalities, and childhood mortality. Other features like lens dislocation and skeletal abnormalities were not reported.

2. Methionine adenosyltransferase deficiency: Causes hypermethioninemia, neurological symptoms, and liver dysfunction. However, this patient has hypomethioninemia rather than elevated methionine levels.

3. Disorders of cobalamin metabolism (e.g. methylmalonic acidemia): Can present with hypotonia, neurologic deterioration, anemia, and immunodeficiency. Specific metabolites like methylmalonic acid and homocysteine would need to be measured.

4. Congenital disorders of glycosylation: A group of disorders that can cause hypotonia, liver dysfunction, coagulopathy, and immunodeficiency. Additional findings may include failure to thrive and abnormal transferrin glycoforms.

5. Zellweger spectrum disorders (peroxisome biogenesis disorders): Characterized by hypotonia, liver dysfunction, and neurodevelopmental abnormalities. Elevated very long chain fatty acids and abnormal bile acid intermediates would support this diagnosis.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia type I: Hypertyrosinemia, abnormality of prenatal development, death in infancy/childhood; may not explain the airway symptoms

2. Phenylketonuria (PKU): Hyperphenylalaninemia, can cause intellectual disability and early death if untreated; does not typically cause airway obstruction 

3. Tracheal agenesis or severe tracheal stenosis: Congenital upper airway obstruction, chronic pulmonary obstruction, neonatal death; would not cause amino acid abnormalities

4. Surfactant protein deficiency: Chronic pulmonary obstruction, neonatal/childhood death; does not explain airway obstruction or metabolic disturbances

5. Zellweger spectrum disorder: Abnormality of prenatal development, neonatal death, chronic pulmonary obstruction, can be associated with amino acid abnormalities; may not cause frank airway obstruction",Hereditary metabolic disorders
['Biotinidase deficiency'],"1. Propionic acidemia: Consistent with seizures, spasticity, elevated urinary carboxylic acid, and potential for death in infancy. Key symptoms not reported include vomiting, lethargy, and ketoacidosis.

2. Methylmalonic acidemia: Matches the neurological symptoms, elevated urinary carboxylic acid, and risk of infant death. Additional symptoms may include vomiting, dehydration, and hepatomegaly.

3. Isovaleric acidemia: Aligns with the elevated urinary carboxylic acid and potential for severe, early-onset disease. Other symptoms often include vomiting, lethargy, and odor of ""sweaty feet.""

4. Glutaric acidemia type 1: Consistent with the neurological symptoms and elevated urinary carboxylic acid. Macrocephaly is a key feature not reported in this case.

5. Multiple carboxylase deficiency: A less common consideration, but could explain the elevated urinary carboxylic acid, neurological symptoms, alopecia, and fatigue. Dermatitis and conjunctivitis are additional characteristic symptoms.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia type I: Elevated tyrosine, liver dysfunction, risk of liver failure and early death. Other features like renal dysfunction and neurologic symptoms not reported.

2. Phenylketonuria (PKU): Elevated phenylalanine, can cause intellectual disability, seizures, and behavioral problems if untreated. Routine newborn screening usually detects classic PKU. Milder variants may escape early detection.

3. Maple syrup urine disease (MSUD): Disorder of branched-chain amino acid metabolism, presenting with poor feeding, vomiting, lethargy, and maple syrup odor to urine. Can be life-threatening if untreated. Specific amino acids not reported.

4. Urea cycle disorders: Defects in ammonia detoxification leading to hyperammonemia, altered mental status, seizures, coma, and death. Usually present in the neonatal period. Plasma ammonia level not provided.

5. Mitochondrial disorders: Can present with a wide range of symptoms and multi-system involvement. Some types associated with liver dysfunction and early death. Evaluation requires multiple biochemical and genetic tests.",Hereditary metabolic disorders
['Biotinidase deficiency'],"1. Propionic acidemia: Consistent with alopecia, metabolic acidosis, increased CSF lactate, aminoaciduria, and elevated urinary carboxylic acid. Can present in infancy. Lacking report of vomiting, lethargy, failure to thrive.

2. Methylmalonic acidemia: Matches alopecia, metabolic acidosis, increased CSF lactate, aminoaciduria, elevated urinary carboxylic acid. Onset often in infancy. Missing report of vomiting, dehydration, hepatomegaly.

3. Biotinidase deficiency: Aligns with skin rash, alopecia, metabolic acidosis, infant presentation. Would expect to see seizures, hypotonia, hearing loss.

4. Multiple carboxylase deficiency: Fits with skin rash, alopecia, metabolic acidosis, aminoaciduria, elevated urinary carboxylic acid. Typically presents with vomiting, lethargy, seizures in infancy.

5. Glutaric acidemia type 2: Consistent with skin rash, metabolic acidosis, aminoaciduria, elevated urinary carboxylic acid. Usually associated with congenital anomalies, hypoglycemia, cardiomyopathy.",Hereditary metabolic disorders
['Vitamin B12-unresponsive methylmalonic acidemia'],"1. Methylmalonic acidemia: Hallmark finding of decreased methylmalonyl-CoA mutase activity. Presents with lethargy, vomiting, dehydration, and feeding problems in the neonatal period. Can be life-threatening if untreated.

2. Propionic acidemia: Another organic acidemia that can present similarly to methylmalonic acidemia in neonates. Key distinguishing factor is the specific enzyme deficiency.

3. Urea cycle disorders: Group of conditions that cause hyperammonemia and can present with poor feeding, lethargy, and vomiting in the neonatal period. Additional key features not reported include respiratory alkalosis and neurologic abnormalities.

4. Galactosemia: Usually presents within the first few weeks of life with vomiting, jaundice, hepatomegaly, and E. coli sepsis. Feeding difficulties can occur but the other cardinal symptoms were not described.

5. Zellweger syndrome: Rare peroxisomal biogenesis disorder that can cause hypotonia, seizures, and early death. Feeding problems are common but characteristic dysmorphic features and liver dysfunction were not mentioned.",Hereditary metabolic disorders
['Biotinidase deficiency'],"1. Propionic acidemia: Caused by propionyl-CoA carboxylase deficiency, leading to buildup of propionic acid. Consistent with lethargy, hypotonia, metabolic acidosis, increased lactate, fever, and death in infancy if untreated. May also have hyperammonemia and pancytopenia.

2. Pyruvate carboxylase deficiency: Decreased pyruvate carboxylase activity results in lactic acidosis, hypotonia, lethargy, developmental delay, and failure to thrive. Can be rapidly progressive in infancy.

3. Methylmalonic acidemia: Defects in metabolism of certain amino acids cause methylmalonic acid buildup. Presents with lethargy, metabolic acidosis, hypotonia, failure to thrive, and rapid deterioration. May have pancytopenia, hyperammonemia, and ketoacidosis. 

4. Non-ketotic hyperglycinemia: Abnormal glycine metabolism leads to elevated glycine levels in blood and CSF. Characterized by lethargy, hypotonia, seizures, apnea, and rapid progression in infancy. EEG may show burst suppression pattern.

5. Multiple carboxylase deficiency: Defects in biotin metabolism impair multiple carboxylase enzymes. Features include hypotonia, lethargy, seizures, skin rash, alopecia, and metabolic acidosis. May also have hearing/vision problems and candidiasis.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia type I: Consistent with hypertyrosinemia, abnormality of prenatal development, and early death. May also have symptoms not reported like liver failure, kidney dysfunction, and rickets.

2. Phenylketonuria (PKU): Matches hyperphenylalaninemia and can cause abnormal development and intellectual disability if untreated. However, early death is less common than in tyrosinemia.

3. Maple syrup urine disease: Can cause neonatal death and severe neurological symptoms due to buildup of branched-chain amino acids. Characteristic odor of urine not reported.

4. Homocystinuria: Inborn error of methionine metabolism that can cause developmental delay, eye problems, and thromboembolic events. Can be fatal but less commonly in infancy compared to tyrosinemia.

5. Zellweger spectrum disorder: Peroxisomal biogenesis disorder causing abnormal development, hypotonia, seizures, and early death. May have additional symptoms like distinctive facial features and liver dysfunction.",Hereditary metabolic disorders
['3-hydroxy-3-methylglutaric aciduria'],"1. 3-Methylglutaconic aciduria type I: Caused by 3-methylglutaconyl-CoA hydratase deficiency. Consistent with patient's 3-methylglutaric aciduria, dicarboxylic aciduria, and elevated urinary carboxylic acid. Can present with neonatal death.

2. Glutaric acidemia type II: Caused by defects in electron transfer flavoprotein or its dehydrogenase. Leads to impaired fatty acid and amino acid oxidation. Matches dicarboxylic aciduria and early death. Would expect to see other abnormal metabolites as well.

3. Long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency: Disorder of long-chain fatty acid oxidation. Fits with dicarboxylic aciduria. Can cause severe neonatal presentation and early death. Expect to see abnormal acylcarnitine profile.

4. Propionic acidemia: Defect in propionyl-CoA carboxylase. Can present in infancy with lethargy, vomiting, metabolic acidosis, and early death. Causes elevated 3-hydroxypropionate and methylcitrate, which were not reported here.

5. Methylmalonic acidemia: Defect in methylmalonyl-CoA mutase. Also presents in infancy with vomiting, lethargy, failure to thrive, metabolic acidosis. Key finding of elevated methylmalonic acid was not reported in this case.",Hereditary metabolic disorders
['Wilson disease'],"1. Wilson's disease: Characterized by decreased ceruloplasmin and copper, increased urinary copper, liver dysfunction, and neuropsychiatric symptoms. Consistent with patient's presentation, though some classic features like Kayser-Fleischer rings not mentioned.

2. Hemochromatosis: Iron overload disorder that can cause liver disease, diabetes, and bronze skin pigmentation. While the patient has liver issues, their iron levels are low, making this diagnosis less likely.

3. Porphyria: Group of disorders causing abnormal porphyrin metabolism, with symptoms including abdominal pain, neurological issues, and photosensitivity. Patient's abnormal porphyrin levels fit, but more details on specific symptoms are needed.

4. Tyrosinemia type 1: Inherited disorder of tyrosine metabolism causing liver failure, kidney dysfunction, and peripheral neuropathy. Some overlap with patient's liver issues and early death, but other key features missing.

5. Glycogen storage disease type IV: Rare disorder involving defective glycogen synthesis, leading to liver cirrhosis, failure to thrive, and muscle weakness. Could explain some hepatic and metabolic abnormalities, but does not fully match patient's presentation.",Hereditary metabolic disorders
['Medium chain acyl-CoA dehydrogenase deficiency'],"1. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: Inborn error of fatty acid oxidation that can cause complications in the neonatal period including hypoglycemia, lethargy, seizures, and sudden death. Abnormal carnitine levels are often seen.

2. Carnitine uptake defect (CUD): Disorder of carnitine transport leading to low tissue and plasma carnitine levels. Can cause cardiomyopathy, muscle weakness, and episodes of hypoglycemia or sudden death in infancy.

3. Trisomy 18 (Edwards syndrome): Chromosomal disorder associated with severe developmental delays, multiple congenital anomalies, and high mortality in infancy. Intrauterine growth restriction and stillbirth are common.

4. Zellweger spectrum disorders: Group of peroxisomal biogenesis disorders causing severe neurological dysfunction, craniofacial abnormalities, and liver disease. Often fatal in infancy. May have abnormal very long-chain fatty acid levels.

5. Spinal muscular atrophy (SMA) type 0: Severe form of SMA with onset in prenatal period. Causes profound hypotonia, respiratory failure and death usually within 6 months. Decreased fetal movements in utero.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia type I: Characterized by hypertyrosinemia, can lead to liver failure and death in untreated infants and children. Does not typically cause immunodeficiency or hyperphenylalaninemia.

2. Phenylketonuria (PKU): Causes hyperphenylalaninemia and intellectual disability if untreated, but not usually death in infancy/childhood. Hypertyrosinemia and immunodeficiency are not typical features.  

3. Severe combined immunodeficiency (SCID): Can present with recurrent viral and other infections leading to death in infancy. May have secondary metabolic abnormalities but these are not classic findings.

4. Methylmalonic acidemia: A metabolic disorder that can cause severe illness and death in infancy/early childhood. While it can lead to secondary tyrosinemia, hyperphenylalaninemia is not characteristic.

5. Propionic acidemia: Another metabolic condition that can be life-threatening in infancy and cause complications like hyperammonemia. Tyrosine and phenylalanine levels may be secondarily affected but are not diagnostic hallmarks.",Hereditary metabolic disorders
['3-methylcrotonyl-CoA carboxylase deficiency'],"1. Propionic acidemia: Consistent with elevated urinary carboxylic acids. May also have ketosis and hyperammonemia which were not reported.

2. Methylmalonic acidemia: Also causes elevated urinary carboxylic acids. Patients often have metabolic acidosis, ketosis, and neutropenia in addition to the reported symptoms.

3. Non-ketotic hyperglycinemia: Explains the aminoaciduria and abnormal glycine levels. Patients typically have severe neurological symptoms starting in infancy which were not mentioned.

4. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: A disorder of fatty acid oxidation that causes abnormal carnitine levels. Episodes of hypoglycemia and hepatomegaly are common but were not reported.

5. Carnitine transporter deficiency: Leads to very low blood carnitine levels. Patients may have cardiomyopathy, hypoglycemia, and liver problems in addition to the carnitine deficiency.",Hereditary metabolic disorders
['Carbamoyl-phosphate synthetase 1 deficiency'],"1. Barth syndrome: Generalized hypotonia, 3-methylglutaconic aciduria, feeding difficulties, and risk of neonatal death are consistent with this rare X-linked mitochondrial disorder. Hepatomegaly and tachypnea can also occur. Neutropenia and cardiomyopathy are other key features not reported here.

2. Leigh syndrome: This mitochondrial disorder can present with hypotonia, tachypnea, feeding difficulties, and early death. 3-methylglutaconic aciduria has been reported in some cases. Hepatomegaly is less common. Other symptoms may include seizures, dystonia, and developmental regression.

3. Glutaric acidemia type 2: Generalized hypotonia, tachypnea, feeding problems, and risk of neonatal death fit with this organic acidemia. 3-methylglutaconic aciduria can be seen. Hepatomegaly is not typically a prominent feature. Characteristic odor and congenital anomalies are not mentioned here.

4. 3-methylglutaconic aciduria type 1: The elevated 3-methylglutaconic acid along with hypotonia, feeding issues, and early mortality match this disorder. Hepatomegaly and tachypnea are not classic features. Delayed development, seizures, and spasticity are often seen.

5. Congenital disorder of glycosylation type 1a: Feeding problems, hypotonia, hepatomegaly, and risk of early death are consistent. 3-methylglutaconic aciduria and tachypnea are not typically described. Other common features include abnormal fat pads, failure to thrive, and cerebellar hypoplasia.",Hereditary metabolic disorders
['Citrullinemia type I'],"1. Ornithine transcarbamylase (OTC) deficiency: Delayed development, hypoglycemia, hyperammonemia, respiratory alkalosis, and elevated plasma citrulline are consistent with this urea cycle disorder. Acute and chronic liver dysfunction can occur. Not typically associated with hyperhidrosis, pustules, or hypothermia.

2. Citrullinemia type I: Another urea cycle disorder that fits with the developmental delays, hyperammonemia, elevated citrulline, liver dysfunction, and potential for neonatal or childhood death. Additional symptoms like hypoglycemia and oroticaciduria can be seen.

3. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: Can present with hypoglycemia, lethargy, hepatic dysfunction, and risk of sudden death, especially in infancy or childhood. Developmental delays and hyperammonemia are less common features.  

4. Pyruvate dehydrogenase complex (PDHC) deficiency: Characterized by lactic acidosis, hypoglycemia, developmental delays, and potential liver abnormalities. Elevated citrulline and hyperammonemia would be less typical.

5. Glutaric aciduria type II: Can manifest with hypoglycemia, metabolic acidosis, liver enlargement and dysfunction, hypotonia, and risk of neonatal or infant death. Pustular skin lesions have been reported. Hyperammonemia, respiratory alkalosis, and elevated citrulline would be less common.",Hereditary metabolic disorders
['Glutaryl-CoA dehydrogenase deficiency'],"1. Glutaric acidemia type 1: Macrocephaly, seizures, hypotonia, athetosis, and glutaric aciduria are hallmark features. Can be fatal in infancy or early childhood if untreated.

2. Canavan disease: Macrocephaly, seizures, hypotonia, and visual impairment can occur. Urine organic acid testing would show elevated N-acetylaspartic acid.

3. Mitochondrial encephalomyopathy: Can present with hypotonia, seizures, and developmental regression. Specific findings depend on the genetic mutation. Elevated lactate and abnormal muscle biopsy are common.  

4. Infantile neuronal ceroid lipofuscinosis: Presents with seizures, vision loss, hypotonia, and rapid developmental regression in infancy. Lacks macrocephaly and movement disorder typically.

5. Alexander disease: Macrocephaly, seizures, hypotonia, and developmental delays with onset in infancy. MRI shows characteristic white matter abnormalities. Athetosis and aciduria would be atypical.",Hereditary metabolic disorders
['Tyrosinemia type 1'],"1. Tyrosinemia type 1: Characterized by hypertyrosinemia, 4-hydroxyphenylpyruvic aciduria, and elevated delta-aminolevulinic acid. Can cause liver failure, renal dysfunction, and neurological problems. Delayed development and risk of early death fit the patient's presentation.

2. Phenylketonuria (PKU): The abnormal phenylalanine concentration is the key finding pointing to PKU. Untreated PKU causes intellectual disability, delayed development, seizures, and behavioral problems. However, the patient's other symptoms (4-hydroxyphenylpyruvic aciduria, elevated delta-aminolevulinic acid) are not typical of PKU.

3. Hepatorenal tyrosinemia (tyrosinemia type 1 with renal involvement): This could explain the elevated delta-aminolevulinic acid (due to renal impairment) in addition to the other findings consistent with tyrosinemia type 1. 

4. Transient tyrosinemia of the newborn: A benign condition causing temporarily elevated tyrosine levels. However, this would not explain the patient's other symptoms and poor prognosis.

5. Hawkinsinuria: A rare disorder of tyrosine metabolism characterized by hypertyrosinemia and metabolic acidosis. Can be associated with failure to thrive in infancy. However, hawkinsinuria is generally considered a benign condition, so the patient's risk of childhood death would be unusual.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Phenylketonuria (PKU): Characterized by hyperphenylalaninemia, can cause irreversible intellectual disability, seizures, and early death if untreated. Patient's obesity is atypical but can occur in some cases.

2. Tyrosinemia type I: Presents with hypertyrosinemia, elevated urinary carboxylic acids, and can be fatal in infancy or childhood due to liver failure or hepatocellular carcinoma. Consistent with patient's profile.

3. Maple syrup urine disease (MSUD): Features poor feeding, lethargy, and maple syrup odor of urine and cerumen, progressing to coma and central respiratory failure if untreated. Can cause neonatal death. Elevated branched-chain amino acids would be expected in addition to patient's findings.

4. Glutaric acidemia type I: Causes elevated urinary carboxylic acids, hypotonia, dyskinesia, and brain atrophy, with risk of metabolic crisis and sudden death, especially in infancy. Additional symptoms may include macrocephaly and subdural hemorrhage.

5. 3-Methylcrotonyl-CoA carboxylase deficiency (3-MCC deficiency): Can present with elevated urinary carboxylic acids, hypotonia, seizures, and intellectual disability. Often asymptomatic between acute episodes. Patient's hypertyrosinemia and hyperphenylalaninemia would be atypical.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Phenylketonuria (PKU): Characterized by hyperphenylalaninemia, intellectual disability, seizures, and other neurological symptoms. The severe phenotype described could represent untreated classical PKU.

2. Tyrosinemia type II: Features hypertyrosinemia, intellectual disability, and short stature. The additional symptoms of seizures and early mortality suggest a particularly severe presentation. 

3. Mucopolysaccharidosis type III (Sanfilippo syndrome): A lysosomal storage disorder causing progressive neurodegeneration, hyperactivity, intellectual disability, seizures, and shortened lifespan. Coarse facial features and skeletal abnormalities may be present.

4. Niemann-Pick disease type C: Characterized by intellectual decline, seizures, and vertical gaze palsy. Visceral symptoms like hepatosplenomegaly are common. Prognosis is poor without treatment.

5. Mitochondrial disorder: The combination of neurological symptoms, growth failure, elevated metabolites, and multi-system involvement is consistent with a mitochondrial disorder, though the exact subtype would require further genetic and biochemical testing to elucidate. Many are associated with reduced life expectancy.",Hereditary metabolic disorders
['Vitamin B12-unresponsive methylmalonic acidemia'],"1. Methylmalonic acidemia: Characterized by methylmalonic acidemia/aciduria, metabolic acidosis, hyperammonemia, seizures, hypotonia, vomiting, and high mortality in infancy if untreated. May also cause neutropenia and thrombocytopenia.

2. Propionic acidemia: Another organic acidemia that can present similarly with metabolic acidosis, hyperammonemia, poor feeding, lethargy, hypotonia, and seizures in the neonatal period. Thrombocytopenia and neutropenia can occur. Key distinguishing factor from methylmalonic acidemia is lack of methylmalonic acid on labs.

3. Urea cycle disorders (e.g. CPS1 deficiency, OTC deficiency): Cause hyperammonemia and associated encephalopathy, seizures, hypotonia, and vomiting. However, the presence of methylmalonic acidemia/aciduria makes a urea cycle disorder less likely as the primary diagnosis here.

4. Glutaric acidemia type 1: Can present with metabolic acidosis, hypotonia, and seizures. Typically does not cause hematologic abnormalities like thrombocytopenia/leukopenia. Distinct urine organic acid profile with 3-hydroxyglutaric acid and glutaric acid.

5. Pyruvate dehydrogenase deficiency: Severe cases can manifest in infancy with lactic acidosis, metabolic acidosis, hypotonia, seizures, and failure to thrive. Absence of lactic acidosis and presence of methylmalonic acidemia makes this less likely here.",Hereditary metabolic disorders
['Medium chain acyl-CoA dehydrogenase deficiency'],"1. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: Consistent with neonatal death, abnormal carnitine levels. May not explain prenatal abnormalities.

2. Carnitine palmitoyltransferase I (CPT I) deficiency: Matches abnormal carnitine concentration, neonatal death. Other symptoms can include hypoketotic hypoglycemia and liver problems.

3. Trisomy 18 (Edwards syndrome): Associated with prenatal abnormalities, high infant mortality. Additional symptoms often include growth deficiency, microcephaly, clenched fists.

4. Zellweger spectrum disorders: Consistent with abnormal prenatal development, neonatal issues, early death. May also have distinct facial features, seizures, liver dysfunction.

5. Smith-Lemli-Opitz syndrome: Matches prenatal abnormalities, possible neonatal complications. Other features can include microcephaly, cleft palate, syndactyly of the 2nd and 3rd toes.",Hereditary metabolic disorders
['Vitamin B12-unresponsive methylmalonic acidemia'],"1. Methylmalonic acidemia: Caused by methylmalonyl-CoA mutase deficiency, leading to methylmalonic aciduria, metabolic acidosis, hyperammonemia, vomiting, and risk of death in infancy if untreated. May also have ketoacidosis, neutropenia, and pancytopenia which were not reported here.

2. Propionic acidemia: Another organic acidemia caused by propionyl-CoA carboxylase deficiency. Also presents with metabolic acidosis, hyperammonemia, vomiting in infancy. Would expect propionic aciduria rather than methylmalonic aciduria.

3. Holocarboxylase synthetase deficiency: Leads to multiple carboxylase deficiency, including methylmalonyl-CoA mutase. Presents similarly in infancy with metabolic acidosis, hyperammonemia, vomiting, and risk of death. Urine organic acids would show methylmalonic aciduria plus other abnormalities.  

4. Cobalamin defects (e.g. cblA, cblB, cblC, cblD): Disrupt synthesis of adenosylcobalamin, a cofactor for methylmalonyl-CoA mutase, leading to methylmalonic aciduria. Present similarly to isolated methylmalonic acidemia. Megaloblastic anemia may be present but was not reported.

5. Transient maternal B12 deficiency: Inadequate B12 transfer to the fetus can cause methylmalonic aciduria and symptoms that mimic an inborn error of metabolism. Maternal B12 levels and response to B12 supplementation help distinguish this.",Hereditary metabolic disorders
['Ornithine transcarbamylase deficiency'],"1. Ornithine transcarbamylase (OTC) deficiency: Matches the patient's hyperammonemia, seizures, cerebral edema, and high risk of neonatal/infant death. The orotic aciduria is a key finding that suggests OTC deficiency over other urea cycle disorders.

2. Citrullinemia type I (argininosuccinate synthetase deficiency): Can present similarly to OTC deficiency with hyperammonemia, neurological deterioration, and risk of death. However, the orotic aciduria is not typical.

3. Argininosuccinic aciduria (argininosuccinate lyase deficiency): Another urea cycle disorder that can cause neonatal hyperammonemia, seizures, and death. Orotic aciduria would be unusual.

4. Carbamoyl phosphate synthetase I deficiency: The most severe of the urea cycle disorders. Typically presents with hyperammonemia and rapid deterioration within the first few days of life. Orotic aciduria is not expected.

5. Pyruvate dehydrogenase complex deficiency: A mitochondrial disorder that can present in the neonatal period with seizures, encephalopathy, and lactic acidosis. However, would not expect to see the orotic aciduria.",Hereditary metabolic disorders
['Biotinidase deficiency'],"1. Menkes disease: Seizures, hypotonia, growth delay, death in infancy, alopecia. Key features not reported include hypopigmented or kinky hair, hypothermia, and bladder diverticula.

2. Biotinidase deficiency: Seizures, hypotonia, alopecia, developmental delay, metabolic acidosis. Hearing loss and skin rash are additional cardinal features.

3. Leigh syndrome: Seizures, hypotonia, growth delay, death in infancy, elevated urinary carboxylic acid. Other symptoms may include eye movement abnormalities, dystonia, and cardiomyopathy. 

4. Infantile neuroaxonal dystrophy: Seizures, hypotonia, growth delay, death in infancy. Rapid loss of skills, vision impairment, and abnormal eye movements are often seen.

5. Congenital disorder of glycosylation type 1a: Seizures, hypotonia, growth delay, death in infancy. Inverted nipples, abnormal fat distribution, and failure to thrive are additional hallmarks.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Alkaptonuria: Characterized by elevated blood tyrosine and phenylalanine, can also cause early arthritis and heart valve disease leading to premature mortality. Lacks the obesity and hypercholesterolemia seen in this patient.

2. Tyrosinemia type 1: Features hypertyrosinemia, liver dysfunction, renal tubular dysfunction, and risk of liver cancer at a young age. Does not typically involve obesity or hypercholesterolemia.

3. Niemann-Pick disease type B: Lipid storage disorder causing hepatosplenomegaly, hypercholesterolemia, and early mortality from liver failure or pulmonary disease. Elevated tyrosine and phenylalanine would be atypical.

4. Familial hypercholesterolemia: Causes very high LDL cholesterol and premature cardiovascular disease, but would not explain the elevated tyrosine and phenylalanine levels.

5. Glycogen storage disease type Ia: Leads to obesity, hypercholesterolemia, lactic acidosis, and liver adenomas with risk of early mortality. High tyrosine and phenylalanine are not characteristic features.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Smith-Lemli-Opitz syndrome: Characterized by hypospadias, growth retardation, intellectual disability, and abnormal cholesterol metabolism. Consistent with patient's hypospadias and severe short stature. May also have cleft palate and congenital heart defects, which were not reported.

2. Zellweger spectrum disorders: Group of rare metabolic disorders causing severe neurological dysfunction, liver disease, and early death. Fits with hypertyrosinemia, hyperphenylalaninemia, premature birth, and death in infancy. Other features may include seizures, hearing loss, and vision impairment.

3. Edwards syndrome (Trisomy 18): Chromosomal disorder associated with severe intellectual disability, growth deficiency, microcephaly, congenital heart defects, and early mortality. Matches severe short stature, premature birth, and neonatal/infant death. Would expect clenched fists and rocker-bottom feet as well.

4. Patau syndrome (Trisomy 13): Another chromosomal disorder characterized by severe intellectual disability, microcephaly, cleft lip/palate, congenital heart defects, and very limited life expectancy. Consistent with premature birth and early death. Polydactyly and eye defects are other common features.

5. Beckwith-Wiedemann syndrome: Overgrowth disorder that can cause omphalocele, macroglossia, hypoglycemia, and increased risk of certain childhood cancers. The reported hernia could represent an omphalocele. Premature birth is consistent, but severe short stature is not. Usually have macrosomia rather than growth retardation.",Hereditary metabolic disorders
['Smith-Lemli-Opitz syndrome'],"1. Smith-Lemli-Opitz syndrome: Microcephaly, intellectual disability, developmental delay, craniofacial abnormalities, syndactyly, short stature, and elevated 7-dehydrocholesterol are classic features. Additional features can include cleft palate, cardiac defects, and underdeveloped external genitalia in males.

2. Trisomy 18 (Edwards syndrome): Microcephaly, low-set ears, developmental delay, intellectual disability, short stature, and difficulty walking/climbing stairs can be seen. However, elevated dehydrocholesterol levels would be unusual. Other features may include clenched hands, rocker-bottom feet, and cardiac defects.

3. Cornelia de Lange syndrome: Microcephaly, developmental delay, intellectual disability, short stature, and hearing loss can occur. Craniofacial features may include synophrys (single eyebrow), long eyelashes, and thin downturned lips. Limb abnormalities are common but syndactyly would be atypical.

4. Rubinstein-Taybi syndrome: Intellectual disability, developmental delay, short stature, and craniofacial abnormalities can be seen. Typical facial features include downslanted palpebral fissures, broad thumbs and great toes, and a beaked nose. Strabismus and hearing loss may occur but elevated dehydrocholesterol levels would not be expected.

5. Seckel syndrome: Microcephaly, intellectual disability, developmental delay, and short stature are characteristic. A beak-like protrusion of the nose may be present. Skeletal abnormalities can include hip dysplasia and scoliosis. Biochemical abnormalities are not typical of this condition.",Hereditary metabolic disorders
['Glutaryl-CoA dehydrogenase deficiency'],"1. Glutaric acidemia type 1: The patient's neurological symptoms, glutaric aciduria, elevated glutaric acid, abnormal acylcarnitine profile, and decreased plasma carnitine are all consistent with this inborn error of lysine and tryptophan metabolism. Decompensation during acute illness is characteristic.

2. Leigh syndrome (subacute necrotizing encephalomyelopathy): Progressive neurological deterioration, ataxia, and death in childhood can be seen with this mitochondrial disorder. However, the specific biochemical findings are more suggestive of glutaric acidemia.

3. Propionic acidemia: Another organic acidemia that can present with neurological symptoms, metabolic decompensation, and hyperammonemia. The patient's glutaric aciduria points away from this diagnosis.

4. Infantile neuroaxonal dystrophy: Ataxia, athetosis, and progressive neurological deterioration are consistent, but this is a rare disorder and would not cause the metabolic abnormalities seen.

5. Molybdenum cofactor deficiency: Can cause intractable seizures, opisthotonus, and death in early infancy. Absence of seizures and presence of glutaric aciduria make this diagnosis less likely.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia type I: Autosomal recessive disorder causing hypertyrosinemia, failure to thrive, liver dysfunction, and risk of early death. Consistent with patient's hypertyrosinemia, abnormal development, hypotonia, and infant/neonatal death.

2. Phenylketonuria (PKU): Autosomal recessive disorder of phenylalanine metabolism causing hyperphenylalaninemia, intellectual disability, seizures, and musculoskeletal abnormalities if untreated. Matches patient's hyperphenylalaninemia, motor delay, hypotonia, and hip dysplasia. No report of fair complexion, eczema, or intellectual disability.

3. Peroxisomal biogenesis disorders (e.g. Zellweger syndrome): Autosomal recessive disorders impairing peroxisome function, causing abnormal development, hypotonia, skeletal abnormalities, and early death. Aligns with patient's presentation, but no report of hearing/vision impairment, seizures, or liver dysfunction.

4. Maple syrup urine disease: Autosomal recessive branched-chain amino acid disorder, causing poor feeding, lethargy, hypotonia, intellectual disability, and risk of metabolic decompensation and death. Some overlap with patient's symptoms, but no report of maple syrup odor to urine or episodic decompensation.

5. Smith-Lemli-Opitz syndrome: Autosomal recessive cholesterol synthesis disorder causing intellectual disability, hypotonia, failure to thrive, and multiple congenital anomalies. Matches some of patient's features, but no mention of characteristic facial features, cleft palate, heart defects, or genital abnormalities.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia type I: Hypertyrosinemia, seizures, hypotonia, and high mortality rate consistent; other features can include liver dysfunction and renal tubular acidosis

2. Phenylketonuria (PKU): Hyperphenylalaninemia, seizures, and intellectual disability consistent; fair hair and blue eyes, eczema, and musty body odor not reported

3. Zellweger spectrum disorder: Hypotonia, seizures, abnormal facial features, and neonatal issues consistent; hearing loss, vision problems, and liver dysfunction not mentioned

4. Maple syrup urine disease: Poor feeding, lethargy, seizures, opisthotonus, and high mortality consistent; characteristic urine odor not reported

5. Nonketotic hyperglycinemia: Hypotonia, seizures, apnea episodes, and high mortality consistent; hiccups and myoclonic jerks not specifically noted",Hereditary metabolic disorders
['Tyrosinemia type 1'],"1. Phenylketonuria (PKU): Characterized by intellectual disability, seizures, motor delay, and hyperphenylalaninemia. Other features can include autism, hyperactivity, and self-injurious behavior. The patient's elevated phenylalanine level is a key finding.

2. Tyrosinemia type I: Features acute liver failure, renal dysfunction, and neurological problems including intellectual disability, self-mutilation, and hyperactivity. The patient's hypertyrosinemia fits, but additional findings of liver disease and renal tubular dysfunction are not reported.

3. Lesch-Nyhan syndrome: An X-linked disorder of purine metabolism causing intellectual disability, self-mutilating behavior, motor delay, and hyperuricemia. Seizures and early death can occur. The patient's self-injury is characteristic, but uric acid levels are not mentioned.

4. Mucopolysaccharidosis type III (Sanfilippo syndrome): A lysosomal storage disorder with progressive neurodegeneration, causing intellectual decline, autistic behaviors, hyperactivity, and seizures. Early mortality is common. Lacking are coarse facial features and hepatomegaly typical of this condition.

5. Maple syrup urine disease: A disorder of branched-chain amino acid metabolism, presenting with poor feeding, vomiting, lethargy, intellectual disability, seizures, and a maple syrup odor to the urine. Can be life-threatening in infancy. The patient's elevated alanine could fit, but additional features of metabolic decompensation are not described.",Hereditary metabolic disorders
['Classic galactosemia'],"1: Galactosemia: The patient's hypergalactosemia, vomiting, and increased bilirubin are consistent with classic galactosemia, a disorder of galactose metabolism that can lead to liver damage, sepsis, and death if untreated. Missing symptoms include cataracts, jaundice, and hepatomegaly.

2: Hereditary fructose intolerance: Although less likely given the hypergalactosemia, this disorder can also present with vomiting, liver dysfunction, and early death. Additional symptoms may include hypoglycemia and aversion to sweets.

3: Tyrosinemia type 1: Another metabolic disorder that can cause liver failure, increased bilirubin, vomiting, and early death. However, characteristic symptoms like ""boiled cabbage"" odor and renal tubular dysfunction are not reported.

4: Niemann-Pick disease type A: This lysosomal storage disorder often presents in infancy with hepatosplenomegaly, jaundice, and failure to thrive, progressing rapidly to death. Vomiting and hypergalactosemia are not typical features.

5: Zellweger spectrum disorders: These peroxisomal biogenesis disorders can manifest with hypotonia, seizures, liver dysfunction, and early death. However, other characteristic features like distinctive facial features are not mentioned.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Phenylketonuria (PKU), severe form: Characterized by hyperphenylalaninemia and can cause intellectual disability, seizures, and death if untreated. Abnormality of prenatal development and neonatal death are consistent.

2. Tyrosinemia type I: Causes abnormal tyrosine levels and can lead to liver failure, kidney dysfunction, and neurological problems. Neonatal death is characteristic of the severe acute form.

3. Maple syrup urine disease (MSUD): Disrupts metabolism of branched-chain amino acids, causing a toxic buildup that leads to poor feeding, lethargy, seizures, coma and death in untreated neonates. Patient's symptoms fit but elevated branched-chain amino acids not specifically mentioned.

4. Nonketotic hyperglycinemia (NKH): Impairs glycine breakdown, causing lethargy, hypotonia, seizures and apnea in neonates. Can be rapidly progressive and fatal. Glycine levels not reported for this patient.

5. Multiple congenital anomalies-hypotonia-seizures syndrome (MCAHS): Rare condition causing prenatal developmental abnormalities, hypotonia, seizures and intellectual disability. Can be fatal in neonatal period but specific amino acid abnormalities not usually seen.",Hereditary metabolic disorders
['Biotinidase deficiency'],"1. Very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency: Characterized by obesity, carnitine deficiency, and high risk of early death due to cardiac or liver failure, especially triggered by fasting or illness. Key symptoms not reported include hypoglycemia, cardiomyopathy, and muscle weakness.

2. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: Causes impaired ability to break down medium-chain fats, leading to symptoms during fasting or stress. Consistent with reported early mortality risk, but obesity is less common. Additional symptoms may include vomiting, lethargy, seizures, and coma.

3. Carnitine palmitoyltransferase II (CPT II) deficiency: Leads to reduced ability to transport long-chain fatty acids for energy production. Matches reported carnitine abnormality and increased mortality risk. Other symptoms often include recurrent muscle pain and weakness, especially with exercise.

4. Glycogen storage disease type Ia (von Gierke disease): A glycogen storage disorder causing hypoglycemia, growth retardation, and early mortality risk. Consistent with reported childhood deaths, but obesity and carnitine abnormalities are less typical. Additional symptoms usually include enlarged liver, kidney dysfunction, and uric acid buildup.

5. Congenital generalized lipodystrophy: A rare condition of near total body fat loss, insulin resistance, and metabolic abnormalities. Matches reported altered fat metabolism and early mortality, but is inconsistent with obesity. Patients often have a distinct muscular appearance, enlarged liver, high blood sugar, and high triglycerides.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia type I: Characterized by hypertyrosinemia, intellectual disability, and high mortality in untreated patients. Other features can include liver dysfunction, renal tubular dysfunction, and neurological crises.

2. Phenylketonuria (PKU): Causes hyperphenylalaninemia and intellectual disability if untreated. Neonatal screening and early treatment can prevent severe symptoms. Patient's hypertyrosinemia and reported deaths would be atypical.

3. Tyrosinemia type II: Presents with hypertyrosinemia and intellectual disability, but is generally less severe than type I. Lacks the liver and kidney dysfunction and high mortality risk seen in this patient.

4. Hawkinsinuria: A rare disorder of tyrosine metabolism causing hypertyrosinemia, metabolic acidosis, and failure to thrive in infancy. Intellectual disability is not a typical feature.

5. Transient tyrosinemia of the newborn: A benign condition causing temporarily elevated tyrosine levels in neonates. Intellectual disability and early death would not be expected.",Hereditary metabolic disorders
['Smith-Lemli-Opitz syndrome'],"1. Smith-Lemli-Opitz syndrome: Characterized by the patient's multiple congenital anomalies, intellectual disability, failure to thrive, and elevated 7-dehydrocholesterol. The patient's neurological, eye, and skin findings are consistent. Severe cases can result in infant death.

2. Inborn error of metabolism (other than Smith-Lemli-Opitz): The patient's neurological symptoms, failure to thrive, skin findings, and metabolic abnormalities suggest a possible metabolic disorder, though the elevated 7-dehydrocholesterol points specifically to Smith-Lemli-Opitz. Further metabolic testing could evaluate for other disorders.

3. Chromosomal disorder (e.g. trisomy): Patient's multiple congenital anomalies, intellectual disability, and neurological findings could fit with a chromosomal abnormality. Would expect other structural birth defects. Karyotype or microarray could evaluate for this.

4. Congenital infection (e.g. CMV, toxoplasmosis): Microcephaly, intellectual disability, hearing loss, eye findings, and rash could be explained by a congenital infection. However, this would not account for the elevated 7-dehydrocholesterol.

5. Primary immunodeficiency: The patient's recurrent viral infections suggest immune dysfunction. However, a primary immunodeficiency would not typically cause multiple congenital anomalies, intellectual disability, or elevated 7-dehydrocholesterol.",Hereditary metabolic disorders
['Canavan disease'],"1. Canavan disease: Rare autosomal recessive leukodystrophy characterized by hypotonia, macrocephaly, seizures, and early death. Consistent with patient's hypotonia, cerebral atrophy, and death in infancy. Key features not reported include macrocephaly and seizures.

2. Maple syrup urine disease: Autosomal recessive disorder of branched-chain amino acid metabolism causing poor feeding, lethargy, hypotonia, and cerebral edema. Matches patient's hypotonia, cerebral atrophy, and abnormal amino acids. Typical symptoms not mentioned are maple syrup odor of urine and episodic metabolic decompensation.

3. Niemann-Pick disease type A: Lysosomal storage disorder causing hepatosplenomegaly, hypotonia, and psychomotor deterioration. Fits with hypotonia and early death. Expected features lacking are cherry-red spot on retinal exam and hepatosplenomegaly.

4. Zellweger syndrome: Peroxisomal biogenesis disorder with craniofacial dysmorphism, hypotonia, seizures, and hepatic dysfunction. Matches hypotonia, cerebral atrophy, and early death. Facial dysmorphism, seizures, and liver problems not noted.

5. Spinal muscular atrophy type 1: Autosomal recessive motor neuron disease with profound hypotonia, weakness, and respiratory failure. Consistent with hypotonia and death in infancy. Lacks expected areflexia and fasciculations. Strabismus and metabolic disturbance less typical.",Hereditary metabolic disorders
['Phenylketonuria'],"1+ Inborn error of metabolism: The patient's hypertyrosinemia and hyperphenylalaninemia, along with obesity, are consistent with an inherited metabolic disorder. The family history of early deaths also fits. Other symptoms would depend on the specific enzyme deficiency.

2+ Congenital heart disease: The patient's coarctation of the aorta is a major congenital heart defect. This can lead to heart failure, aortic rupture, and early death if not surgically repaired. The patient's history of pneumonia could be related to heart failure.

3+ Chromosomal disorder: A chromosomal abnormality or microdeletion syndrome could explain the patient's multiple congenital anomalies, intellectual disability (if present), and family history of early deaths. Genetic testing would be needed for diagnosis.

4+ Primary immune deficiency: The patient's history of fever and pneumonia could indicate an inherited immune system disorder. Some immune deficiencies can also affect other organs like the heart. Frequent or unusual infections would be expected.

5+ Prader-Willi syndrome: This is a rare genetic disorder characterized by obesity, intellectual disability, short stature, and other features. However, the patient's heart defect and metabolic issues are not typical of Prader-Willi syndrome.",Hereditary metabolic disorders
['Homocystinuria due to cystathionine beta-synthase deficiency'],"1. Classical homocystinuria: Characterized by elevated homocysteine and methionine, developmental delay, and early mortality if untreated. Matches the patient's aminoaciduria, hyperhomocystinemia, hypermethioninemia, and death in infancy/childhood.

2. Methionine adenosyltransferase deficiency: Causes elevated methionine and homocysteine, neurologic symptoms, and liver disease. Consistent with the patient's hypermethioninemia, hyperhomocystinemia, and potentially the prenatal abnormalities and childhood death.

3. Methylenetetrahydrofolate reductase (MTHFR) deficiency: Leads to hyperhomocysteinemia, neurologic deficits, and vascular complications. Matches the hyperhomocystinemia but missing other characteristic symptoms like seizures, microcephaly, and psychiatric disturbances.

4. Propionic acidemia: Can present with metabolic acidosis, hyperammonemia, developmental delay, and early death. The aminoaciduria fits but key symptoms of lactic acidosis and ketosis are not reported.

5. Ornithine transcarbamylase (OTC) deficiency: A urea cycle defect causing hyperammonemia, encephalopathy, and respiratory alkalosis. May explain the prenatal abnormalities and infant death but missing characteristic symptoms of vomiting, lethargy, and coma.",Hereditary metabolic disorders
[],"1. Dihydropyrimidine dehydrogenase deficiency: Autosomal recessive disorder causing deficient breakdown of pyrimidines. Consistent with patient's ataxia, hypotonia, elevated pyrimidines and uracil, and potential for early death. Seizures and intellectual disability also common but not reported here.

2. Dihydropyrimidinase deficiency: Autosomal recessive condition with deficient second step of pyrimidine degradation. Matches patient's ataxia, hypotonia, uraciluria, and elevated pyrimidines. However, this is usually less severe than dihydropyrimidine dehydrogenase deficiency.

3. Beta-ureidopropionase deficiency: Rare autosomal recessive disorder of pyrimidine metabolism. Fits with ataxia, hypotonia, abnormal pyrimidine levels and uraciluria. Additional features can include seizures, intellectual disability, and autistic behaviors.

4. Mitochondrial DNA depletion syndrome: Group of autosomal recessive disorders causing progressive multi-organ dysfunction. Some forms involve the brain and liver, consistent with neurological symptoms and metabolic abnormalities. However, specific pyrimidine defects are not typical.

5. Inborn error of pyrimidine synthesis (e.g. orotic aciduria): Disorders of pyrimidine synthesis are less likely here, as they typically cause blood cell abnormalities due to impaired DNA/RNA production. Neurological symptoms can occur but are not primary features.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia type I: Characterized by hypertyrosinemia, hyperphenylalaninemia, and early death if untreated. Can also cause liver failure, kidney dysfunction, and peripheral neuropathy.

2. Phenylketonuria (PKU): Causes hyperphenylalaninemia and intellectual disability if untreated, but not typically hypertyrosinemia. With early treatment, patients can have a normal lifespan.

3. Alkaptonuria: A rare disorder of tyrosine metabolism causing hypertyrosinemia and darkened urine, but normal phenylalanine levels. Leads to arthritis and heart valve problems but normal lifespan.

4. Tyrosinemia type II: Presents with hypertyrosinemia and eye/skin symptoms but normal phenylalanine and normal lifespan with treatment. Lacks the severe features seen in this patient.

5. Hawkinsinuria: An unusual disorder with hypertyrosinemia and metabolic acidosis. Transient in infancy and has good prognosis, inconsistent with this patient's early death.",Hereditary metabolic disorders
[],"1. Dihydropyrimidine dehydrogenase (DPD) deficiency: Consistent with death in infancy, neonatal death, respiratory insufficiency, abnormal pyrimidine levels, and uraciluria. May also cause seizures and neurological abnormalities not reported.

2. Zellweger spectrum disorder: Could explain infant death, respiratory issues, and multi-system abnormalities. Usually also involves distinctive facial features, liver dysfunction, and vision/hearing problems not mentioned.

3. Spinal muscular atrophy (SMA) type 0: Matches infant death and respiratory failure due to severe muscle weakness. Does not explain metabolic abnormalities.

4. Surfactant metabolism dysfunction, pulmonary: Rare lung disorders leading to progressive respiratory failure and early death. Specific metabolic changes and uraciluria less likely.

5. Severe combined immunodeficiency (SCID): Can result in early death from infections, but usually not immediately in the neonatal period. Metabolic abnormalities not typical.",Hereditary metabolic disorders
['Tyrosinemia type 1'],"1. Tyrosinemia type 1: Characterized by liver dysfunction, renal tubular dysfunction, and neurologic symptoms. Consistent with patient's hypertyrosinemia, liver abnormalities, ascites, anemia, and aminoaciduria.

2. Erythropoietic protoporphyria: Can present with photosensitivity, liver disease, and gallstones. Matches patient's abnormal porphyrin levels and liver dysfunction. Additional symptoms may include rash and red urine.

3. Biliary atresia: Causes neonatal obstructive jaundice and progressive liver damage. Explains elevated liver enzymes, ascites, hypoalbuminemia, and coagulopathy. Pale stools and dark urine would support this diagnosis.

4. Neonatal hemochromatosis: Leads to liver failure and can cause anemia, thrombocytopenia, hypoglycemia, and ascites as seen in this patient. Ferritin levels and liver biopsy would help diagnose.

5. Niemann-Pick disease type C: Lysosomal storage disorder causing hepatosplenomegaly, developmental delay, and neurologic symptoms. Could explain liver abnormalities and ascites. May have cherry-red spot on eye exam.",Hereditary metabolic disorders
['Canavan disease'],"1. Citrullinemia type I: Fits with the hyperammonemia, seizures, motor delay, and early death. The aspartate elevation is a key finding, as citrulline is made from aspartate in the urea cycle. Patients may lack other typical urea cycle disorder symptoms like vomiting and lethargy.

2. Argininosuccinic aciduria: Another urea cycle disorder that could explain the symptoms and aspartate elevation. Additional findings might include high citrulline, argininosuccinic acid elevations, and hyperammonemia. Trichorrhexis nodosa (abnormal hair) is sometimes seen.  

3. Canavan disease: A leukodystrophy causing progressive motor delay, seizures, and early death. Marked elevations in N-acetylaspartic acid (a derivative of aspartate) are diagnostic. Macrocephaly and white matter changes on brain MRI are common.

4. Aspartate-glutamate carrier deficiency: A very rare mitochondrial disorder that can present with seizures, motor delay and elevated aspartate. Patients may also have global developmental delay, hypotonia, and brain atrophy.

5. Molybdenum cofactor deficiency: Can cause seizures, motor delay and early death. Aspartate may be elevated along with sulfite, thiosulfate, S-sulfocysteine, and xanthine. Key features not reported include dysmorphic facies, ectopia lentis, and brain atrophy or cysts.",Hereditary metabolic disorders
['Isovaleric acidemia'],"1. Propionic acidemia: Consistent with neonatal/childhood death, vomiting, abdominal symptoms, body odor, and abnormal glycine. Key features not reported include hypotonia, seizures, and lethargy.

2. Methylmalonic acidemia: Matches death in infancy/childhood, GI symptoms, body odor, and abnormal glycine. Additional symptoms can include lethargy, hypotonia, and developmental delay.

3. Isovaleric acidemia: Aligns with vomiting, abdominal pain, body odor, and childhood mortality risk. Other symptoms may include lethargy, hypotonia, and seizures.  

4. Urea cycle disorders (e.g., CPS1 deficiency, OTC deficiency): Consistent with neonatal/childhood death, vomiting, and abnormal glycine. Patients may also exhibit lethargy, hypotonia, and respiratory alkalosis.

5. Severe combined immunodeficiency (SCID): Matches recurrent viral infections and risk of childhood death. However, does not readily explain the metabolic and GI abnormalities reported.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia type II: Characterized by hypertyrosinemia, intellectual disability, and elevated urinary carboxylic acids. However, this condition is not typically associated with hyperphenylalaninemia or early mortality.

2. Phenylketonuria (PKU): Features hyperphenylalaninemia and intellectual disability if untreated. However, PKU does not cause hypertyrosinemia, carboxylic aciduria, or death in adolescence/early adulthood when treated.

3. Hawkinsinuria: A rare disorder of tyrosine metabolism causing hypertyrosinemia, metabolic acidosis, and failure to thrive in infancy. However, it is not associated with hyperphenylalaninemia, intellectual disability, or early mortality.

4. Glutaric aciduria type I: An organic aciduria presenting with elevated urinary carboxylic acids, metabolic acidosis, and neurological deterioration, often leading to early mortality. However, amino acid abnormalities are not typical.

5. 3-Hydroxy-3-methylglutaryl-CoA lyase deficiency: A severe organic aciduria characterized by hypoketotic hypoglycemia, metabolic acidosis, elevated urinary carboxylic acids, intellectual disability, and early mortality. Amino acid abnormalities can occur secondarily. This condition most closely fits the patient's overall presentation.",Hereditary metabolic disorders
['Medium chain acyl-CoA dehydrogenase deficiency'],"1. Pyruvate dehydrogenase complex deficiency: Consistent with hyperalaninemia, abnormal carnitine, neonatal/childhood death. May also have lactic acidosis and neurological abnormalities.

2. Propionic acidemia: Features hyperalaninemia, abnormal carnitine, poor growth, and risk of early death. Severe cases can have hearing loss. Lactic acidosis and hyperammonemia may be present.  

3. Methylmalonic acidemia: Similar presentation to propionic acidemia with hyperalaninemia, abnormal carnitine, growth restriction, and early mortality risk. Can also involve hearing loss.

4. GRACILE syndrome: Rare condition featuring growth restriction, aminoaciduria, cholestasis, iron overload, lactic acidosis, and early death. Hearing impairment can occur.

5. Zellweger spectrum disorder: Includes prenatal growth restriction, metabolic abnormalities, and risk of infant death. Often involves liver dysfunction, vision/hearing impairment, and bone abnormalities. Lactic acidosis may be seen.",Hereditary metabolic disorders
['Ornithine transcarbamylase deficiency'],"1. Ornithine transcarbamylase (OTC) deficiency: Matches the patient's oroticaciduria, abnormal ornithine levels, neurological symptoms, and early death. A key feature not mentioned is hyperammonemia.

2. Carbamoyl phosphate synthetase I (CPS1) deficiency: Also fits the oroticaciduria, lethargy, and infant death. Would expect to see hyperammonemia and more significantly elevated plasma glutamine.

3. Citrullinemia type I: Could explain the neurological symptoms and early death. Typically causes elevated citrulline and hyperammonemia, which were not reported.

4. Argininosuccinic aciduria: Another urea cycle defect that matches the lethargy and infant death. Characteristic findings include elevated argininosuccinic acid and citrulline.

5. HHH syndrome (hyperornithinemia-hyperammonemia-homocitrullinuria): Fits the abnormal ornithine and neurological symptoms. Would also expect to see hyperammonemia and homocitrullinuria.",Hereditary metabolic disorders
['Glutaryl-CoA dehydrogenase deficiency'],"1. Glutaric acidemia type 1: Glutaric aciduria, ataxia, dystonia, abnormal cerebral morphology, abnormal myelination, and death in childhood are all consistent with this diagnosis. Decreased plasma carnitine is sometimes seen as well.

2. Propionic acidemia: Can present with metabolic acidosis, neurological symptoms, abnormal brain development, and risk of childhood death similar to this patient. However, glutaric aciduria is not typically seen.

3. Methylmalonic acidemia: Another organic acidemia that shares features with propionic acidemia and could explain many of the patient's symptoms. Glutaric aciduria would be unusual though.

4. Primary carnitine deficiency: The decreased plasma free carnitine raises this possibility. It can cause neurological symptoms and metabolic crises, but the degree of cerebral abnormalities and childhood mortality risk may be less severe than this patient's presentation.

5. Multiple acyl-CoA dehydrogenase deficiency (MADD): A fatty acid oxidation disorder that can lead to low carnitine, metabolic acidosis, neurological impairment, and risk of childhood death. The specific finding of glutaric aciduria would be atypical but has been reported in rare cases.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Phenylketonuria (PKU): Characterized by hyperphenylalaninemia and can lead to severe intellectual disability, seizures, and death if untreated in infancy. Consistent with this patient's hyperphenylalaninemia and neonatal death.

2. Defects in biopterin metabolism (e.g. dihydropteridine reductase deficiency): Can cause hyperphenylalaninemia and neurologic deterioration in infancy. May fit with hyperphenylalaninemia and neonatal death in this case.

3. Tyrosinemia type I: Another disorder of amino acid metabolism that can present with failure to thrive and death in infancy if untreated. Usually also have liver dysfunction and renal tubular dysfunction. Patient's hyperphenylalaninemia could be secondary to liver disease.

4. Maple syrup urine disease: Disorder of branched-chain amino acid metabolism presenting in the neonatal period with poor feeding, lethargy, and death if untreated. Urine has characteristic sweet odor. Hyperphenylalaninemia not typically seen.

5. Urea cycle disorders (e.g. ornithine transcarbamylase deficiency): Cause hyperammonemia and encephalopathy, often progressing rapidly in the neonatal period. Can be fatal if not promptly treated. Hyperphenylalaninemia is not a primary feature.",Hereditary metabolic disorders
['Systemic primary carnitine deficiency'],"1. Propionic acidemia: Symptoms consistent with this diagnosis include encephalopathy, cardiomyopathy, hypotonia, anemia, hypoglycemia, hepatomegaly, and elevated transaminases. Key features also include the decreased plasma carnitine and abnormal circulating amino acids. Vomiting is common during acute decompensation episodes.

2. Methylmalonic acidemia: Many of the patient's symptoms overlap with propionic acidemia and can be seen in methylmalonic acidemia, including encephalopathy, hypotonia, anemia, hypoglycemia, hepatomegaly, and elevated transaminases. Decreased plasma carnitine and abnormal circulating amino acids also fit. Additional symptoms that would support this diagnosis include renal dysfunction and pancytopenia.

3. Mitochondrial disorder: The brain, heart, and liver are commonly affected in mitochondrial disorders. Symptoms consistent with a mitochondrial disorder include encephalopathy, hypotonia, cardiomyopathy, hepatomegaly, hypoglycemia, and elevated transaminases. Vomiting and anemia can also occur. Other symptoms that would support a mitochondrial disorder include seizures, vision/hearing impairment, and lactic acidosis.

4. Urea cycle disorder: The patient's irritability, encephalopathy, hypotonia, vomiting, and elevated transaminases could be consistent with a urea cycle disorder. Hyperammonemia is a key feature of urea cycle disorders that is not reported here but would be expected. Anemia, cardiomyopathy and hepatomegaly are less common in urea cycle disorders.

5. Porphyria: The patient's neurological symptoms, abdominal pain (possibly the cause of irritability), and abnormal circulating porphyrins raise the possibility of porphyria. However, porphyria would be less likely to cause cardiomyopathy, hepatomegaly, hypoglycemia and the other metabolic abnormalities seen in this patient. Skin blistering and reddish urine are common symptoms of some porphyrias that are not mentioned here.",Hereditary metabolic disorders
['PMM2-CDG'],"1. Joubert syndrome: Characterized by cerebellar vermis hypoplasia, hypotonia, ataxia, abnormal eye movements, and developmental delays. Matches the patient's cerebellar dysfunction, eye findings, hypotonia, and delays. 

2. Pontocerebellar hypoplasia (PCH): A group of autosomal recessive disorders causing degeneration of the cerebellum and pons. Consistent with the patient's cerebellar atrophy/agenesis, generalized hypotonia, developmental delays, and poor prognosis.

3. Walker-Warburg syndrome: A congenital muscular dystrophy with brain and eye abnormalities. Fits with the patient's hypotonia, eye findings (possible retinal abnormalities), cerebellar malformation, developmental delays, and high infantile mortality.

4. Congenital disorder of glycosylation (CDG): A group of inherited metabolic disorders causing severe neurological dysfunction. Matches the patient's cerebellar atrophy, hypotonia, ataxia, strabismus, psychomotor retardation, and failure to thrive. Additional symptoms may include seizures and distinctive facial features.

5. Zellweger spectrum disorder: A peroxisomal biogenesis disorder characterized by craniofacial dysmorphism, neurological dysfunction, and multi-organ involvement. Consistent with the patient's hypotonia, nystagmus, psychomotor delays, and early mortality. May also have hearing and vision impairment, seizures, and liver dysfunction.",Hereditary metabolic disorders
['Homocystinuria due to cystathionine beta-synthase deficiency'],"1. Homocystinuria: Characterized by ectopia lentis, intellectual disability, developmental delay, hyperhomocystinemia, and aminoaciduria. The patient's dyskinesia and early mortality in some cases are also consistent. Lacking features like Marfanoid habitus and skeletal abnormalities.

2. Sulfite oxidase deficiency: Can present with ectopia lentis, intellectual disability, and early death. Hyperhomocystinemia and aminoaciduria may occur. Additional symptoms like seizures, movement disorders, and spasticity are not reported.

3. Marfan syndrome: Shares features of myopia, ectopia lentis, and intellectual disability in some cases. However, lacking other key features like tall stature, long limbs, scoliosis, and aortic root dilation. Hyperhomocystinemia and aminoaciduria are not typical.

4. Molybdenum cofactor deficiency: Can cause intellectual disability, developmental delay, ectopia lentis, and early death. Seizures and dysmorphic facial features are often present. Hyperhomocystinemia is not characteristic.

5. Lowe syndrome: X-linked disorder with intellectual disability, hypotonia, aminoaciduria, and eye abnormalities like cataracts and glaucoma. Ectopia lentis is less common. Hyperhomocystinemia and hypermethioninemia are not typical features.",Hereditary metabolic disorders
['Ornithine transcarbamylase deficiency'],"1. Ornithine transcarbamylase (OTC) deficiency: Hyperammonemia, seizures, lethargy, metabolic acidosis, and death in childhood/adolescence are consistent. Oroticaciduria is a key finding. Fever and diarrhea are not typical.

2. Propionic acidemia: Metabolic acidosis, hyperammonemia, lethargy, seizures, and death in childhood fit. Ataxia and hyperreflexia can occur. Oroticaciduria would be unusual.

3. Methylmalonic acidemia: Presents similarly to propionic acidemia with metabolic acidosis, hyperammonemia, lethargy, seizures, and death in childhood. Oroticaciduria is not expected.

4. Urea cycle disorders (other than OTC deficiency): Hyperammonemia, seizures, lethargy, and death in childhood/adolescence fit. Specific disorders like citrullinemia or argininosuccinic aciduria are possible. Ataxia, hyperreflexia, and oroticaciduria are less common.  

5. Mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS): Seizures, ataxia, lethargy, and metabolic acidosis fit. Fever and diarrhea could occur. Hyperammonemia and oroticaciduria would be unusual. Stroke-like episodes and lactic acidosis are not reported.",Hereditary metabolic disorders
['Smith-Lemli-Opitz syndrome'],"1. Smith-Lemli-Opitz syndrome: Characterized by intellectual disability, microcephaly, ptosis, syndactyly, failure to thrive, and elevated 7-dehydrocholesterol. Key features not reported include 2-3 toe syndactyly, hypospadias, and cleft palate.

2. Desmosterolosis: Presents with microcephaly, intellectual disability, strabismus, failure to thrive, and elevated desmosterol levels (related to 7-dehydrocholesterol). Lacking features include macrocephaly, frontal bossing, and joint contractures.

3. Lathosterolosis: Features intellectual disability, microcephaly, syndactyly, and elevated lathosterol (related to 7-dehydrocholesterol). However, also typically causes liver dysfunction and gallstones, which were not reported.

4. X-linked dominant chondrodysplasia punctata: Can cause microcephaly, intellectual disability, craniofacial abnormalities, and skeletal abnormalities. However, other expected features like chondrodysplasia punctata and skin lesions were not noted.

5. Congenital disorder of glycosylation type 1a: May explain failure to thrive, intellectual disability, hypotonia, ataxia, and hyperreflexia. However, lacks the characteristic cholesterol abnormalities and has additional features like inverted nipples and abnormal fat pads.",Hereditary metabolic disorders
['Glycogen storage disease due to glycogen debranching enzyme deficiency'],"1. Pyruvate dehydrogenase complex deficiency: Consistent with lactic acidosis, hypotonia, and early death. May also have seizures and brain abnormalities not reported here.

2. Mitochondrial DNA depletion syndrome: Fits with lactic acidosis, liver dysfunction, hypotonia and infantile death. Specific type would depend on organs involved and genetic mutations.

3. Fatty acid oxidation disorder (e.g. VLCAD deficiency, CPT II deficiency): Could explain hypertriglyceridemia, hepatomegaly, hypotonia, high CK and lactate. Usually also have low blood sugar and heart involvement.

4. Propionic or methylmalonic acidemia: Presents with lactic acidosis, hypotonia, abnormal amino acids, and can have early death. Typically also causes ketoacidosis and hyperammonemia.

5. Respiratory chain complex deficiency (e.g. Complex I, IV): Can have lactic acidosis, hypotonia, liver dysfunction, and infantile death. May have additional features like cardiomyopathy and distinct brain findings depending on the specific complex affected.",Hereditary metabolic disorders
['Glutaryl-CoA dehydrogenase deficiency'],"1. Glutaric acidemia type 1: Characterized by macrocephaly, progressive dystonia and athetosis, hypotonia, glutaric aciduria, and characteristic brain atrophy/lesions. Fits well with this patient's presentation.

2. Pyruvate dehydrogenase deficiency: Can present with microcephaly, hypotonia, lactic acidosis, and early death. Brain abnormalities and athetosis can occur. Elevated pyruvate and lactate levels would support this.

3. Propionic acidemia: Features can include hypotonia, movement disorders, metabolic acidosis, hyperammonemia, and early death. Microcephaly and brain atrophy are less common. Propionyl carnitine would be elevated.

4. Molybdenum cofactor deficiency: Causes microcephaly, neonatal seizures, and early death. Hypotonia and brain changes can be seen. Sulfite oxidase deficiency may co-occur. Urine sulfite and xanthine levels would be high.

5. Zellweger syndrome (a peroxisomal biogenesis disorder): Classic signs include profound hypotonia, distinctive facies, seizures, and early death. Microcephaly and brain abnormalities are typical. Elevated very long chain fatty acids would be expected.",Hereditary metabolic disorders
['Propionic acidemia'],"1. Propionic acidemia: Hyperammonemia, vomiting, death in infancy/childhood, abnormal carnitine and amino acids. May not explain ichthyosis.

2. Methylmalonic acidemia: Shares many features with propionic acidemia including hyperammonemia, vomiting, and biochemical abnormalities. Also does not typically cause ichthyosis.

3. Nonketotic hyperglycinemia: Explains hyperglycinemia and hyperglycinuria. Can cause infant death but hyperammonemia and ichthyosis would be atypical. 

4. Isovaleric acidemia: Another organic acidemia that can present with vomiting, hyperammonemia, and abnormal biochemical findings. Ichthyosis would be unusual.

5. Carnitine palmitoyltransferase II deficiency: Can cause infant death, hyperammonemia, and abnormal carnitine. Ichthyosis is not a typical feature. Hyperglycinemia would not be expected.",Hereditary metabolic disorders
['Succinic semialdehyde dehydrogenase deficiency'],"1. Glutaric acidemia type 1: Intellectual disability, motor delay, elevated urinary carboxylic acids. Can also cause macrocephaly and subdural hematomas which were not reported.

2. Propionic acidemia: Intellectual disability, abnormal facial shape, elevated blood and urine carboxylic acids, risk of early death. Episodes of metabolic decompensation and hyperammonemia would be expected.

3. 3-Methylcrotonyl-CoA carboxylase deficiency: Intellectual disability, elevated urinary 3-methylcrotonylglycine. Typically milder than other organic acidemias. Alopecia and skin rashes can occur but were not mentioned.

4. Menkes disease: Intellectual disability, abnormal facial shape, abnormal skull shape, death in childhood. Caused by copper transport defects. Steely hair, seizures, and blood vessel abnormalities are common features not reported here.

5. Mucopolysaccharidosis type II (Hunter syndrome): Intellectual disability, abnormal facial shape, death in childhood. Caused by lysosomal enzyme deficiency. Coarse facies, hepatosplenomegaly, joint contractures, and airway obstruction are typical signs that were not noted in this case.",Hereditary metabolic disorders
['Classic galactosemia'],"1. Galactosemia: Symptoms consistent with this diagnosis include hypergalactosemia, liver failure, prolonged PTT, intellectual disability, and death in infancy. Key symptoms not reported include cataracts and sepsis.

2. Tyrosinemia type 1: Fits with the liver failure, intellectual disability, abnormal amino acids, and early death. Additional symptoms can include renal dysfunction and peripheral neuropathy.

3. Ornithine transcarbamylase deficiency (urea cycle disorder): The patient's intellectual disability, liver failure, and early death align with this. Characteristic symptoms also include hyperammonemia and respiratory alkalosis.

4. Niemann-Pick disease type C: Explains the liver dysfunction, developmental delays, and premature death. Patients may also have vertical gaze palsy and cerebellar ataxia.

5. Zellweger spectrum disorder: Matches the patient's intellectual disability, liver dysfunction, and early death. Other features include vision/hearing impairment and facial dysmorphism.",Hereditary metabolic disorders
['Neonatal intrahepatic cholestasis due to citrin deficiency'],"1. Citrullinemia Type 1: Matches the patient's elevated citrulline, hyperammonemia, neonatal presentation, and high mortality. A key feature not mentioned is acute encephalopathy and coma.

2. Argininosuccinic aciduria: Also fits the hyperammonemia, elevated citrulline, and neonatal onset with high mortality. Would expect to see argininosuccinic acid in urine.

3. Hyperprolinemia Type 2: The abnormal proline level fits, though proline is usually only mildly elevated. Other features like seizures and intellectual disability were not described.

4. Pyruvate carboxylase deficiency: Can cause neonatal hyperammonemia and death as well as abnormal amino acid levels, though proline and citrulline are not typically the most prominent amino acids elevated.

5. Ornithine transcarbamylase deficiency: Another urea cycle defect that matches the hyperammonemia and high mortality, but would expect low citrulline and elevated ornithine and glutamine rather than high citrulline.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia type I: Hypertyrosinemia, liver dysfunction, and renal tubular dysfunction. Can be fatal in infancy and childhood without treatment. Patient did not report liver or kidney issues.

2. Phenylketonuria (PKU): Hyperphenylalaninemia leading to intellectual disability, seizures, and skin conditions if untreated. Strict dietary management is required. No mention of neurological symptoms or rash.

3. Hereditary hemochromatosis: Disorder of iron metabolism causing elevated ferritin and iron overload. Can lead to liver disease, diabetes, and heart failure. Patient has low rather than high ferritin.

4. Acute intermittent porphyria (AIP): Defect in heme synthesis leading to acute neurovisceral attacks. Elevated urine porphyrins and carboxylic acids during attacks. Usually presents in adulthood. Unclear if patient has acute attacks or neurological symptoms.

5. Methylmalonic acidemia: Disorder of organic acid metabolism causing elevated methylmalonic acid and hyperammonemia. Can present with failure to thrive, intellectual disability, and metabolic crises. Patient's age of onset fits but specific metabolites are not reported.",Hereditary metabolic disorders
['Maple syrup urine disease'],"1. Maple syrup urine disease (MSUD): Characterized by lethargy, hypotonia, tremor, opisthotonus, and drowsiness in the neonatal period. Elevated leucine levels and a distinctive sweet body odor are hallmarks. Can be fatal if untreated.

2. Propionic acidemia: Can present with lethargy, hypotonia, and death in infancy. Elevated urinary carboxylic acids are a key finding. Tremor and opisthotonus are less common but can occur.

3. Methylmalonic acidemia: Similar presentation to propionic acidemia with lethargy, hypotonia, and elevated urinary carboxylic acids. Can also cause death in infancy.

4. Isovaleric acidemia: Another organic acidemia that can cause lethargy, hypotonia, and a characteristic sweaty feet odor. Elevated urinary C5 carboxylic acid is diagnostic. Tremor and opisthotonus are not typical.

5. Glutaric aciduria type 1: Can present with hypotonia, lethargy, and a high-pitched cry in infancy. Opisthotonus and a characteristic ""sweaty feet"" odor may occur. Tremor is not a classic finding. Elevated urinary glutaric acid and 3-hydroxyglutaric acid aid diagnosis.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Hereditary tyrosinemia type 1: Characterized by hypertyrosinemia, hyperphenylalaninemia, liver dysfunction, renal tubular defects, and risk of early death. Key features not reported include liver failure, rickets, and neurologic crises.

2. Thalassemia major: Severe anemia requiring frequent transfusions, leading to iron overload which can cause endocrine abnormalities and death. Premature birth is not typical. Genetic testing would confirm.

3. Zellweger spectrum disorder: Generalized hypotonia, liver dysfunction, and early death are consistent. Can also have anemia, bone abnormalities, and hearing/vision problems. Lacks hypertyrosinemia and hyperphenylalaninemia.

4. Congenital toxoplasmosis: Pregnancy exposure can lead to hydrocephalus, seizures, eye abnormalities, and developmental delays. Anemia and metabolic abnormalities are less common features.

5. Vitamin D-dependent rickets type 1A: Characterized by hypocalcemia, hypophosphatemia, elevated alkaline phosphatase, and rickets/osteomalacia leading to bone deformities and hypotonia. Hypertyrosinemia and neonatal death are not typical.",Hereditary metabolic disorders
['Smith-Lemli-Opitz syndrome'],"1. Smith-Lemli-Opitz syndrome: Consistent with facial dysmorphism, developmental delays, behavioral issues, skeletal anomalies, and elevated 7-dehydrocholesterol. Missing typical 2-3 toe syndactyly.

2. Inborn error of cholesterol metabolism (other than SLOS), e.g. desmosterolosis: Explains abnormal cholesterol levels and potentially some developmental issues. Less likely to cause the facial and skeletal features seen.

3. Cornelia de Lange syndrome: Could explain facial features, growth and developmental delays, and behavioral problems. However, cholesterol abnormalities are not typical. Usually see more significant limb defects.

4. Chromosomal disorder, e.g. partial trisomy: Depending on the specific chromosomes involved, could cause a similar constellation of dysmorphic features and delays. Less likely to target cholesterol pathways specifically.

5. CHARGE syndrome: Associated with dysmorphic features, developmental delays, and sensory impairments. Can have limb anomalies but cholesterol abnormalities would be atypical. Usually see coloboma and choanal atresia.",Hereditary metabolic disorders
['Vitamin B12-unresponsive methylmalonic acidemia'],"1. Methylmalonic acidemia: The patient's methylmalonic acidemia, aciduria, and decreased methylmalonyl-CoA mutase activity are diagnostic of this condition. Other consistent symptoms include intellectual disability, motor delay, failure to thrive, metabolic acidosis, hyperammonemia, and acute kidney injury. Typical symptoms not reported include pancreatitis and optic nerve atrophy.

2. Propionic acidemia: Features consistent with propionic acidemia include intellectual disability, hypotonia, failure to thrive, anemia, metabolic acidosis, hyperammonemia, hypoglycemia, and acute kidney injury. However, the patient's methylmalonic acidemia and aciduria are more specific for methylmalonic acidemia.

3. Cobalamin C, D, or F deficiency: These disorders can cause methylmalonic acidemia and aciduria, intellectual disability, failure to thrive, anemia, metabolic strokes, and renal disease. Additional findings may include homocystinuria, megaloblastic anemia, and retinopathy.  

4. Glycine encephalopathy: The patient's hyperglycinemia, hyperglycinuria, intellectual disability, hypotonia, and failure to thrive could suggest glycine encephalopathy. However, this would not explain the methylmalonic acidemia and aciduria.

5. Glutaric acidemia type 1: Some symptoms that overlap with the patient's presentation include intellectual disability, motor delay, hypotonia, failure to thrive, and metabolic acidosis. Key features not reported are macrocephaly, dystonia, and glutaric aciduria.",Hereditary metabolic disorders
[],"1. Dihydropyrimidine dehydrogenase deficiency: Characterized by ataxia, hypotonia, lethargy, intellectual disability, seizures, and uraciluria. Can be fatal in infancy without treatment.

2. Dihydropyrimidinase deficiency: Symptoms include hypotonia, drowsiness, developmental delay, and abnormal uracil levels. Fewer than 20 cases reported worldwide.

3. Beta-ureidopropionase deficiency: Rare disorder causing intellectual disability, hypotonia, ataxia, and abnormal pyrimidine levels. Symptoms present in infancy.

4. Hereditary orotic aciduria: Pyrimidine synthesis disorder leading to hypotonia, developmental delay, and orotic acid crystalluria. Anemia and immune deficiency also occur.

5. Mitochondrial DNA depletion syndrome: Group of disorders causing progressive muscle weakness, hypotonia, and organ dysfunction. Can be fatal in infancy. Some forms impact pyrimidine metabolism.",Hereditary metabolic disorders
['Isovaleric acidemia'],"1. Propionic acidemia: Consistent with hyperammonemia, abnormal glycine, and high mortality. May also have ketoacidosis and hypoglycemia.

2. Methylmalonic acidemia: Also features hyperammonemia, metabolic acidosis, and high mortality. Elevated methylmalonic acid levels would support this diagnosis.

3. Nonketotic hyperglycinemia: Hallmark is abnormally high glycine levels. Also associated with neonatal onset, encephalopathy, and high mortality. Absence of metabolic acidosis would favor this over an organic acidemia.

4. Carnitine uptake defect: The abnormal carnitine levels fit, as does the potential for life-threatening episodes. However, this alone would not explain the hyperammonemia and glycine abnormality.

5. Ornithine transcarbamylase deficiency: An X-linked urea cycle defect that can present with hyperammonemia and high mortality, especially in males. However, the glycine and carnitine abnormalities are less typical.",Hereditary metabolic disorders
['Biotinidase deficiency'],"1. Propionic acidemia: Characterized by seizures, hypotonia, elevated urinary propionylcarnitine and methylcitrate, and often presents in the neonatal period with risk of death if untreated. Patient's symptoms fit this diagnosis.

2. Methylmalonic acidemia: Also presents with seizures, hypotonia, and elevated methylmalonic acid in urine. Can be life-threatening in infancy without treatment. Matches patient's presentation.

3. Isovaleric acidemia: Another organic acidemia with symptoms of seizures, hypotonia, and a characteristic ""sweaty feet"" odor. Elevated isovalerylcarnitine and isovalerylglycine in urine. Patient's symptoms consistent but odor not mentioned.

4. Glutaric acidemia type 1: Characterized by hypotonia, dystonia, and risk of striatal injury during acute decompensation. Elevated glutaric acid in urine. Some similarities to patient's presentation but dystonia not reported.

5. Multiple carboxylase deficiency: Presents with seizures, hypotonia, and elevated multiple carboxylic acids (e.g. 3-hydroxyisovaleric acid, 3-methylcrotonylglycine) in urine due to defects in biotin metabolism. Fits patient's symptoms and lab findings.",Hereditary metabolic disorders
['Medium chain acyl-CoA dehydrogenase deficiency'],"1. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: Consistent with decreased plasma carnitine and 3-hydroxyacyl-CoA dehydrogenase. Can present with hypoglycemia, lethargy, seizures, and sudden death in infancy or childhood, especially during illness or fasting. Patient did not report episodes of hypoglycemia or seizures.

2. Very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency: Matches decreased plasma carnitine and 3-hydroxyacyl-CoA dehydrogenase. Severe neonatal-onset form can cause cardiomyopathy, hypotonia, hypoglycemia, and early death. Cardiomyopathy and hypotonia not mentioned in this patient.

3. Long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency: Aligns with decreased 3-hydroxyacyl-CoA dehydrogenase. Characterized by hypoglycemia, cardiomyopathy, hypotonia, and liver dysfunction. Can be fatal in infancy or early childhood. Hypoglycemia, cardiomyopathy and liver issues not reported.

4. Carnitine transporter deficiency (primary carnitine deficiency): Consistent with low plasma carnitine. Causes episodes of hypoglycemia, hepatic encephalopathy, cardiomyopathy, and muscle weakness. Can progress to sudden infant death. No mention of hepatic encephalopathy or cardiomyopathy.

5. Trifunctional protein deficiency: Rare disorder of fatty acid oxidation causing decreased 3-hydroxyacyl-CoA dehydrogenase. Severe neonatal presentation with hypoglycemia, cardiomyopathy, liver dysfunction, and early death. Milder forms with later-onset myopathy and neuropathy. Hypoglycemia and cardiomyopathy not noted.",Hereditary metabolic disorders
['Maple syrup urine disease'],"1. Maple syrup urine disease (MSUD): Symptoms consistent with MSUD include metabolic acidosis, feeding difficulties, body odor, neurological symptoms like seizures, hypotonia, and spasticity, and risk of infant death. Key symptoms also reported include the specific amino acid elevations (hypervalinemia, hyperleucinemia, hyperisoleucinemia).

2. Propionic acidemia: Matches the patient's symptoms of metabolic acidosis, feeding difficulties, hypotonia, seizures, and risk of death in infancy. Episodes of dyspnea, apnea, and opisthotonus also fit. Additional symptoms of propionic acidemia can include cardiomyopathy and pancytopenia.

3. Methylmalonic acidemia: Also features metabolic acidosis, feeding problems, hypotonia, seizures, and high mortality in infancy. Matches the respiratory and neurological symptoms reported. Other symptoms not mentioned can include vomiting, dehydration, lethargy, and intellectual disability in survivors.

4. Isovaleric acidemia: The body odor is a key feature, along with feeding difficulties, seizures, and risk of infant death. Hypotonia and respiratory symptoms are common. Additional symptoms can include vomiting, lethargy, and coma.

5. Glutaric acidemia type 1: Characterized by metabolic acidosis, hypotonia, spasticity, seizures, feeding problems, and high mortality. The motor delay and spastic diplegia/tetraplegia are consistent. Macrocephaly is a key feature not reported in this patient.",Hereditary metabolic disorders
['Propionic acidemia'],"1. Propionic acidemia: Intellectual disability, osteoporosis, anemia, hyperammonemia, abnormal carnitine, body odor, early mortality. Does not explain the hearing loss or porphyrin abnormality.

2. Methylmalonic acidemia: Intellectual disability, osteoporosis, anemia, renal dysfunction, hyperammonemia, abnormal carnitine, early mortality. Does not account for hearing loss, porphyrin or glycine abnormalities.  

3. Homocystinuria: Intellectual disability, osteoporosis, kyphoscoliosis, short stature, early mortality. Does not explain the hearing impairment or abnormal lab values.

4. Alkaptonuria: Kyphoscoliosis, osteoporosis, hearing loss. Does not account for the majority of the patient's symptoms including intellectual disability, metabolic abnormalities or early death.

5. Multiple carboxylase deficiency (biotinidase deficiency): Intellectual disability, osteoporosis, hearing loss, metabolic acidosis, organic aciduria, hyperammonemia. Shortened lifespan possible. Does not specifically explain anemia, porphyrin or glycine abnormalities.",Hereditary metabolic disorders
['L-2-hydroxyglutaric aciduria'],"1. L-2-hydroxyglutaric aciduria: The patient's intellectual disability, seizures, ataxia, tremor, and confirmed L-2-hydroxyglutaric aciduria are all consistent with this rare neurometabolic disorder. The condition typically presents in childhood with progressive neurological deterioration.

2. Canavan disease: This leukodystrophy can cause intellectual disability, seizures, and early death. However, the patient's ataxia, tremor, and L-2-hydroxyglutaric aciduria are not typical of Canavan disease.

3. Glutaric aciduria type 1: Intellectual disability and seizures can occur, but this disorder more commonly causes macrocephaly and dystonia rather than ataxia and tremor. L-2-hydroxyglutaric aciduria would not be expected.

4. Mitochondrial encephalomyopathy: Various mitochondrial disorders can present with intellectual disability, seizures, ataxia, and other neurological deficits. However, L-2-hydroxyglutaric aciduria is not a feature of mitochondrial disease.

5. Rett syndrome: This condition can cause intellectual disability, seizures, and early mortality in childhood. However, it primarily affects girls and is characterized by repetitive hand movements and regression after initial normal development, which were not described in this patient. L-2-hydroxyglutaric aciduria is also not associated with Rett syndrome.",Hereditary metabolic disorders
['Canavan disease'],"1. Argininosuccinic aciduria: Characterized by elevated argininosuccinic acid, ammonia, and citrulline levels. Causes developmental delay, seizures, and early death if untreated. Consistent with the patient's motor delay and death in infancy.

2. Citrullinemia type I: Deficiency of argininosuccinate synthetase leading to elevated citrulline and ammonia. Presents with lethargy, poor feeding, seizures, coma and death in the neonatal period. Matches the patient's early death and likely motor delay.

3. Maple syrup urine disease: Disorder of branched-chain amino acid metabolism causing elevated levels of leucine, isoleucine, and valine. Leads to poor feeding, lethargy, developmental delay, and death if untreated. Aligns with motor delay and death, but patient is not reported to have the characteristic maple syrup odor.

4. Pyruvate dehydrogenase deficiency: Impairs aerobic metabolism and leads to elevated lactate and pyruvate. Causes developmental delay, hypotonia, seizures and early death. Fits with motor delay and death, but lactate and pyruvate levels are not mentioned.

5. Nonketotic hyperglycinemia: Glycine accumulation in the brain due to defects in the glycine cleavage system. Results in hypotonia, seizures, apnea, coma and early death. Consistent with motor delay and early death, but patient's glycine levels are not noted.",Hereditary metabolic disorders
['Citrullinemia type I'],"1. Citrullinemia type I: Elevated plasma citrulline, hyperammonemia, death in infancy
2. Ornithine transcarbamylase (OTC) deficiency: Hyperammonemia, increased total bilirubin, neonatal death. Plasma citrulline may not be as high as in citrullinemia.
3. Carbamoyl phosphate synthetase I (CPS1) deficiency: Hyperammonemia, neonatal death. Citrulline would be low/absent in contrast to this patient.  
4. Propionic acidemia (severe neonatal form): Hyperammonemia, increased total bilirubin, neonatal death. Plasma citrulline not typically elevated.
5. Methylmalonic acidemia (severe neonatal form): Hyperammonemia, neonatal death. Increased methylmalonic acid rather than citrulline would be expected.",Hereditary metabolic disorders
['3-hydroxy-3-methylglutaric aciduria'],"1. Propionic acidemia: Lethargy, metabolic acidosis, hypoglycemia, hyperammonemia, vomiting, hepatomegaly, 3-methylglutaric aciduria, and elevated urinary carboxylic acid are all consistent. May also have neutropenia and thrombocytopenia (not reported).

2. Methylmalonic acidemia: Shares many features with propionic acidemia including lethargy, metabolic acidosis, hypoglycemia, hyperammonemia, vomiting, hepatomegaly, and elevated urinary carboxylic acid. Presence of megaloblastic anemia would further support this diagnosis.

3. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: Lethargy, hypoglycemia, vomiting, and hepatomegaly fit, as do the dicarboxylic aciduria and elevated urinary carboxylic acid. Absence of metabolic acidosis and hyperammonemia would be unusual. Hypoketotic hypoglycemia is a key feature.

4. Glutaric acidemia type 1: Presents with metabolic acidosis, hypoglycemia, hepatomegaly, and elevated urinary carboxylic acid. Characteristic neuroimaging findings of fronto-temporal atrophy and basal ganglia injury were not mentioned. 

5. Multiple acyl-CoA dehydrogenase deficiency (MADD): Can explain the lethargy, metabolic acidosis, hypoglycemia, vomiting, hepatomegaly, sleep disturbance, dicarboxylic aciduria and elevated urinary carboxylic acid. Muscle weakness and pain are common but not reported here.",Hereditary metabolic disorders
['Cystinuria'],"1. Niemann-Pick disease type A: Characterized by hepatosplenomegaly, failure to thrive, and progressive neurodegeneration leading to death usually by 3 years of age. Consistent with patient's splenomegaly and death in infancy. May have cherry-red spot on retinal exam.

2. Zellweger spectrum disorders: Group of rare congenital disorders causing severe neurological dysfunction, seizures, vision/hearing impairment, and liver dysfunction. Often fatal in infancy or early childhood. Matches patient's seizures, early death, and multi-organ involvement.

3. Krabbe disease (globoid cell leukodystrophy): Autosomal recessive lysosomal storage disorder causing progressive neurologic deterioration. Infantile form presents with irritability, seizures, feeding difficulties, vision loss, and death usually by age 2. Explains patient's seizures and early death.

4. Alpers syndrome: Rare neurologic disorder causing progressive cerebral degeneration, refractory seizures, liver dysfunction, and respiratory compromise. Typically presents in infancy or early childhood. Matches patient's seizures, respiratory issues, and death in infancy. 

5. Mitochondrial DNA depletion syndromes: Group of autosomal recessive disorders causing progressive multi-organ dysfunction due to impaired mitochondrial function. Can present with seizures, respiratory failure, and early death. May have liver failure or dysfunction of other organs/systems.",Hereditary metabolic disorders
['Vitamin B12-unresponsive methylmalonic acidemia'],"1. Methylmalonic acidemia: Intellectual disability, motor delay, hypotonia, hyperammonemia, feeding difficulties, methylmalonic aciduria. May not explain the amino acid abnormalities.

2. Propionic acidemia: Intellectual disability, hypotonia, hyperammonemia, vomiting, feeding issues, methylmalonic aciduria. Hypervalinemia and isoleucine abnormalities are consistent.  

3. Isovaleric acidemia: Intellectual disability, hypotonia, hyperammonemia, vomiting, failure to thrive. Characteristic odor not mentioned. Valine and other amino acid abnormalities fit.

4. 3-Methylcrotonyl-CoA carboxylase deficiency: Intellectual disability, hypotonia, hyperammonemia, feeding problems, methylmalonic aciduria. Isoleucine abnormalities are consistent.

5. Multiple carboxylase deficiency (biotinidase deficiency): Intellectual disability, hypotonia, hyperammonemia, skin rash (not mentioned), hearing loss (not mentioned). Organic aciduria fits but amino acid abnormalities unexplained.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia type I: Hypertyrosinemia, elevated urinary succinylacetone (a carboxylic acid), can cause early death and increased susceptibility to infections. Hyperphenylalaninemia is not typically seen.

2. Maple syrup urine disease: Causes elevated branched-chain amino acids and their ketoacids (carboxylic acids), can present with recurrent infections, early death possible in severe cases. Hypertyrosinemia and hyperphenylalaninemia are not expected.

3. Methylmalonic acidemia: Elevated methylmalonic acid (a carboxylic acid), can cause recurrent infections and early death. Hypertyrosinemia and hyperphenylalaninemia would be unusual.

4. Glutaric acidemia type I: Elevated glutaric acid and 3-hydroxyglutaric acid (carboxylic acids), associated with increased susceptibility to infections. Hypertyrosinemia and hyperphenylalaninemia are not typical.

5. Propionic acidemia: Elevated propionic acid and other carboxylic acids, can present with recurrent infections and early death. Hypertyrosinemia and hyperphenylalaninemia are not characteristic.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Phenylketonuria (PKU): The patient's intellectual disability, hyperphenylalaninemia, and potential for early death fit with untreated PKU. However, strabismus and obesity are not typical of PKU.

2. Tyrosinemia type I: This disorder of tyrosine metabolism can cause intellectual disability, failure to thrive, liver failure, and early death if untreated. The patient's hypertyrosinemia fits, but obesity and strabismus are not characteristic.

3. Prader-Willi syndrome: A genetic disorder causing intellectual disability, obesity, and multiple congenital abnormalities. Can be associated with strabismus and premature death. However, the metabolic disturbances in this patient are not typical of Prader-Willi syndrome.

4. Mucopolysaccharidosis type I (Hurler syndrome): A lysosomal storage disorder causing coarse facial features, corneal clouding, intellectual disability, airway obstruction, cardiomyopathy, and death often by adolescence if untreated. Some features fit, but the patient's metabolic abnormalities are not consistent with Hurler syndrome.

5. Congenital disorder of glycosylation (CDG): A group of disorders causing a wide range of symptoms including failure to thrive, intellectual disability, eye movement disorders, seizures, liver dysfunction, and early death. Could potentially explain this patient's multi-system issues, but more specific testing would be needed.",Hereditary metabolic disorders
['Ornithine transcarbamylase deficiency'],"1. Ornithine transcarbamylase (OTC) deficiency: Matches the patient's presentation of hyperammonemia, vomiting, and oroticaciduria. As an X-linked disorder, this could also explain death in infancy if the patient had a severe mutation. Does not fully account for the bleeding/coagulation symptoms.

2. Other urea cycle disorders (citrullinemia, argininosuccinic aciduria, etc.): Also consistent with hyperammonemia, vomiting, oroticaciduria and potential neonatal death. Specific disorders can be distinguished by plasma amino acid profiles. Bleeding abnormalities are still unexplained.

3. Organic acidemias (propionic acidemia, methylmalonic acidemia): Can present with hyperammonemia, vomiting, and metabolic decompensation in infancy. Oroticaciduria would be unusual. Additional findings may include metabolic acidosis and ketonuria. Coagulation cascade involvement is atypical.

4. Factor deficiencies (Hemophilia A or B, von Willebrand disease): The patient's abnormal bleeding and coagulation cascade abnormality raise suspicion for an inherited clotting factor deficiency. However, the metabolic disturbances like hyperammonemia and oroticaciduria do not fit.

5. Liver failure due to another cause (viral hepatitis, Wilson disease, etc.): Liver dysfunction could lead to both hyperammonemia and coagulation abnormalities due to decreased clotting factor synthesis. Vomiting may occur with advanced disease. However, oroticaciduria strongly points to a primary urea cycle defect instead.",Hereditary metabolic disorders
['L-2-hydroxyglutaric aciduria'],"1. L-2-Hydroxyglutaric Aciduria: Characterized by elevated L-2-hydroxyglutaric acid, intellectual disability, hypotonia, seizures, and abnormal white matter on MRI. Consistent with patient's L-2-hydroxyglutaric acidemia, intellectual disability, hypotonia, and abnormal myelination.

2. Ornithine Transcarbamylase (OTC) Deficiency: An inherited urea cycle disorder causing hyperammonemia, intellectual disability, hypotonia, seizures, and early death. Matches patient's hyperammonemia, intellectual disability, hypotonia, and death in childhood. 

3. Canavan Disease: A leukodystrophy causing intellectual disability, hypotonia, macrocephaly, and hyperreflexia. White matter degeneration on MRI. Fits patient's intellectual disability, hypotonia, hyperreflexia, and abnormal myelination. Patient is not reported to have macrocephaly.

4. Glutaric Aciduria Type 1: Disorder of lysine and tryptophan metabolism causing macrocephaly, intellectual disability, hypotonia, and dystonia. Hyperammonemia and white matter abnormalities can occur. Matches patient's intellectual disability, hypotonia, hyperammonemia, and abnormal myelination. No dystonia or macrocephaly reported.

5. Alexander Disease: A leukodystrophy causing intellectual disability, hypotonia, hyperreflexia, macrocephaly, and seizures. Characteristic white matter abnormalities on MRI. Consistent with patient's intellectual disability, hypotonia, hyperreflexia, and abnormal myelination. Macrocephaly and seizures not reported.",Hereditary metabolic disorders
['PMM2-CDG'],"1. Joubert syndrome: Characterized by absence or underdevelopment of the cerebellar vermis, leading to ataxia, developmental delay, and intellectual disability. Additional features like abnormal breathing and eye movements are not reported here.

2. Zellweger spectrum disorders: Group of rare genetic disorders causing severe neurological dysfunction, intellectual disability, and potentially life-threatening complications in infancy. Absence of other key features like vision/hearing loss, seizures, and liver dysfunction.

3. COL4A1-related disorders: Genetic conditions involving dysfunction of collagen, a key protein in blood vessels and other tissues. Can cause stroke-like episodes, cerebral atrophy, intellectual disability, and other variable symptoms. Specific facial features and eye abnormalities not noted.

4. Congenital disorder of glycosylation (CDG): Rare group of genetic disorders affecting glycosylation, an important process for protein and tissue development. Can cause cerebellar atrophy, stroke-like episodes, intellectual disability, and early death. Other characteristic symptoms like failure to thrive and vision abnormalities not reported.  

5. MELAS syndrome: Mitochondrial disorder that can present with stroke-like episodes, intellectual decline, and potentially cerebellar atrophy. Onset is often in childhood after a period of normal development. Other common features like short stature, hearing loss, and diabetes are not mentioned.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia type I: Characterized by hypertyrosinemia, this disorder can cause liver failure, renal dysfunction, and neurological problems in infancy if untreated. Consistent with premature birth, neonatal death, and infant death.

2. Phenylketonuria (PKU): Causes hyperphenylalaninemia and intellectual disability if untreated. Classic PKU is usually not fatal in infancy, but a severe form could potentially explain the other symptoms.

3. Alkaptonuria: A rare disorder of tyrosine metabolism that causes buildup of homogentisic acid. Usually has a milder course but in severe cases could lead to ochronosis and early death.

4. Maple syrup urine disease: Causes buildup of branched-chain amino acids and their toxic metabolites. Can be fatal in infancy if untreated. Patient's symptoms are atypical but a severe presentation is possible.

5. Tyrosinemia type II (Richner-Hanhart syndrome): Characterized by hypertyrosinemia, eye and skin lesions, and intellectual disability. Rarely fatal in infancy but a severe case could potentially fit this presentation.",Hereditary metabolic disorders
['Propionic acidemia'],"1. Propionic acidemia: Explains hyperammonemia, increased lactate, seizures, hypotonia, developmental delays, vomiting, and early death. Key features not reported include ketoacidosis and cardiomyopathy.

2. Methylmalonic acidemia: Also causes lethargy, intellectual disability, seizures, metabolic acidosis with increased lactate, hyperammonemia, neutropenia, and early death. Pancytopenia and renal disease were not mentioned. 

3. Maple syrup urine disease: The patient's lethargy, vomiting, seizures, intellectual disability, and elevated BUN, lactate, and branched-chain amino acids (valine) fit, but the characteristic urine odor was not described.

4. Phenylketonuria: Severe cases can present in infancy with lethargy, seizures, vomiting, developmental delays, and the reported amino acid abnormalities, but eczema and light pigmentation were not noted.

5. Mitochondrial disorder (e.g. Leigh syndrome): Could explain the neurological decline, seizures, hypotonia, GI symptoms, lactic acidosis, and childhood death, but specific findings like basal ganglia changes on MRI are needed to confirm.",Hereditary metabolic disorders
['Wilson disease'],"1. Wilson's disease: Characterized by low ceruloplasmin and copper levels, liver dysfunction (elevated transaminases), and often presenting in childhood or adolescence. Polydipsia is not a typical symptom but could result from metabolic derangements. Fatal if untreated.

2. Menkes disease: Another disorder of copper metabolism causing low copper and ceruloplasmin levels and early death, but usually manifests in infancy with neurological symptoms and distinctive ""kinky hair."" Liver dysfunction is possible but less prominent than in Wilson's.

3. Chronic liver disease (e.g., viral hepatitis, autoimmune hepatitis): Can cause elevated liver enzymes and lead to cirrhosis and liver failure, but would not typically cause isolated low ceruloplasmin and copper levels or death in adolescence.

4. Nephrogenic diabetes insipidus: A rare disorder characterized by inability to concentrate urine, leading to polyuria, polydipsia, and dehydration. However, it does not cause liver dysfunction or copper abnormalities.

5. Familial hypoceruloplasminemia: A rare genetic condition causing low ceruloplasmin levels, but typically without significant clinical consequences. Copper levels and liver function are usually normal, and it does not lead to early death.",Hereditary metabolic disorders
['Ornithine transcarbamylase deficiency'],"1. Ornithine transcarbamylase deficiency: Seizures, lethargy, hypotonia, vomiting, and hyperglutaminemia with oroticaciduria are all consistent. Can cause neonatal death if severe. Elevated ammonia levels would be expected but were not reported.

2. Citrullinemia: Another urea cycle defect that can present with lethargy, hypotonia, seizures, and vomiting leading to neonatal death. Hyperglutaminemia and oroticaciduria may be seen. Plasma citrulline level would be elevated.

3. Propionic acidemia: An organic acidemia presenting with lethargy, hypotonia, seizures, and vomiting. Sleep disturbances are common. Hyperglutaminemia can occur. Elevated propionylcarnitine on newborn screen and propionic acid in urine organic acids would be diagnostic.  

4. Argininosuccinic aciduria: Urea cycle defect with seizures, lethargy, hypotonia, and vomiting. Oroticaciduria and hyperglutaminemia are seen. Plasma argininosuccinic acid is elevated. High ammonia and neonatal death in severe cases.

5. Methylmalonic acidemia: Another organic acidemia with lethargy, hypotonia, seizures, and vomiting. Hyperglutaminemia may be present. Methylmalonic acid is elevated in urine organic acids. Can be life-threatening in the neonatal period.",Hereditary metabolic disorders
['Classic galactosemia'],"1. Galactosemia: Consistent with hypergalactosemia, feeding difficulties, failure to thrive, intellectual disability, speech delay, and cataracts (not reported). Key additional symptoms may include hepatomegaly, jaundice, and E. coli sepsis.

2. PKU (Phenylketonuria): Consistent with intellectual disability, motor delay, microcephaly, and hypotonia. Patients may also have light pigmentation, eczema, and a ""mousy"" odor (not reported).

3. Zellweger Spectrum Disorder: Consistent with hypotonia, intellectual disability, abnormal prenatal development, and feeding difficulties. Additional findings may include distinctive facial features, hepatic dysfunction, and renal cysts (not reported).

4. Menkes Disease: Consistent with intellectual disability, hypotonia, failure to thrive, and abnormal hair (pili torti, not reported). Patients may also have seizures, cutis laxa, and occipital horn exostoses.

5. Congenital Disorder of Glycosylation (CDG): Consistent with intellectual disability, hypotonia, failure to thrive, and feeding difficulties. Patients may have inverted nipples, abnormal fat pads, cerebellar hypoplasia, and esotropia (not reported).",Hereditary metabolic disorders
['Biotinidase deficiency'],"1. Urea cycle disorder: Hyperammonemia and death in childhood are key features. Specific disorders like ornithine transcarbamylase deficiency are possible.

2. Prader-Willi syndrome: Characterized by obesity, intellectual disability, and distinctive facial features and body shape. Abnormal foot morphology may be present. Usually not fatal in childhood.

3. Bardet-Biedl syndrome: Features obesity, intellectual disability, abnormalities of the hands/feet, and organ dysfunction. Can be life-threatening but many survive to adulthood.

4. Beckwith-Wiedemann syndrome: Causes overgrowth, abdominal wall defects, and increased risk of childhood cancers. Hyperammonemia and death are atypical.

5. Congenital lactic acidosis: Group of metabolic disorders causing toxic lactic acid and ammonia buildup. Often presents in infancy with failure to thrive, organ dysfunction, and high mortality.",Hereditary metabolic disorders
['Canavan disease'],"1. Canavan disease: Rare genetic disorder causing abnormal aspartate metabolism, leading to abnormal myelination, developmental delay, feeding problems, and early death. Key symptom not reported: macrocephaly.

2. Phenylketonuria (PKU): Inherited disorder of amino acid metabolism causing intellectual disability, behavioral problems, and lighter skin/hair. Abnormal aspartate levels may be seen. Key symptoms not reported: seizures, skin rash.

3. Maple syrup urine disease: Inherited disorder of branched-chain amino acid metabolism, causing poor feeding, lethargy, developmental delay, and maple syrup odor to urine. Can be fatal if untreated. Abnormal aspartate levels may occur.

4. Leukodystrophy (e.g. Krabbe disease): Group of disorders causing abnormal myelination, leading to developmental delay, feeding problems, muscle weakness and early death. Key symptom not reported: vision/hearing problems.

5. Mitochondrial disorder: Group of disorders caused by mitochondrial dysfunction, with symptoms including developmental delay, feeding problems, muscle weakness, and increased risk of early death. Can cause secondary amino acid abnormalities.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Phenylketonuria (PKU): Consistent with hyperphenylalaninemia, abnormal prenatal development, and risk of intellectual disability and neurological problems if untreated. Key symptoms not reported include musty body odor, fair skin/hair, and hyperactivity.

2. Tetrahydrobiopterin (BH4) deficiency: Can cause hyperphenylalaninemia and neurological dysfunction similar to PKU. Additional symptoms may include microcephaly, hypotonia, and autonomic dysfunction.

3. Maternal phenylketonuria: Uncontrolled high phenylalanine levels in the mother during pregnancy can cause birth defects, intellectual disability, and early death in the infant. Maternal PKU symptoms were not reported.

4. Zellweger spectrum disorder: A group of rare congenital disorders that can cause abnormal brain development, hypotonia, seizures, and early death. May have characteristic facial features and liver dysfunction.

5. Trisomy 13 (Patau syndrome): A chromosomal disorder causing severe intellectual disability, congenital heart defects, brain/spinal cord malformations, and very limited life expectancy. Additional symptoms may include cleft lip/palate, microphthalmia, and polydactyly.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Phenylketonuria (PKU): Delayed development, hyperphenylalaninemia. Can also have microcephaly, seizures, and light pigmentation not reported here.

2. Tyrosinemia type I: Hypertyrosinemia, risk of early death. Other features can include liver failure, renal dysfunction, and peripheral neuropathy.

3. Maple syrup urine disease (MSUD): Neonatal onset, risk of death in infancy if untreated. Causes elevated branched-chain amino acids and neurological deterioration.

4. Homocystinuria: Developmental delay, early mortality. Can also have skeletal abnormalities, eye problems, and thromboembolism. Specific amino acids not reported.

5. Glutaric aciduria type 1: Abnormal development, high mortality risk. Typically presents with macrocephaly and dystonia/dyskinesia after acute decompensation. Amino acid levels not specified.",Hereditary metabolic disorders
[],"1. Noonan syndrome: Characterized by congenital heart defects (especially pulmonic stenosis), cardiomyopathy, renal anomalies, and hypotonia. Other features like short stature and facial dysmorphism were not mentioned.

2. Barth syndrome: X-linked disorder causing cardiomyopathy, hypotonia, and cyclic neutropenia (not mentioned). Ventricular septal defects and renal problems can occur. Typically affects males and can be lethal in infancy.

3. Pompe disease (glycogen storage disease type II): Autosomal recessive disorder with infantile-onset hypotonia, cardiomyopathy, and high mortality. Key features not reported include enlarged tongue and liver.

4. Zellweger spectrum disorders: Group of rare autosomal recessive conditions with hypotonia, brain malformations (not mentioned), liver dysfunction (not mentioned), and renal cysts. Cardiac defects and early lethality can occur in severe cases.

5. LEOPARD syndrome: Shares features with Noonan syndrome like pulmonic stenosis and hypertrophic cardiomyopathy. Also characterized by skin lentigines (not mentioned), ocular hypertelorism (not mentioned), and sensorineural deafness (not mentioned).",Hereditary metabolic disorders
['Phenylketonuria'],"1. Phenylketonuria (PKU): Characterized by hyperphenylalaninemia, intellectual disability, and fair complexion. The patient's elevated phenylalanine levels and neurological symptoms are consistent, but death in infancy would be atypical for PKU alone.

2. Tyrosinemia type I: Features hypertyrosinemia, liver dysfunction, renal tubular dysfunction, and peripheral neuropathy. Matches the patient's elevated tyrosine, though additional symptoms of liver and kidney disease were not reported.

3. Maple syrup urine disease (MSUD): Presents with poor feeding, vomiting, lethargy, dystonia, and a characteristic maple syrup odor to the urine. The neurological symptoms fit, but the patient's elevated tyrosine and phenylalanine are not typical of MSUD.

4. Glutaric aciduria type 1: Causes macrocephaly, dystonia, spasticity, and intellectual disability. The spasticity matches the patient's presentation. Urine organic acid analysis could detect the diagnostic glutaric acid elevation.

5. Mitochondrial disorder: Can manifest with a wide range of symptoms including muscle weakness, seizures, developmental delays, and increased susceptibility to illness. The patient's neurological issues and recurrent infections could fit this diagnosis, but the specific amino acid elevations are less consistent.",Hereditary metabolic disorders
['Medium chain acyl-CoA dehydrogenase deficiency'],"1. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: Consistent with neonatal death, abnormal carnitine levels. May not explain prenatal abnormalities.

2. Carnitine palmitoyltransferase I (CPT I) deficiency: Matches abnormal carnitine concentration, neonatal death. Other symptoms can include hypoketotic hypoglycemia and liver problems.

3. Trisomy 18 (Edwards syndrome): Associated with prenatal abnormalities, high infant mortality. Additional symptoms often include growth deficiency, microcephaly, clenched fists.

4. Zellweger spectrum disorders: Consistent with abnormal prenatal development, neonatal issues, early death. May also have distinct facial features, seizures, liver dysfunction.

5. Smith-Lemli-Opitz syndrome: Matches prenatal abnormalities, possible neonatal complications. Other features can include microcephaly, cleft palate, syndactyly of the 2nd and 3rd toes.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia type I: Characterized by hypertyrosinemia, failure to thrive, liver dysfunction, renal tubular dysfunction, and risk of early death. Consistent with the patient's hypertyrosinemia, developmental delays, hypotonia, and childhood mortality.

2. Phenylketonuria (PKU): Caused by impaired metabolism of phenylalanine leading to hyperphenylalaninemia and severe intellectual disability if untreated. Matches the patient's hyperphenylalaninemia and delayed development. However, PKU is not typically fatal in infancy/childhood if treated.

3. Maple syrup urine disease (MSUD): A disorder of branched-chain amino acid metabolism causing poor feeding, lethargy, hypotonia, seizures, and risk of neonatal death without rapid treatment. Aligns with generalized hypotonia, neonatal mortality, and metabolic abnormalities, but the patient's amino acids are not reported.

4. Zellweger spectrum disorder: A peroxisomal biogenesis disorder featuring hypotonia, seizures, distinctive facial features, and hepatic dysfunction. Can be fatal in infancy or early childhood. Matches hypotonia and early mortality, but other key features are not described. 

5. Niemann-Pick disease type A: A lysosomal storage disorder causing developmental regression, hypotonia, hepatosplenomegaly, and death usually by 3 years of age. Consistent with hypotonia, developmental delays, and childhood death, but the patient is not reported to have organomegaly or regression.",Hereditary metabolic disorders
['Glutaryl-CoA dehydrogenase deficiency'],"1. Glutaric acidemia type 1: Symptoms consistent with this diagnosis include seizures, encephalopathy, opisthotonus, glutaric aciduria, elevated glutaric acid, and early death. Decreased plasma carnitine is also often seen.

2. Canavan disease: Some consistent symptoms are seizures, encephalopathy, and early death. However, the specific glutaric aciduria and elevated glutaric acid make this less likely than glutaric acidemia type 1.

3. Mitochondrial encephalomyopathy: Symptoms like seizures, encephalopathy, and decreased plasma carnitine can be seen with mitochondrial disorders. Additional symptoms not reported here that are common include developmental delays, hypotonia, and lactic acidosis.

4. Propionic acidemia: Another organic acidemia that can cause symptoms like seizures, encephalopathy, and early death. Glutaric aciduria would not be expected though, making this less likely than glutaric acidemia type 1.

5. Leigh syndrome: A mitochondrial disorder that can present with seizures, encephalopathy, opisthotonus and early death. Specific findings of glutaric aciduria and elevated glutaric acid are not typical of Leigh syndrome.",Hereditary metabolic disorders
[],"1. Menkes disease: Explains neurological abnormalities, hypotonia, seizures, developmental delay, fair hair, and early mortality. Key features not reported include hypothermia, bladder diverticula, and tortuous arteries.

2. Krabbe disease (Globoid cell leukodystrophy): Accounts for spastic tetraplegia, motor delay, seizures, intellectual disability, opisthotonus, and early death. Peripheral neuropathy and vision loss are additional cardinal signs.

3. Mitochondrial disorder (e.g., Leigh syndrome): The neurological, musculoskeletal, and multisystem involvement could fit. Specific findings like strabismus, nystagmus, metabolic acidosis, and hepatomegaly are consistent. Depending on the specific mitochondrial disorder, other features like cardiomyopathy, renal tubular acidosis, or diabetes may be seen.

4. Zellweger spectrum disorder: Severe hypotonia, intellectual disability, seizures, hepatomegaly, and distinctive facial features are consistent. Other signs that would support this diagnosis include renal cysts and stippled epiphyses on X-ray.

5. Canavan disease: Could explain intellectual disability, hypotonia, seizures, and early death. Macrocephaly and optic atrophy are key features not reported here.",Hereditary metabolic disorders
['PMM2-CDG'],"1. Cerebrotendinous xanthomatosis (CTX): Rare lipid storage disorder causing neurological deterioration (ataxia, intellectual disability, hypotonia), cataracts, diarrhea, and tendon xanthomas. Patient's neurological symptoms fit but no mention of cataracts, diarrhea or xanthomas.

2. Niemann-Pick disease type C (NPC): Lysosomal storage disorder with progressive neurological decline (ataxia, dysarthria, cognitive impairment), vertical gaze palsy, and hepatosplenomegaly. Explains neurological and hepatic features but patient lacks report of vertical gaze palsy or enlarged liver/spleen.

3. Congenital disorders of glycosylation (CDGs): Group of disorders causing neurological impairment (hypotonia, ataxia, seizures, developmental delay), liver dysfunction, coagulopathy, and failure to thrive. Matches patient's neurological, hepatic and coagulation issues but no mention of failure to thrive or seizures.

4. Ataxia telangiectasia (AT): Autosomal recessive disorder with progressive cerebellar ataxia, oculomotor apraxia, immunodeficiency, and telangiectasias. Fits cerebellar degeneration but patient lacks classic eye movement abnormality, immunodeficiency and telangiectasias.

5. Infantile neuroaxonal dystrophy (INAD): Rare inherited neurological disorder with progressive psychomotor regression, hypotonia, ataxia, and vision impairment. Matches neurological decline but no report of vision loss, and hepatic/hematologic issues are atypical.",Hereditary metabolic disorders
['Canavan disease'],"1. Maple syrup urine disease: Presents with poor feeding, irritability, hypotonia, seizures, and high levels of branched-chain amino acids. Can be fatal in infancy if untreated. Patient's symptoms fit but would need to check for characteristic urine odor.

2. Phenylketonuria (PKU): Causes intellectual disability, seizures, hypotonia, and eczema if untreated. Elevated phenylalanine levels on newborn screening. Patient has many consistent symptoms but eczema not mentioned.

3. Nonketotic hyperglycinemia: Characterized by hypotonia, seizures, feeding problems, and respiratory issues in infancy. Caused by defective glycine breakdown. Patient's presentation matches but glycine levels need to be checked.

4. Glutaric aciduria type 1: Features macrocephaly, hypotonia, dystonia, and encephalopathic crises that can be fatal. Organic acid testing reveals high glutaric acid. Some shared symptoms but patient's head size is unknown.

5. Molybdenum cofactor deficiency: Rare disorder causing intractable seizures, severe developmental delays, and lens dislocation. Elevated sulfite, xanthine and hypoxanthine levels. Matches patient's neurological symptoms but no mention of eye findings.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia type I: Characterized by hypertyrosinemia, this disorder can cause failure to thrive, liver dysfunction, and neurological problems in infancy. Consistent with abnormal prenatal development, neonatal complications and death, and GI issues. 

2. Phenylketonuria (PKU): A disorder of phenylalanine metabolism causing hyperphenylalaninemia. Can lead to severe intellectual disability, seizures, and behavioral problems if untreated. Matches elevated phenylalanine, though other classic symptoms like light skin/hair and musty body odor are not reported.

3. Maple syrup urine disease (MSUD): Defective metabolism of branched-chain amino acids presenting in the neonatal period with poor feeding, vomiting, lethargy, and a distinctive sweet odor to the urine. Aligns with neonatal complications and GI symptoms, but the patient's elevated tyrosine and phenylalanine are not typical of MSUD.

4. Niemann-Pick disease type A: A severe lipid storage disorder causing neurodevelopmental deterioration and death usually by age 3. Fits the pattern of abnormal development and early death, but would not characteristically cause hypertyrosinemia or hyperphenylalaninemia.

5. Zellweger syndrome: A peroxisomal biogenesis disorder causing craniofacial abnormalities, hypotonia, seizures, and liver dysfunction. Can present with neonatal complications and early death. While it may explain some of the patient's symptoms, the amino acid abnormalities reported are not classic for Zellweger syndrome.",Hereditary metabolic disorders
['Maple syrup urine disease'],"1. Maple syrup urine disease: Presents with metabolic acidosis, cerebral edema, hyperleucinemia, and neurological deterioration leading to coma and death if untreated. Does not typically cause immunodeficiency or alopecia.

2. Canavan disease: A leukodystrophy causing abnormal white matter, hypotonia, macrocephaly, and developmental regression. Fits with cerebral edema and abnormal white matter but would not be expected to cause metabolic acidosis, hyperleucinemia or immunodeficiency.

3. Methylmalonic acidemia: Can present with metabolic acidosis, cerebral edema, hypotonia, and developmental regression. May be associated with neutropenia and pancytopenia but not typically immunodeficiency or alopecia.

4. Severe combined immunodeficiency (SCID): Characterized by recurrent, severe infections due to lack of T and B cell immunity. Can be associated with alopecia and failure to thrive but would not typically cause the neurological and metabolic abnormalities seen.

5. Urea cycle disorder (e.g. ornithine transcarbamylase deficiency): Presents with hyperammonemia, encephalopathy, cerebral edema, and respiratory alkalosis. Can progress to coma and death. Does not fit well with hyperleucinemia, immunodeficiency or alopecia.",Hereditary metabolic disorders
['Acute intermittent porphyria'],"1. Acute intermittent porphyria: Characterized by abdominal pain and elevated urinary delta-aminolevulinic acid. Can have childhood onset but death in childhood would be atypical.

2. Hereditary coproporphyria: Another porphyria that can present with abdominal pain, elevated urinary delta-aminolevulinic acid. Severity can vary but childhood death would be uncommon.

3. Congenital erythropoietic porphyria: A rare porphyria with severe cutaneous symptoms beginning in infancy. Elevated urinary delta-aminolevulinic acid and early death can occur. Abdominal pain is not typical.

4. Lead poisoning: Can cause abdominal pain and elevated delta-aminolevulinic acid. Severity depends on lead levels. Additional symptoms may include anemia, kidney dysfunction, and neurological symptoms.

5. Rare mitochondrial disorder (e.g. GRACILE syndrome): Can present in infancy/childhood with multi-system symptoms including metabolic abnormalities, kidney dysfunction, neurological impairment. Specific symptoms vary but early death is possible. Abdominal pain and elevated delta-aminolevulinic acid are not classic findings but could potentially occur.",Hereditary metabolic disorders
['Vitamin B12-unresponsive methylmalonic acidemia'],"1. Methylmalonic acidemia: Methylmalonic aciduria, metabolic acidosis, seizures, neonatal presentation and death. A key symptom not reported is developmental delay.

2. Propionic acidemia: Methylmalonic aciduria (as methylmalonic acid is derived from propionic acid), metabolic acidosis, seizures, neonatal presentation and death. Other symptoms may include poor feeding and lethargy.

3. Cobalamin C, D, or F deficiency: Methylmalonic aciduria, metabolic acidosis, seizures, neonatal presentation and death. May also have megaloblastic anemia and homocystinuria.

4. 3-Methylcrotonyl-CoA carboxylase deficiency: Methylmalonic aciduria, metabolic acidosis, seizures, neonatal presentation. Symptoms not reported include hypoglycemia and hyperammonemia.

5. Holocarboxylase synthetase deficiency: Metabolic acidosis, seizures, neonatal presentation and death. Methylcitric acid may be present in addition to methylmalonic acid. Symptoms not reported include skin rash and alopecia.",Hereditary metabolic disorders
['Alkaptonuria'],"1. Mitochondrial disorder: Symptoms of seizures, hypotonia, growth delay, and childhood death are consistent. Lethargy and dark urine can also occur. Additional symptoms may include vision/hearing problems, heart issues, diabetes, and kidney dysfunction.

2. Urea cycle disorder: Presents with lethargy, drowsiness, seizures, hypotonia, growth delay, and high risk of death. Dark urine and sleep abnormalities may be seen. Symptoms worsen with high-protein meals. Extremely high blood ammonia levels on lab testing.

3. Organic acidemia (e.g. propionic acidemia): Lethargy, seizures, hypotonia, growth delay, and childhood death highly consistent. Drowsiness and sleep issues common. Dark urine occurs during episodes of metabolic crisis. Vomiting and trouble feeding are other typical symptoms.

4. Zellweger spectrum disorder: Seizures, hypotonia, and growth delay are cardinal features, along with risk of early death. Lethargy/drowsiness likely. Dark urine not usually reported. Distinctive facial features, liver dysfunction, and vision/hearing problems are additional signs.

5. Krabbe disease (globoid cell leukodystrophy): Presents with seizures, lethargy, hypotonia, growth delay, and death in early childhood. Drowsiness, sleep issues and dark urine may be seen. Blindness, deafness, and periventricular white matter changes on brain MRI are characteristic.",Hereditary metabolic disorders
['Maple syrup urine disease'],"1. Maple syrup urine disease (MSUD): Characterized by elevated branched-chain amino acids, seizures, and risk of neonatal death if untreated. Urine may have a distinct sweet odor. Patient's aminoaciduria and abnormal leucine, isoleucine and valine levels fit.

2. Propionic acidemia: Can present with seizures, elevated ammonia, and death in untreated cases. May have abnormal branched-chain amino acid levels. Additional symptoms of vomiting, lethargy and acidosis not reported here.

3. Methylmalonic acidemia: Another organic acidemia that can present in infancy with seizures, lethargy, vomiting, metabolic acidosis and high ammonia levels. Branched-chain amino acids can be elevated. Acidosis not noted in this case.

4. Isovaleric acidemia: Can cause seizures and elevated branched-chain amino acids. Sweet odor may be noted. Usually presents with vomiting and acidosis as well, which were not reported.

5. Branched-chain ketoacid dehydrogenase kinase (BCKDK) deficiency: A very rare disorder of branched-chain amino acid metabolism. Causes seizures, brain damage and elevated branched-chain amino acids without significant acidosis. Symptoms fit but condition is less likely due to rarity.",Hereditary metabolic disorders
['Very long chain acyl-CoA dehydrogenase deficiency'],"1. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: Consistent with early-childhood presentation, cardiomegaly, hepatomegaly, hypoglycemia, dicarboxylic aciduria, and abnormal carnitine levels. 

2. Long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency: Matches symptoms of cardiomegaly, hepatomegaly, hypoglycemia, lactic acidosis, and dicarboxylic aciduria. May also have pigmentary retinopathy and peripheral neuropathy.

3. Carnitine palmitoyltransferase II (CPT II) deficiency: Aligns with cardiomegaly, hepatomegaly, hypoglycemia, lactic acidosis, dicarboxylic aciduria, and low carnitine levels. Typically also have myoglobinuria and rhabdomyolysis.

4. Mitochondrial trifunctional protein (MTP) deficiency: Consistent with cardiomegaly, hepatomegaly, hypoglycemia, lactic acidosis, and dicarboxylic aciduria. May also have pigmentary retinopathy and peripheral neuropathy like LCHAD deficiency.

5. Glutaric acidemia type II: Multiple acyl-CoA dehydrogenase deficiency causing cardiomegaly, hepatomegaly, hypoglycemia, metabolic acidosis, dicarboxylic aciduria and abnormal carnitine levels. Usually have significant neurological involvement as well.",Hereditary metabolic disorders
['3-hydroxy-3-methylglutaric aciduria'],"1. Propionic acidemia: Consistent with lethargy, metabolic acidosis, hypoglycemia, seizures, intellectual disability, and elevated 3-methylglutaric acid. May also have hyperammonemia and pancytopenia which were not reported.

2. Methylmalonic acidemia: Matches the neurological symptoms, metabolic acidosis, hypoglycemia, and elevated methylmalonic acid expected in this disorder. Patients may also have hyperammonemia, neutropenia, and megaloblastic anemia.

3. Glycine encephalopathy (nonketotic hyperglycinemia): The abnormal glycine concentration, lethargy, seizures, and neurologic deterioration fit this diagnosis. Additional symptoms may include hypotonia, apnea, and corpus callosum abnormalities.  

4. Glutaric acidemia type 1: Glutaric aciduria, along with neurological symptoms like seizures and neurologic deterioration, are hallmarks of this disorder. Patients often have large heads and characteristic brain MRI findings.

5. Isovaleric acidemia: Could explain the neurological symptoms, metabolic acidosis, hypoglycemia, and glutaric aciduria. Patients typically have a ""sweaty feet"" odor and may develop pancytopenia and hyperammonemia during acute episodes.",Hereditary metabolic disorders
['MODY'],"1. Acute intermittent porphyria: Characterized by hypoglycemia and abnormal porphyrin levels. Glycosuria is not typical but can occur.

2. Variegate porphyria: Another acute porphyria that can present with hypoglycemia and abnormal porphyrin levels. Additional symptoms like photosensitivity and blistering skin lesions are not reported here.

3. Type 1 diabetes mellitus: The combination of hypoglycemia and glycosuria is consistent with diabetes, but the abnormal porphyrin levels would be atypical. Polyuria, polydipsia, and weight loss are other common symptoms not mentioned.

4. Drug-induced porphyria: Certain medications can trigger acute porphyria symptoms in susceptible individuals, leading to hypoglycemia and abnormal porphyrin levels. More information is needed about potential drug exposures.

5. Liver disease: Advanced liver disease can cause abnormal porphyrin metabolism. Hypoglycemia may occur with liver failure, but glycosuria would be unusual. Other signs of liver dysfunction are not reported.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Phenylketonuria (PKU): Abnormality of prenatal development, intellectual disability, hyperphenylalaninemia. Can lead to early death if untreated. Additional symptoms may include a musty body odor, light pigmentation, eczema, and seizures.

2. Tetrahydrobiopterin (BH4) deficiency: Hyperphenylalaninemia, intellectual disability, abnormal brain development, early death. May have additional symptoms of dystonia, seizures, and autonomic dysfunction.

3. Maternal phenylketonuria: Abnormality of prenatal development, intellectual disability, hyperphenylalaninemia in the mother leading to birth defects in the child. Severity depends on maternal phenylalanine levels during pregnancy.

4. Zellweger spectrum disorder: Abnormality of prenatal development, hypotonia, seizures, vision/hearing impairment, early death. May have a characteristic facial appearance and liver dysfunction. Hyperphenylalaninemia can occur.

5. Walker-Warburg syndrome: Severe brain and eye abnormalities, hypotonia, seizures, intellectual disability, early death. Can have additional symptoms of hydrocephalus and abnormal genitalia. Hyperphenylalaninemia is not typically reported.",Hereditary metabolic disorders
['Glutaryl-CoA dehydrogenase deficiency'],"1. Glutaric aciduria type 1: Matches patient's macrocephaly, dystonia, seizures, cerebral atrophy, and glutaric aciduria. Can also cause lethargy, hyperhidrosis, and death in childhood. Does not explain all symptoms.

2. Leigh syndrome (mitochondrial disease): Explains neurological symptoms like seizures, dystonia, opisthotonus, as well as cerebral atrophy, respiratory and feeding difficulties, and early mortality. Additional symptoms can include vomiting, lethargy, and sleep disturbances.  

3. Krabbe disease (leukodystrophy): Accounts for neurological deterioration with seizures, spasticity, vision loss, feeding problems, leading to death in infancy or early childhood. Also associated with fever, vomiting, and irritability. Does not fit cerebral atrophy.

4. Alexander disease: Matches macrocephaly, seizures, spasticity, developmental delays and early death. Can also present with vomiting, sleep disturbances and respiratory issues. Increased CSF protein is a key finding. Hydrocephalus present but not cerebral atrophy.

5. Aicardi-Gouti√®res syndrome: Fits hydrocephalus, seizures, dystonia, cerebral atrophy, and early mortality. Other features include fever, hepatosplenomegaly, thrombocytopenia, and skin lesions. Increased CSF lymphocytes and interferon are diagnostic clues not mentioned here.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia type I: Consistent with hypertyrosinemia, abnormality of prenatal development, and early death. May also have symptoms not reported like liver failure, kidney dysfunction, and rickets.

2. Phenylketonuria (PKU): Matches hyperphenylalaninemia and can cause abnormal development and intellectual disability if untreated. However, early death is less common than in tyrosinemia.

3. Maple syrup urine disease: Can cause neonatal death and severe neurological symptoms due to buildup of branched-chain amino acids. Characteristic odor of urine not reported.

4. Homocystinuria: Inborn error of methionine metabolism that can cause developmental delay, eye problems, and thromboembolic events. Can be fatal but less commonly in infancy compared to tyrosinemia.

5. Zellweger spectrum disorder: Peroxisomal biogenesis disorder causing abnormal development, hypotonia, seizures, and early death. May have additional symptoms like distinctive facial features and liver dysfunction.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia type I: Characterized by hypertyrosinemia, liver dysfunction, renal tubular dysfunction, and risk of early death if untreated. Consistent with patient's hypertyrosinemia and early mortality.

2. Phenylketonuria (PKU): Causes hyperphenylalaninemia and intellectual disability if untreated, but not typically associated with hypertyrosinemia, preeclampsia or early death. Additional symptoms of PKU not reported include fair complexion, eczema, and musty body odor.

3. Hawkinsinuria: Rare disorder of tyrosine metabolism causing hypertyrosinemia and metabolic acidosis. Can be associated with failure to thrive in infancy. Preeclampsia and early death are not typical features.

4. Tyrosinemia type II: Also known as Richner-Hanhart syndrome. Characterized by hypertyrosinemia, eye and skin lesions, and intellectual disability. Early death and preeclampsia are not common.

5. Alkaptonuria: Disorder of phenylalanine/tyrosine metabolism causing darkening of urine, ochronosis, and arthritis in adulthood. Hypertyrosinemia can occur but the other reported symptoms would be atypical.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia type I: Defect in tyrosine catabolism leading to liver failure, kidney dysfunction, and neurological problems. Consistent with hypertyrosinemia, elevated urinary carboxylic acids, and early death.

2. Phenylketonuria (PKU): Phenylalanine hydroxylase deficiency causing intellectual disability and other neurological issues if untreated. Matches hyperphenylalaninemia but elevated tyrosine is atypical. Usually not fatal in infancy.

3. Maple syrup urine disease: Defect in branched-chain amino acid metabolism characterized by poor feeding, lethargy, and a maple syrup odor to the urine. Can be fatal in infancy but specific amino acids are not consistent.

4. Glutaric acidemia type I: Disorder of lysine and tryptophan metabolism associated with macrocephaly, dystonia, and striatal degeneration. Matches elevated urinary carboxylic acids but other symptoms are not typical.

5. Mitochondrial disorder: Dysfunction of cellular energy production that can manifest with a wide range of symptoms and organ involvement. Could potentially explain multisystem issues but amino acid abnormalities are less characteristic.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia type I: Consistent with hypertyrosinemia, abnormality of prenatal development, and early death. May also have symptoms not reported like liver failure, kidney dysfunction, and rickets.

2. Phenylketonuria (PKU): Matches hyperphenylalaninemia and can cause abnormal development and intellectual disability if untreated. However, early death is less common than in tyrosinemia.

3. Maple syrup urine disease: Can cause neonatal death and severe neurological symptoms due to buildup of branched-chain amino acids. Characteristic odor of urine not reported.

4. Homocystinuria: Inborn error of methionine metabolism that can cause developmental delay, eye problems, and thromboembolic events. Can be fatal but less commonly in infancy compared to tyrosinemia.

5. Zellweger spectrum disorder: Peroxisomal biogenesis disorder causing abnormal development, hypotonia, seizures, and early death. May have additional symptoms like distinctive facial features and liver dysfunction.",Hereditary metabolic disorders
['Hereditary orotic aciduria'],"1. Urea cycle disorder, such as ornithine transcarbamylase (OTC) deficiency: Consistent with hyperammonemia, lethargy, hypotonia, feeding difficulties, and risk of death in infancy/childhood. The ornithinuria is a key finding. Patients may lack the classic symptoms of vomiting and cerebral edema.

2. Organic acidemia, such as propionic acidemia or methylmalonic acidemia: Can present with lethargy, hypotonia, vomiting, hepatomegaly, and risk of death in infancy. The metabolic acidosis and ketosis characteristic of these disorders cannot be confirmed based on provided information. 

3. Lysinuric protein intolerance: Features include failure to thrive, hepatosplenomegaly, muscle hypotonia, and nephropathy which can be seen in this patient. The characteristic findings of low plasma lysine and elevated arginine, ornithine, and ammonia are not specifically mentioned.

4. Glycine encephalopathy (nonketotic hyperglycinemia): The hyperglycinuria, lethargy, hypotonia, and risk of death in infancy fit with this diagnosis. Patients typically have intractable seizures which are not described here.

5. Galactosemia: Can cause lethargy, hypotonia, feeding difficulties, hepatomegaly, and risk of sepsis/death in untreated infants. Without knowing the patient's age or newborn screen results, this remains on the differential, although the other lab abnormalities would be atypical.",Hereditary metabolic disorders
['Holocarboxylase synthetase deficiency'],"1. Propionic acidemia: Caused by propionyl-CoA carboxylase deficiency. Consistent with patient's cyanosis, hypotonia, hyperammonemia, metabolic acidosis, and death in infancy. Can also cause skin rash. Diagnosis confirmed by elevated glycine and propionylcarnitine.

2. Methylmalonic acidemia: Can cause similar presentation to propionic acidemia with cyanosis, lethargy, metabolic acidosis, hyperammonemia, and death in infancy if untreated. Skin rash not typically seen. Diagnosis confirmed by elevated methylmalonic acid.

3. Pyruvate carboxylase deficiency: Matches patient's decreased pyruvate carboxylase activity, hypotonia, metabolic acidosis, and hyperammonemia. Can be rapidly progressive in infancy. Additional findings may include seizures and brain abnormalities.

4. Glutaric acidemia type 2: Multiple acyl-CoA dehydrogenase deficiency causing acidosis, hypoglycemia, hyperammonemia, hypotonia, and coma. Consistent with patient's metabolic acidosis, hypotonia, and hyperammonemia. Distinctive urine organic acid profile.

5. Isovaleric acidemia: Caused by isovaleryl-CoA dehydrogenase deficiency. Can present in infancy with poor feeding, vomiting, lethargy, hypotonia, metabolic acidosis, and hyperammonemia, similar to this patient's presentation. Characterized by elevated isovalerylglycine in urine.",Hereditary metabolic disorders
['Ornithine transcarbamylase deficiency'],"1+ Ornithine transcarbamylase (OTC) deficiency: This is the most common urea cycle disorder and fits well with the patient's hyperammonemia, neurological symptoms, and oroticaciduria. It is an X-linked disorder which could explain adolescent death in affected males.

2+ Other urea cycle disorders (e.g., citrullinemia, argininosuccinic aciduria): These disorders also cause hyperammonemia and neurological symptoms. Additional metabolic testing could help differentiate them.

3+ Organic acidemias (e.g., propionic acidemia, methylmalonic acidemia): While these disorders typically present earlier in infancy, they can have a more chronic progressive course. They are associated with hyperammonemia, neurological symptoms, and metabolic acidosis.

4+ Mitochondrial disorders: These disorders can cause a wide range of neurological and multisystem symptoms. Some forms are associated with hyperammonemia. However, the oroticaciduria would be unusual.

5+ Lysinuric protein intolerance: This is a rare metabolic disorder associated with hyperammonemia, orotic aciduria, and neurological symptoms. However, it typically also includes growth failure and protein intolerance.",Hereditary metabolic disorders
[],"1. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: Consistent with vomiting, hypoglycemia (implied by timing of death), ethylmalonic aciduria, and decreased acyl-CoA dehydrogenase activity. May also have hyperammonemia and liver dysfunction.

2. Long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency: Matches the decreased 3-hydroxyacyl-CoA dehydrogenase level, ethylmalonic aciduria, and early death. Other symptoms may include hypoglycemia, cardiomyopathy, and retinopathy.

3. Glutaric acidemia type 2: Also causes ethylmalonic aciduria, low carnitine, and decreased acyl-CoA dehydrogenase activities. Can present with hypoglycemia, metabolic acidosis, cardiomyopathy, and early death.

4. Propionic acidemia: May have vomiting, lethargy progressing to coma, cardiomyopathy, and early death. Would expect to see propionylcarnitine on acylcarnitine profile and methylcitrate in urine.

5. Carnitine-acylcarnitine translocase deficiency: Impairs carnitine shuttle and fatty acid oxidation, causing low free carnitine, high acylcarnitines, hypoglycemia, hyperammonemia, and early death. Ethylmalonic aciduria may be less prominent than in other fatty acid oxidation disorders.",Hereditary metabolic disorders
['Smith-Lemli-Opitz syndrome'],"1. Smith-Lemli-Opitz syndrome (SLOS): Consistent with patient's dysmorphic features, intellectual disability, elevated 7-dehydrocholesterol, and severe disease course. May also have 2-3 toe syndactyly and genital anomalies (not reported).

2. Noonan syndrome: Some overlapping features like ptosis, low-set ears, short stature, and developmental delay. However, lacks characteristic heart defects and does not explain the cholesterol abnormalities.

3. Cornelia de Lange syndrome: Similar dysmorphic facial features, growth restriction, and intellectual disability. However, usually has smaller head size, hirsutism, and limb reduction defects (not reported). Biochemical profile is not consistent.

4. Desmosterolosis: Rare disorder of cholesterol synthesis that can cause similar dysmorphic features, intellectual disability, and failure to thrive. Would have elevated desmosterol levels rather than 7-dehydrocholesterol.

5. Lathosterolosis: Another rare cholesterol biosynthesis disorder with overlapping features to SLOS. Key difference is an elevation of lathosterol rather than 7-dehydrocholesterol.",Hereditary metabolic disorders
['L-2-hydroxyglutaric aciduria'],"1. L-2-hydroxyglutaric aciduria: The patient's intellectual disability, ataxia, tremor, cerebral atrophy, and abnormal basal ganglia, in combination with documented L-2-hydroxyglutaric aciduria, are highly consistent with this rare metabolic disorder. Seizures were not reported but can be a feature.

2. Glutaric aciduria type 1: Can cause intellectual disability, ataxia, dystonia, and basal ganglia abnormalities. However, L-2-hydroxyglutaric aciduria is not a feature.

3. Canavan disease: A leukodystrophy that can present with intellectual disability, ataxia, and cerebral atrophy. However, the basal ganglia are typically spared and L-2-hydroxyglutaric aciduria is not seen.

4. Mitochondrial disorder: Certain mitochondrial disorders such as PDH deficiency can cause intellectual disability, ataxia, and cerebral atrophy. However, basal ganglia abnormalities and L-2-hydroxyglutaric aciduria would be unusual.

5. Cerebellar ataxia with developmental delay: A heterogeneous group of disorders that can cause ataxia and intellectual disability, but would not typically feature L-2-hydroxyglutaric aciduria or basal ganglia abnormalities.",Hereditary metabolic disorders
['3-hydroxy-3-methylglutaric aciduria'],"1. Glutaric acidemia type II: Featuring hypotonia, metabolic acidosis, dicarboxylic aciduria, and often early death. Seizures and opisthotonus are not typically reported.

2. Canavan disease: Presents with hypotonia, seizures, and early death, but 3-methylglutaconic aciduria would be unusual. Macrocephaly is a key feature not reported here.

3. Leigh syndrome: Can explain seizures, hypotonia, metabolic acidosis, and early mortality. Dicarboxylic and 3-methylglutaconic aciduria may occur. Other features like developmental regression, ataxia, and optic atrophy are not mentioned.

4. Propionic acidemia: The metabolic acidosis, hypotonia, seizures and potential for early death fit, but dicarboxylic aciduria would be atypical. Hyperammonemia is a key feature missing from the reported symptoms.

5. 3-Methylglutaconic aciduria type I: Matches the 3-methylglutaconic aciduria, hypotonia, seizures, and early death. However, this type does not usually cause dicarboxylic aciduria, and characteristic hepatomegaly is not reported.",Hereditary metabolic disorders
['L-2-hydroxyglutaric aciduria'],"1. Inborn error of metabolism: The patient's seizures, skin rash, death in infancy, and L-2-hydroxyglutaric aciduria are consistent with a metabolic disorder. However, fever and elevated CRP are not typical.

2. Neonatal lupus erythematosus: The skin rash, fever, elevated CRP, and decreased iron levels could fit with neonatal lupus. Key features not reported include congenital heart block and liver abnormalities.  

3. Incontinentia pigmenti: This genetic disorder can cause skin rash, seizures, and potentially death in infancy in severe cases. However, the patient's fever, elevated CRP, and metabolic disturbances are not characteristic.

4. Neonatal herpes simplex virus infection: HSV can cause seizures, skin lesions, fever, and elevated CRP in neonates and can be fatal. However, the rash may have a vesicular rather than eczematoid appearance, and the other metabolic abnormalities would be unusual.

5. Langerhans cell histiocytosis: This rare disorder can present in infancy with skin rash, fever, and systemic symptoms. While seizures and death can occur in severe cases, the specific pattern of lab abnormalities seen here would be atypical.",Hereditary metabolic disorders
['X-linked hypophosphatemia'],"1. Hypophosphatemic rickets: Characterized by low blood phosphate, skeletal abnormalities, elevated alkaline phosphatase, and sometimes kidney involvement. However, this condition is not typically fatal in childhood.

2. Autosomal recessive hypophosphatemic rickets: A rare genetic form of rickets causing hypophosphatemia, bone deformities, and often kidney disease. Onset is usually in childhood but life expectancy varies.

3. Dent disease: An X-linked disorder of the kidneys that causes hypophosphatemia, kidney dysfunction, and elevated alkaline phosphatase. It does not usually involve significant skeletal abnormalities or childhood mortality.

4. Generalized arterial calcification of infancy: A very rare genetic condition causing extensive calcification and stenosis of arteries, leading to nephritis, abnormal bone development, and early death in infancy or childhood. Hypophosphatemia is not a typical feature.

5. Metaphyseal chondrodysplasia, Murk Jansen type: An extremely rare skeletal dysplasia characterized by bone abnormalities, hypophosphatemia due to kidney losses, and elevated alkaline phosphatase. Affected individuals have short stature but normal life expectancy.",Hereditary metabolic disorders
['Propionic acidemia'],"1. Nonketotic hyperglycinemia: Elevated glycine levels in blood and urine, developmental delay, early mortality. Does not explain the skin findings or other metabolic abnormalities.

2. Propionic or methylmalonic acidemia: Hyperammonemia, leukopenia, developmental delay, early death. Elevated carboxylic acids expected. Skin and alkaline phosphatase findings still unexplained.

3. Urea cycle disorders (e.g. CPS1 deficiency): Hyperammonemia, developmental delay, early mortality. Does not account for abnormal amino acids, skin rash, or elevated alkaline phosphatase.

4. Netherton syndrome: Eczematoid skin rash, elevated IgE, failure to thrive, recurrent infections. Could explain skin findings and early death, but does not fit the metabolic abnormalities.

5. Autosomal recessive cutis laxa type 2B: Developmental delay, wrinkled skin, early mortality. Abnormal amino acid and carboxylic acid profiles can be seen. Does not explain ammonia or glycine elevations.",Hereditary metabolic disorders
"['Methylmalonic acidemia with homocystinuria, type cblC']","1. Methylmalonic acidemia with homocystinuria, cblC type: Characterized by methylmalonic aciduria, hyperhomocystinemia, neurologic dysfunction, and early mortality. Key symptoms not reported include microcephaly, hydrocephalus, and retinopathy.

2. Isolated methylmalonic acidemia, mut0 type: Presents with severe methylmalonic aciduria, metabolic ketoacidosis, hyperammonemia, hypotonia, and failure to thrive in early infancy. Homocystinuria and abnormal cerebral white matter would be atypical.

3. Propionic acidemia: Another organic acidemia that can present with hypotonia, developmental delay, gastrointestinal symptoms, and early mortality. Methylmalonic aciduria and homocystinuria are not typical features.

4. Glutaric acidemia type 1: Can cause hypotonia, developmental delay, and abnormal cerebral white matter. Methylmalonic aciduria and homocystinuria would not be expected. Characteristic finding of fronto-temporal atrophy was not described.

5. Multiple carboxylase deficiency (biotinidase deficiency or holocarboxylase synthetase deficiency): Can present with hypotonia, developmental delay, and metabolic acidosis. Methylmalonic aciduria may be present but homocystinuria and abnormal white matter would be unusual. Characteristic skin rash was not reported.",Hereditary metabolic disorders
['Biotinidase deficiency'],"1. Propionic acidemia: Consistent with neonatal presentation and elevated urinary carboxylic acid. Other symptoms may include poor feeding, lethargy, seizures, and metabolic acidosis.

2. Methylmalonic acidemia: Also presents in the neonatal period with elevated urinary carboxylic acid. Symptoms similar to propionic acidemia.

3. Isovaleric acidemia: Another organic acidemia with neonatal onset and elevated urinary carboxylic acid. Characteristic ""sweaty feet"" odor may be present.  

4. Glutaric acidemia type 2: Fatty acid oxidation disorder with severe neonatal form. Elevated urinary carboxylic acids, hypoglycemia, metabolic acidosis, cardiomyopathy, and liver dysfunction.

5. Neonatal sepsis: Can cause critically ill appearance and rapid deterioration in neonates. Symptoms patient did not report include fever, hypothermia, respiratory distress, and circulatory collapse.",Hereditary metabolic disorders
['Carbamoyl-phosphate synthetase 1 deficiency'],"1. Urea cycle disorder: Hyperammonemia, lethargy, drowsiness, and feeding difficulties are consistent. May have respiratory alkalosis which was not reported.

2. Nonketotic hyperglycinemia: Lethargy, hypotonia, hyperreflexia, feeding problems, and neonatal onset fit. Absence of seizures would be atypical.  

3. Maple syrup urine disease: Poor feeding, lethargy, hypotonia, and sleepiness are consistent. Absence of metabolic acidosis and branched-chain ketoaciduria.

4. Mitochondrial encephalomyopathy: Hypotonia, spasticity, hyperreflexia, and lethargy could fit. Specific neuroimaging and genetic findings were not reported.

5. Zellweger syndrome (a peroxisomal disorder): Hypotonia, feeding difficulties, and neonatal issues are consistent. Absence of dysmorphic features and liver dysfunction.",Hereditary metabolic disorders
['Vitamin B12-unresponsive methylmalonic acidemia'],"1. Methylmalonic acidemia: Hallmark finding of decreased methylmalonyl-CoA mutase activity. Presents with metabolic acidosis, poor feeding, lethargy in infancy. Can be fatal if untreated. Patient's symptoms of death in infancy/childhood are consistent.

2. Propionic acidemia: Can cause similar presentation to methylmalonic acidemia with metabolic acidosis and potential infant death. However, would not cause decreased methylmalonyl-CoA mutase activity.

3. Sepsis: Severe bacterial infection can lead to metabolic acidosis and death in infancy. However, would not cause specific decrease in methylmalonyl-CoA mutase.

4. Congenital heart disease: Certain heart defects can cause death in infancy. However, metabolic acidosis and decreased methylmalonyl-CoA mutase would not be expected.

5. Other rare metabolic disorders: Various other inherited metabolic conditions could potentially lead to infant death and acidosis. However, the decreased methylmalonyl-CoA mutase activity is quite specific for methylmalonic acidemia.",Hereditary metabolic disorders
[],"1. Pyruvate dehydrogenase complex deficiency: Explains the metabolic acidosis, elevated lactate, neurologic symptoms, and early mortality. Does not account for the hemolytic anemia or porphyrin abnormality.

2. Propionic acidemia: The metabolic acidosis, hyperactivity, spasticity, and early death fit with this organic acidemia. Additional symptoms may include ketosis, hyperammonemia, and developmental delays.

3. Erythropoietic protoporphyria: Matches the hemolytic anemia, hyperbilirubinemia, and abnormal porphyrin profile. Symptoms not explained include the neurologic features and early mortality.

4. Pyruvate kinase deficiency: Accounts for the hemolytic anemia, jaundice, and early mortality. The neurologic symptoms and acidosis are less consistent with this diagnosis.

5. Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS): Could explain the neurologic symptoms, metabolic acidosis, elevated lactate, and childhood onset. The hemolytic anemia and porphyrin abnormality are atypical.",Hereditary metabolic disorders
['Neonatal intrahepatic cholestasis due to citrin deficiency'],"1. Citrullinemia type I: Elevated plasma citrulline, hyperammonemia, respiratory distress, and neonatal death are consistent with this urea cycle disorder caused by argininosuccinate synthetase deficiency. May also have seizures and coma.

2. Argininosuccinic aciduria: Another urea cycle disorder with elevated citrulline that could explain the patient's hyperammonemia, respiratory issues, and neonatal death. Caused by argininosuccinate lyase deficiency. Additional symptoms may include hepatomegaly and brittle hair.

3. Carbamoyl phosphate synthetase I deficiency: A severe urea cycle disorder that typically presents in the neonatal period with hyperammonemia, lethargy, poor feeding, and death without prompt treatment. Does not cause elevated citrulline.

4. Transient hyperammonemia of the newborn: A temporary metabolic disturbance in neonates that causes hyperammonemia, respiratory alkalosis, and irritability. Symptoms resolve within a few days. Less likely given this patient's death and elevated citrulline.

5. Pyruvate dehydrogenase deficiency: A rare metabolic disorder that can present in infancy with hypotonia, lethargy, respiratory distress, and lactic acidosis. Can be fatal. Elevated citrulline would be atypical.",Hereditary metabolic disorders
[],"1. Methylmalonic acidemia: Characterized by neurological abnormalities, metabolic acidosis, hyperammonemia, hyperglycinemia, methylmalonic aciduria, and decreased methylmalonyl-CoA mutase activity. Can lead to intellectual disability, seizures, coma, kidney failure, and early death if untreated.

2. Propionic acidemia: Another organic acidemia that can present similarly to methylmalonic acidemia, with poor feeding, vomiting, lethargy, intellectual disability, seizures, and hyperammonemia. Methylcitrate is often elevated rather than methylmalonic acid.

3. Urea cycle disorder: The hyperammonemia, altered mental status, seizures, and early death fit with a urea cycle defect leading to toxic ammonia levels. However, the patient's other metabolic abnormalities are less typical.

4. MSUD (maple syrup urine disease): Can cause poor feeding, vomiting, lethargy, intellectual disability, seizures, brain edema, and a characteristic maple syrup odor. Branched-chain amino acids and keto-acids are elevated. Some features fit but others are less consistent.

5. Mitochondrial disorder: The combination of neurological, kidney, hematologic and metabolic abnormalities could fit with a mitochondrial disorder affecting energy production. However, the specific metabolic derangements seen are less common.",Hereditary metabolic disorders
['Dihydropteridine reductase deficiency'],"1. Menkes disease: Explains the patient's neurological symptoms (seizures, hypotonia, developmental delay), abnormal hair (alopecia), and shortened lifespan. Key features not reported include hypopigmented or kinky hair and cutis laxa.

2. Zellweger syndrome: Accounts for the microcephaly, seizures, hypotonia, intellectual disability, and early death. May also explain the nystagmus and abnormal brain imaging. Hepatomegaly and distinctive facial features are not mentioned but would support this diagnosis.

3. Phenylketonuria (PKU): The hyperphenylalaninemia fits with PKU, which can cause microcephaly, intellectual disability, seizures, and cerebral white matter abnormalities if untreated. However, PKU does not typically cause nystagmus, alopecia, or death in infancy/childhood.

4. Maple syrup urine disease (MSUD): The patient's neurological symptoms and intellectual disability could be explained by MSUD, which can present in infancy with poor feeding, lethargy, hypotonia, and seizures. The disease can be fatal if untreated. However, the patient's hypertyrosinemia and hyperphenylalaninemia are less consistent with MSUD.

5. Niemann-Pick disease type A: Could explain the psychomotor delay, hypotonia, and early death. Neurodegenerative changes on brain imaging would be expected. The patient's alopecia and nystagmus are atypical for Niemann-Pick. Hepatosplenomegaly and cherry-red spot are not reported here but are key features.",Hereditary metabolic disorders
[],"1. Mitochondrial DNA depletion syndrome: Consistent with the patient's cytochrome C oxidase-negative muscle fibers, feeding difficulties, and death in infancy. Other features like the skin rash and metabolic abnormalities could also fit. Key features not reported include liver dysfunction and neurological abnormalities.

2. Ethylmalonic encephalopathy: The patient's ethylmalonic aciduria, skin lesions, and gastrointestinal symptoms fit with this diagnosis. Cytochrome C oxidase dysfunction can also be seen. However, neurological symptoms and developmental delay were not mentioned.

3. Glutaric acidemia type II: Could explain the patient's ethylmalonic aciduria, glycine abnormality, feeding issues, and early death. Skin findings are not typical of this condition. Hypoglycemia and metabolic acidosis were also not reported.

4. Propionic acidemia: The feeding difficulties, glycine abnormality, and early death fit this diagnosis. Skin lesions are not a classic feature. Other common symptoms not mentioned include lethargy, hypotonia, and developmental delay.  

5. Methylmalonic acidemia: Similar to propionic acidemia, this could cause the feeding issues, metabolic changes, and early death seen in this patient. Skin findings would be unusual. Neurological symptoms and metabolic acidosis are often seen but were not reported.",Hereditary metabolic disorders
['Carbamoyl-phosphate synthetase 1 deficiency'],"1. Arginase deficiency: Hyperammonemia, low plasma citrulline, hypoargininemia, oroticaciduria, seizures, cerebral edema, cyanosis, neonatal/infant death. Key feature not reported: Spasticity.

2. Carbamoyl phosphate synthetase I deficiency: Hyperammonemia, low citrulline, seizures, cerebral edema, cyanosis, neonatal/infant death. Key features not reported: Respiratory alkalosis, no oroticaciduria.

3. Ornithine transcarbamylase deficiency: Hyperammonemia, low citrulline, seizures, cerebral edema, cyanosis, neonatal/infant death (in males). Key features not reported: Orotic aciduria, normal arginine.

4. Propionic acidemia: Hyperammonemia, seizures, cerebral edema, cyanosis, infant death. Key features not reported: Metabolic acidosis, ketonuria, hypoglycemia.

5. Carnitine deficiency: Hyperammonemia, seizures, cerebral edema, cyanosis, infant death. Key features not reported: Hypoketotic hypoglycemia, hepatomegaly, cardiomyopathy.",Hereditary metabolic disorders
['Canavan disease'],"1. Non-ketotic hyperglycinemia (NKH): Characterized by seizures, encephalopathy, and elevated glycine levels in plasma and CSF. Can present in the neonatal period with rapid deterioration and early death. The aminoaciduria and hyperammonemia fit, but the skin rash is not a typical feature.

2. Molybdenum cofactor deficiency: Can cause neonatal seizures, encephalopathy, and early death. Leads to accumulation of sulfite and elevated levels of S-sulfocysteine, taurine, and thiosulfate. Consistent with the seizures and neonatal presentation, but would not expect the skin rash.  

3. Canavan disease: A leukodystrophy causing progressive brain damage, presenting in early infancy with poor head control, seizures, and death often by toddlerhood. Characterized by elevated N-acetylaspartic acid in urine. Matches the seizures and early death, but skin involvement would be unusual.

4. Glutaric aciduria type 1: Typically presents in infancy with encephalopathic crisis, seizures, and hyperammonemia. Can have aminoaciduria and glycine elevation. Usually has characteristic brain findings of fronto-temporal atrophy. The rash makes this less likely.

5. Neonatal lupus erythematosus: Can present with skin rash and rarely with neurological symptoms like seizures. The aminoaciduria and hyperammonemia do not fit this diagnosis. Transplacental passage of maternal antibodies causes the symptoms which often resolve within months.",Hereditary metabolic disorders
['Maple syrup urine disease'],"1. Maple syrup urine disease (MSUD): Seizures, opisthotonus, respiratory insufficiency, feeding difficulties, neonatal death, hypervalinemia, hyperleucinemia, hyperisoleucinemia. Classic MSUD presents in the first week of life with poor feeding, vomiting, lethargy and can rapidly progress to coma and central respiratory failure if untreated.

2. Urea cycle disorder: Seizures, respiratory insufficiency, feeding difficulties, opisthotonus, neonatal death. Additional symptoms may include lethargy, coma, and hyperammonemia which were not reported. 

3. Organic acidemia (e.g. propionic acidemia, methylmalonic acidemia): Seizures, respiratory insufficiency, feeding difficulties, opisthotonus, neonatal death. Other symptoms may include metabolic acidosis, ketosis, and hyperammonemia.

4. Mitochondrial disorder: Seizures, respiratory insufficiency, feeding difficulties, neonatal death. Opisthotonus is less common. Lactic acidosis and other multi-system involvement may be present.

5. Neonatal sepsis: Respiratory insufficiency, feeding difficulties, seizures, death in infancy. Opisthotonus and the specific metabolic abnormalities are not typical of sepsis alone.",Hereditary metabolic disorders
['Medium chain acyl-CoA dehydrogenase deficiency'],"1. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: Consistent with decreased 3-hydroxyacyl-CoA dehydrogenase, episodes of hypoglycemia and metabolic crisis, sudden infant death. Does not typically cause congenital abnormalities.

2. Long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency: Matches decreased enzyme activity, early-onset cardiomyopathy, hypoglycemia, liver disease, and risk of sudden death. Can be associated with congenital anomalies.

3. Carnitine palmitoyltransferase II (CPT2) deficiency: Explains decreased fatty acid oxidation, carnitine abnormalities, episodes of rhabdomyolysis and liver disease. Usually presents in older infants and children.

4. Very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency: Consistent with cardiomyopathy, hypoglycemia, liver disease, and sudden death in severe early-onset form. Abnormal carnitine and 3-hydroxyacyl-CoA levels expected.

5. Glutaric aciduria type 2: Multiple acyl-CoA dehydrogenase deficiency causing congenital anomalies, hypoglycemia, metabolic acidosis, ""sweaty feet"" odor, and early death. Organic acid abnormalities not reported in this patient.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Phenylketonuria: Intellectual disability, seizures, hyperphenylalaninemia. Other key symptoms not reported include fair skin/hair, eczema, and musty body odor.

2. Tyrosinemia type I: Intellectual disability, seizures, hypertyrosinemia, death in infancy/childhood. Hepatic and renal dysfunction are also typically seen.

3. Krabbe disease (globoid cell leukodystrophy): Motor delay, seizures, abnormal white matter, death in infancy/childhood. Peripheral neuropathy and vision loss are other common features.

4. Metachromatic leukodystrophy: Intellectual disability, motor delay, seizures, abnormal white matter, death in childhood. Gait abnormalities and behavioral changes also frequently occur.

5. GM1 gangliosidosis: Intellectual disability, seizures, dyskinesia, death in infancy/childhood. Coarse facial features, hepatosplenomegaly, and skeletal abnormalities are additional signs.",Hereditary metabolic disorders
['Wilson disease'],"1. Wilson disease: characterized by low ceruloplasmin and copper levels in blood, high urine copper, copper accumulation in liver leading to damage (elevated transaminases), hepatomegaly, and splenomegaly. Can present with low muscle tone and lead to early death if untreated.

2. Niemann-Pick disease type C: a lipid storage disorder that can cause hepatosplenomegaly, liver dysfunction, hypotonia, and early death. Does not typically involve copper metabolism abnormalities.

3. Gaucher disease: a lysosomal storage disorder causing hepatosplenomegaly, liver dysfunction, hypotonia, and potentially early death. Also does not classically involve copper abnormalities.

4. Tyrosinemia type 1: an amino acid disorder that can present with liver failure, hypotonia, and early death if untreated. Elevated blood tyrosine and methionine levels and high urine succinylacetone are diagnostic clues not seen here.

5. Mitochondrial hepatopathy: a group of genetic disorders causing liver dysfunction, hypotonia, and potentially early death. Specific findings depend on the exact defect but do not typically include the copper abnormalities seen in this patient.",Hereditary metabolic disorders
['PMM2-CDG'],"1. Joubert syndrome: Characterized by cerebellar vermis hypoplasia, intellectual disability, hypotonia, ataxia, and abnormal eye movements. Key feature not reported is ""molar tooth sign"" on brain MRI.

2. Pontocerebellar hypoplasia (PCH): Autosomal recessive disorder causing cerebellar and pontine hypoplasia/atrophy, severe psychomotor delay, visual impairment, and early death. Strabismus and craniofacial dysmorphism can be seen.

3. Walker-Warburg syndrome: Severe disorder featuring cerebellar malformation, lissencephaly, intellectual disability, hypotonia, eye anomalies, and death usually within first 3 years of life. Hydrocephalus and seizures are common features not mentioned.

4. Congenital disorder of glycosylation (CDG): Group of metabolic disorders that can manifest with cerebellar hypoplasia, severe developmental delay, hypotonia, ataxia, and dysmorphic features. Failure to thrive and multiple organ dysfunction are often present.

5. Dandy-Walker malformation: Characterized by cerebellar vermis hypoplasia, intellectual disability, hypotonia, ataxia, and often hydrocephalus and seizures. Strabismus can occur but craniofacial malformations are less common than in other disorders listed.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia Type I: Hypertyrosinemia, abnormal development, can cause early death if untreated. Other symptoms may include liver dysfunction, renal tubular dysfunction, and neurological issues.

2. Phenylketonuria (PKU): Causes hyperphenylalaninemia and can lead to severe intellectual disability, seizures, and behavioral problems if untreated. Routine newborn screening detects most cases.

3. Maple Syrup Urine Disease: Causes a buildup of branched-chain amino acids and their toxic byproducts. Can rapidly progress to coma and death if untreated. Sweet-smelling urine is a key symptom not mentioned.

4. Homocystinuria: Causes accumulation of homocysteine and its metabolites. Can cause eye problems, skeletal abnormalities, and intellectual disability. Thromboembolism is a major cause of early death. 

5. Glutaric Acidemia Type 1: Causes buildup of glutaric acid and its metabolites. Can present with macrocephaly, subdural hemorrhage, and dystonia after an acute episode. Intellectual disability is common without treatment.",Hereditary metabolic disorders
['Glutaryl-CoA dehydrogenase deficiency'],"1. Glutaric acidemia type 1: Macrocephaly, hypotonia, cerebral atrophy, early death, glutaric aciduria, abnormal lysine. Key symptom not reported: dystonia.

2. Pyruvate dehydrogenase deficiency: Hypotonia, cerebral abnormalities, lactic acidosis, early death. Symptoms not reported: seizures, microcephaly (though macrocephaly can occur).

3. D-2-hydroxyglutaric aciduria: Macrocephaly, hypotonia, cerebral abnormalities, lactic acidosis, early death. Additional finding not reported: seizures.

4. Canavan disease: Macrocephaly, hypotonia, lactic acidosis, cerebral degeneration, early death. Symptom not reported: optic atrophy.

5. Molybdenum cofactor deficiency: Hypotonia, cerebral abnormalities, lactic acidosis, early death. Symptoms not reported: seizures, lens dislocation. Glutaric aciduria and hypercalcemia are atypical.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia type I: Characterized by hypertyrosinemia, failure to thrive, liver failure, renal dysfunction, and high risk of early death. The patient's neonatal/childhood death and hypertyrosinemia fit this diagnosis. Other symptoms not mentioned include skin/eye lesions and neurological issues.

2. Phenylketonuria (PKU): Causes hyperphenylalaninemia and intellectual disability/developmental delay if untreated. Consistent with patient's hyperphenylalaninemia and abnormal development. Usually not fatal in infancy/childhood with modern diagnosis and treatment.

3. Maple syrup urine disease (MSUD): Leads to high levels of branched-chain amino acids and their ketoacids, causing a maple syrup odor in urine. Can present with neonatal encephalopathy, failure to thrive, and risk of infant death. Patient's neonatal death fits, but classic symptoms of sweet-smelling urine, lethargy, and seizures are not described.

4. Homocystinuria: Causes high homocysteine and methionine levels, developmental delay, visual problems, and skeletal abnormalities. Vascular events can cause early death. Some overlap with patient's symptoms but homocysteine/methionine not specifically mentioned.

5. Urea cycle disorders (e.g. OTC deficiency): Lead to hyperammonemia, encephalopathy, coma, and death, often triggered by high protein intake or stress. Could explain infant/childhood death but characteristic symptoms of vomiting, lethargy, coma not noted, and involves nitrogen metabolism rather than tyrosine or phenylalanine specifically.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Zellweger syndrome: Severe neonatal presentation with growth restriction, microcephaly, effusions, feeding problems, and early death. Caused by a peroxisome biogenesis disorder. Patient's hypertyrosinemia also fits, but characteristic facial features and liver dysfunction are not mentioned.

2. Trisomy 18 (Edwards syndrome): Can cause prenatal growth restriction, microcephaly, short stature, feeding problems, and high infant mortality. Other common features like clenched fists, rocker-bottom feet, and heart defects are not noted.

3. Pyruvate dehydrogenase deficiency: Severe neonatal form can present with microcephaly, growth retardation, brain malformations, lactic acidosis, and early death. Explanation for patient's effusions and amino acid abnormalities is lacking.

4. Nonketotic hyperglycinemia: Neonatal form characterized by microcephaly, hypotonia, feeding difficulties, and early death. Seizures and respiratory problems are common but not reported here. Patient's effusions and short stature are atypical.

5. Congenital disorder of glycosylation type Ia: Can feature microcephaly, growth failure, failure to thrive, and infant death. Inverted nipples, abnormal fat pads, and liver dysfunction are not mentioned. Unclear if accounts for patient's amino acid issues.",Hereditary metabolic disorders
['Ornithine transcarbamylase deficiency'],"1. Ornithine transcarbamylase (OTC) deficiency: The most common urea cycle disorder. Consistent with hyperammonemia, vomiting, hyperglutaminemia, and oroticaciduria. Can be severe and lead to death in childhood if untreated.

2. Carbamoyl phosphate synthetase I (CPS1) deficiency: Another urea cycle disorder that fits the patient's presentation. Typically presents in the neonatal period with hyperammonemia, vomiting, lethargy progressing to coma, and death if untreated. Oroticaciduria may be less prominent than in OTC deficiency.

3. Citrullinemia type I (argininosuccinate synthetase deficiency): Urea cycle disorder characterized by hyperammonemia, vomiting, hyperglutaminemia, and increased citrulline levels. Oroticaciduria is not a typical finding.

4. Argininosuccinic aciduria (argininosuccinate lyase deficiency): Urea cycle disorder with hyperammonemia, vomiting, and increased argininosuccinic acid in blood and urine. Oroticaciduria is not typically seen.

5. Transient hyperammonemia of the newborn: A non-genetic condition that can cause vomiting and hyperammonemia in neonates, but is usually self-limited. Hyperglutaminemia and oroticaciduria would be less likely.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Phenylketonuria (PKU): Hyperphenylalaninemia, abnormal tyrosine levels, and complications from birth are consistent with PKU if untreated. However, the patient is also reported to have elevated urinary carboxylic acids which is not typical of PKU.

2. Tyrosinemia type I: The patient's abnormal tyrosine concentration fits with tyrosinemia. Elevated urinary carboxylic acids (succinylacetone) and severe complications like infant death and liver failure are seen in untreated tyrosinemia type I.

3. Maple syrup urine disease (MSUD): Neonatal presentation with poor feeding, lethargy, and characteristic odor could fit with MSUD. This patient's specific amino acid abnormalities would need to be reviewed.

4. Propionic acidemia: A severe organic acidemia that can present at birth with lethargy, poor feeding, and high ammonia. The elevated urinary carboxylic acids fit, but the amino acid abnormalities are less typical.  

5. Methylmalonic acidemia: Another organic acidemia to consider given the patient's elevated carboxylic acids, severe neonatal presentation and complications. Amino acid abnormalities can sometimes be seen as well.",Hereditary metabolic disorders
['Pearson syndrome'],"1. Methylmalonic acidemia: Consistent with kidney dysfunction, pancreatic insufficiency, hypotonia, lethargy, metabolic abnormalities, and early mortality. Additional symptoms may include intellectual disability and seizures.

2. Propionic acidemia: Matches the patient's kidney issues, hypotonia, lethargy, metabolic changes, feeding problems, and risk of early death. May also present with cardiomyopathy and movement disorders.

3. Mitochondrial DNA depletion syndrome: Explains the multi-organ involvement (kidney, liver, heart, pancreas), hypotonia, feeding issues, and childhood mortality. Other features can include hearing loss and intestinal dysmotility.

4. Carnitine palmitoyltransferase II deficiency: The decreased plasma carnitine, kidney dysfunction, hypoglycemia, and muscle weakness fit this diagnosis. Rhabdomyolysis and liver disease may also occur.

5. Pearson syndrome: A mitochondrial disorder characterized by exocrine pancreatic dysfunction, kidney failure, metabolic acidosis, and cytopenias, all seen in this patient. Hearing loss and ptosis are additional possible features.",Hereditary metabolic disorders
['Smith-Lemli-Opitz syndrome'],"1. Smith-Lemli-Opitz syndrome: Consistent with facial dysmorphism, syndactyly, hypotonia, feeding difficulties, and elevated 7-dehydrocholesterol. This disorder of cholesterol synthesis can be life-threatening in severe cases.

2. Congenital disorders of glycosylation: Some forms can present with facial dysmorphism, hypotonia, feeding problems, and early death. However, the patient's cholesterol abnormalities are not typical.

3. Zellweger spectrum disorders: Facial dysmorphism, hypotonia, and early death can occur. Additional symptoms may include eye abnormalities, liver dysfunction, and hearing loss, which were not reported in this patient.

4. Inborn errors of bile acid synthesis: Can cause cholesterol abnormalities, hypotonia, feeding difficulties, and progressive liver disease leading to early death. Facial features are not a prominent sign.

5. Chromosomal disorders (e.g., trisomies): Many are associated with facial dysmorphism, hypotonia, feeding difficulties, and potentially life-threatening complications. The cholesterol abnormalities would be atypical.",Hereditary metabolic disorders
['Acute intermittent porphyria'],"1. Severe combined immunodeficiency (SCID): Recurrent infections, early childhood death; abdominal issues possible from infection. Key symptom not reported: failure to thrive.

2. Familial Mediterranean fever: Recurrent abdominal pain, vomiting; increased susceptibility to infections. Key symptom not reported: periodic fever.

3. Cystic fibrosis: Recurrent respiratory infections, GI issues leading to pain and vomiting; reduced life expectancy. Key symptom not reported: breathing difficulties.

4. Hirschsprung's disease: Possible cause of abdominal pain and vomiting due to intestinal obstruction; can be life-threatening in infancy if untreated. Key symptom not reported: constipation.

5. Chronic granulomatous disease: Immunodeficiency causing recurrent infections; GI tract can be affected causing pain and vomiting. Key symptom not reported: skin abscesses.",Hereditary metabolic disorders
['Citrullinemia type I'],"1. Argininosuccinic aciduria: Characterized by hyperammonemia, elevated plasma citrulline, argininuria, and can cause neonatal death if untreated. The patient's symptoms align with this condition.

2. Citrullinemia type I: Also a urea cycle disorder that causes hyperammonemia, elevated plasma citrulline, and can be fatal in the neonatal period. Matches the patient's profile but argininuria is not typical.

3. Ornithine transcarbamylase (OTC) deficiency: The most common urea cycle defect. Causes hyperammonemia and can present in infancy, but usually without the elevated citrulline seen in this patient. 

4. Propionic acidemia: An organic acid disorder that can cause metabolic acidosis, hyperammonemia, hyperglycinuria and death in infancy. However, the elevated citrulline and argininuria are not characteristic.

5. Pyruvate dehydrogenase complex deficiency: Can present in infancy with metabolic acidosis and elevated glycine. However, the degree of hyperammonemia and other biochemical abnormalities seen in this patient would be unusual.",Hereditary metabolic disorders
[],"1. Methylmalonic acidemia due to methylmalonyl-CoA mutase deficiency: Consistent with delayed development, lethargy, hypotonia, hyperammonemia, methylmalonic acidemia/aciduria, and decreased plasma carnitine. Can be life-threatening in infancy.

2. Cobalamin C deficiency (combined methylmalonic acidemia and homocystinuria): Matches the methylmalonic acidemia, hyperhomocystinemia, developmental delay, lethargy, and hypotonia. Additional symptoms may include microcephaly, seizures, and retinal degeneration.

3. Propionic acidemia: Can explain the delayed development, hypotonia, lethargy, hyperammonemia, and metabolic acidosis. However, methylmalonic acid excretion and homocysteine are typically normal.

4. 3-Methylcrotonyl-CoA carboxylase deficiency: Presents with hypotonia, developmental delay, and metabolic acidosis. However, this condition is usually milder and hyperammonemia would be unusual.

5. Glutaric acidemia type 1: Associated with hypotonia, developmental regression, and metabolic acidosis. However, methylmalonic acid and homocysteine levels are normal, and characteristic brain findings are absent here.",Hereditary metabolic disorders
['Very long chain acyl-CoA dehydrogenase deficiency'],"1. Propionic acidemia: Consistent with hyperammonemia, abnormal amino acids, hypotonia, and high risk of early death. May also have ketoacidosis and pancytopenia.

2. Methylmalonic acidemia: Similar presentation to propionic acidemia with hyperammonemia, metabolic acidosis, hypotonia, and lethargy. May have megaloblastic anemia.

3. Carnitine uptake defect (primary carnitine deficiency): Matches the low plasma carnitine. Can cause hypoketotic hypoglycemia, liver dysfunction, cardiomyopathy and sudden death in infancy.

4. Very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency: A fatty acid oxidation disorder with low carnitine, hypotonia, hyperammonemia, cardiomyopathy, and risk of early death.

5. Ornithine transcarbamylase (OTC) deficiency: A urea cycle defect leading to hyperammonemia, altered mental status, hypotonia and seizures. Typically X-linked, affecting males more severely.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Trisomy 18 (Edwards syndrome): Abnormality of prenatal development, high infant mortality rate, upper airway obstruction. Other features not mentioned include congenital heart defects, clenched hands, and rocker-bottom feet.

2. Tyrosinemia type I: Hypertyrosinemia, risk of neonatal death if untreated. Additional symptoms may include liver failure, renal tubular dysfunction, and neurological crises.

3. Phenylketonuria (PKU): Hyperphenylalaninemia, can lead to severe intellectual disability and neurological issues if untreated. Screening allows for early diagnosis and dietary management.

4. Congenital central hypoventilation syndrome (CCHS): Upper airway obstruction, chronic pulmonary issues. Caused by mutations affecting autonomic control of breathing. Can be associated with Hirschsprung disease and tumors of neural crest origin.

5. Zellweger spectrum disorders: Abnormality of prenatal development, neonatal complications, risk of infant death. Caused by peroxisomal biogenesis disorders. Can present with dysmorphic features, hypotonia, seizures, and liver dysfunction.",Hereditary metabolic disorders
['Medium chain acyl-CoA dehydrogenase deficiency'],"1. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: Consistent with decreased plasma carnitine, 3-hydroxyacyl-CoA dehydrogenase, hypoxemia, and early death. Usually does not present with spasticity or ileus.

2. Propionic acidemia: Can present with spasticity, ileus, premature birth, and early death. Decreased carnitine is common. Vitamin B12 abnormalities and peritoneal effusion can occur.

3. Methylmalonic acidemia: Similar presentation to propionic acidemia with spasticity, ileus, prematurity, early death, and low carnitine. Vitamin B12 abnormalities are a key feature.

4. Carnitine uptake defect: Severely decreased plasma carnitine leading to hypoxemia, peritoneal effusion, and early death. Spasticity and ileus are atypical.

5. Holocarboxylase synthetase deficiency: A biotin metabolism disorder that can present with spasticity, ileus, and early death. Low carnitine and 3-hydroxyacyl-CoA dehydrogenase can be seen. Ferritin and B12 abnormalities are not typical.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia Type I: Characterized by hypertyrosinemia, liver dysfunction, renal tubular dysfunction, and neurologic crises. Can lead to death in infancy or childhood if untreated. Patient's hypertyrosinemia is consistent, but liver and kidney involvement are not mentioned.

2. Phenylketonuria (PKU): Causes hyperphenylalaninemia and intellectual disability if untreated. Severe cases can lead to early death. Patient has elevated phenylalanine, but presence of intellectual disability is not noted. 

3. Maple Syrup Urine Disease: Disorder of branched-chain amino acid metabolism leading to encephalopathy, feeding difficulties, and urine with a maple syrup odor. Can be fatal in infancy if unrecognized. Additional symptoms not reported by patient.

4. Severe Combined Immunodeficiency (SCID): Group of disorders causing profound defects in cellular and humoral immunity. Leads to recurrent, severe infections and often fatal in infancy without treatment. Consistent with patient's recurrent viral infections and early mortality.

5. Urea Cycle Disorder: Defects in ammonia detoxification leading to hyperammonemia, encephalopathy, and death without prompt treatment. Typical symptoms include vomiting, lethargy, coma, and seizures, which patient does not report.",Hereditary metabolic disorders
['3-methylcrotonyl-CoA carboxylase deficiency'],"1. Propionic acidemia: Fits the profile of an organic acidemia. Characterized by elevated glycine, propionic acid, and other carboxylic acids. Can present with lethargy, vomiting, failure to thrive, and early death if untreated.

2. Methylmalonic acidemia: Another organic acidemia that causes elevated glycine, methylmalonic acid, and other metabolites. Also associated with lethal disease in infancy as well as later-onset forms with varying severity. 

3. Isovaleric acidemia: Can cause the accumulation of isovaleric acid and other abnormal metabolites. Acute symptoms in the newborn period may include poor feeding, vomiting, lethargy, and rapid deterioration.

4. Glutaric acidemia type 1: Characterized by elevated glutaric acid, 3-hydroxyglutaric acid, and glutarylcarnitine. Can present with brain atrophy, macrocephaly, and dystonia in infants. Risk of striatal injury and encephalopathic crisis.

5. Multiple carboxylase deficiency: Group of disorders that disrupt the function of biotin-dependent carboxylases. Leads to elevated levels of multiple carboxylic acids. Can present with seizures, hypotonia, skin rash, and alopecia in addition to metabolic acidosis and organic aciduria.",Hereditary metabolic disorders
['Succinic semialdehyde dehydrogenase deficiency'],"1. Glutaric acidemia type 1: Delayed speech and motor development, seizures, ataxia, hypotonia, and elevated urinary carboxylic acid (glutaric acid). Can present with metabolic stroke and brain atrophy.

2. Propionic acidemia: Developmental delay, seizures, hypotonia, hyperactivity, and elevated urinary carboxylic acid (3-hydroxypropionate). Associated with high risk of early mortality. Ketoacidosis and hyperammonemia may occur.

3. Methylmalonic acidemia: Motor delay, seizures, hypotonia, and elevated urinary carboxylic acid (methylmalonic acid). Can have multisystem involvement. Intellectual disability is common in severe cases.

4. Canavan disease: Delayed development, seizures, hypotonia, and early mortality. Caused by aspartoacylase deficiency. Macrocephaly and leukodystrophy on brain MRI are characteristic.

5. Mitochondrial disorder: Global developmental delay, seizures, ataxia, hypotonia, and elevated lactate. Significant clinical variability. May have additional systemic symptoms. Respiratory chain enzyme analysis can aid diagnosis.",Hereditary metabolic disorders
['Argininosuccinic aciduria'],"1. Galactosemia: Symptoms consistent with patient presentation include vomiting, hepatomegaly, and neonatal death. May also have jaundice, hypoglycemia, and failure to thrive.

2. Fatty acid oxidation disorders (e.g., MCAD deficiency): Consistent symptoms include metabolic acidosis, hepatomegaly, and risk of sudden death in infancy. May also have hypoglycemia, lethargy, and seizures.

3. Organic acidemias (e.g., propionic acidemia): Match patient's metabolic acidosis, tachypnea, vomiting, and high risk of infant death. Can also present with poor feeding, lethargy, and developmental delays.

4. Urea cycle disorders: Explain the patient's tachypnea, vomiting, and increased risk of neonatal death. Characteristic symptoms also include lethargy, poor feeding, and hyperammonemia.

5. Mitochondrial disorders: Can cause metabolic acidosis, tachycardia, hepatomegaly, and early death. Other symptoms may include muscle weakness, seizures, and developmental regression. Broad category of disorders with variable presentations.",Hereditary metabolic disorders
['Gyrate atrophy of choroid and retina'],"1. Nonketotic hyperglycinemia: Consistent with hyperglycinemia, feeding difficulties, and early death. Other features like blindness and hyperammonemia can also occur. Does not explain the hypoargininemia or hyperornithinemia.

2. Ornithine transcarbamylase deficiency: A urea cycle defect that fits with the hyperammonemia, feeding problems, and risk of death in childhood. Protein aversion is common but not mentioned. Unclear if glycine and serine would be abnormal.

3. Homocystinuria: Features of this amino acid disorder include short stature, abnormal serine levels, feeding problems, and intellectual disability (not specifically mentioned). Anemia and vision problems can occur. Unclear if ammonia or other amino acids would be affected.

4. Hartnup disease: This disorder of amino acid transport is consistent with the short stature, malabsorption, and abnormal serine levels. Some cases have anemia. Usually not fatal in childhood. Other amino acid abnormalities would be expected.

5. Serine biosynthesis disorders: Fits with abnormal serine, feeding difficulties, and growth deficiency. Can be associated with microcephaly and intellectual disability. Vision loss is possible but less common. Unclear effects on other metabolites mentioned.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia type I: Consistent with hypertyrosinemia, abnormality of prenatal development, and early death. May also have symptoms not reported like liver failure, kidney dysfunction, and rickets.

2. Phenylketonuria (PKU): Matches hyperphenylalaninemia and can cause abnormal development and intellectual disability if untreated. However, early death is less common than in tyrosinemia.

3. Maple syrup urine disease: Can cause neonatal death and severe neurological symptoms due to buildup of branched-chain amino acids. Characteristic odor of urine not reported.

4. Homocystinuria: Inborn error of methionine metabolism that can cause developmental delay, eye problems, and thromboembolic events. Can be fatal but less commonly in infancy compared to tyrosinemia.

5. Zellweger spectrum disorder: Peroxisomal biogenesis disorder causing abnormal development, hypotonia, seizures, and early death. May have additional symptoms like distinctive facial features and liver dysfunction.",Hereditary metabolic disorders
['Carbamoyl-phosphate synthetase 1 deficiency'],"1. Urea cycle disorder: Hyperammonemia, cerebral edema, apathy/lethargy, hypotonia, feeding difficulties, and death in infancy can be seen. Respiratory alkalosis is often present but not reported here.

2. Organic acidemia (e.g. propionic, methylmalonic): Hypotonia, poor feeding, lethargy, hyperammonemia, and neonatal death can occur. Metabolic acidosis and ketosis are usually seen as well.

3. Pyruvate dehydrogenase deficiency: Hypotonia, lethargy, feeding problems, and cerebral edema can be present. Lactic acidosis and seizures are common features not mentioned.

4. Zellweger syndrome (a peroxisomal disorder): Profound hypotonia, poor feeding, and neonatal death are typical. Distinctive facial features and liver dysfunction are usually present too.

5. Molybdenum cofactor deficiency: Neonatal seizures, hypotonia, feeding difficulties, and death in early infancy are characteristic. High sulfite levels and dislocated lenses are often seen but not reported.",Hereditary metabolic disorders
['Canavan disease'],"1. Canavan disease: Rare inherited disorder that damages the ability of nerve cells to send and receive messages. Consistent with patient's blindness, seizures, hypotonia, motor delays, hearing loss and early death. Caused by aspartoacylase deficiency leading to buildup of N-acetylaspartic acid.

2. Maple syrup urine disease: Inherited disorder preventing the body from processing certain amino acids, leading to a toxic buildup. Matches patient's seizures, hypotonia, opisthotonus, and high levels of aspartate amino acids. Can be fatal in infancy if untreated. Patient did not have the characteristic sweet-smelling urine.

3. Phenylketonuria (PKU): Inherited disorder causing a buildup of phenylalanine which can damage the brain. Explains developmental delays, seizures and hypotonia. Usually also see eczema, small head size and light skin/hair, which patient did not have. 

4. Sulfite oxidase deficiency: Rare inherited metabolic disorder disrupting the nervous system. Matches seizures, motor delays, opisthotonus and early death. Also characterized by dislocation of the lenses of the eyes, not seen in this patient.

5. Menkes disease: Disorder of copper metabolism affecting the nervous system. Consistent with seizures, hypotonia, developmental delays and early death. Patients also have sparse, kinky hair and bony abnormalities, which were not noted here.",Hereditary metabolic disorders
"['Methylmalonic acidemia with homocystinuria, type cblC']","+1: Isolated methylmalonic acidemia: Consistent with methylmalonic aciduria, intellectual disability, metabolic stroke causing hydrocephalus and microcephaly. Does not explain hyperhomocystinemia.

+2: Holocarboxylase synthetase deficiency: Multiple carboxylase deficiency causing methylmalonic aciduria, intellectual disability, and metabolic decompensations. Associated with respiratory insufficiency and childhood death. Hyperhomocystinemia and carnitine abnormalities are atypical.

+3: Molybdenum cofactor deficiency: Matches microcephaly, intellectual disability, neonatal seizures, and early death. Commonly presents with dysmorphic facies and dislocated lenses, which were not reported. Biochemical abnormalities can include sulfite oxidase deficiency.

+4: Zellweger spectrum disorder: Peroxisomal biogenesis disorder consistent with intellectual disability, hypotonia, dyskinesia, and early death. Typical features also include dysmorphic facies, hepatic dysfunction, and stippled epiphyses, which were not mentioned.

+5: Walker-Warburg syndrome: Severe congenital muscular dystrophy with brain and eye anomalies, matching hydrocephalus, intellectual disability, eye movement disorders, and early death. Characteristic brain finding of cobblestone lissencephaly was not described. Metabolic abnormalities would be atypical.",Hereditary metabolic disorders
['Medium chain acyl-CoA dehydrogenase deficiency'],"1. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: Consistent with abnormal prenatal development, vomiting, abnormal carnitine, decreased 3-hydroxyacyl-CoA dehydrogenase. Can lead to sudden infant death. Other symptoms may include lethargy, hypoglycemia.

2. Long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency: Matches abnormal prenatal development, infant death, vomiting, GI issues, abnormal carnitine, decreased 3-hydroxyacyl-CoA dehydrogenase. May also cause hypoglycemia, liver problems, cardiomyopathy.

3. Very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency: Aligns with abnormal prenatal development, infant death, vomiting, abnormal carnitine, decreased 3-hydroxyacyl-CoA dehydrogenase. Can also present with hypotonia, cardiomyopathy, liver dysfunction.

4. Carnitine uptake defect (CUD): Matches abnormal prenatal development, infant death, GI issues, abnormal carnitine. May also cause poor feeding, hypotonia, cardiomyopathy, liver problems.

5. Trifunctional protein (TFP) deficiency: Consistent with abnormal prenatal development, neonatal death, vomiting, abnormal carnitine, decreased 3-hydroxyacyl-CoA dehydrogenase. Can also lead to hypoglycemia, liver disease, cardiomyopathy, neuropathy.",Hereditary metabolic disorders
['Biotinidase deficiency'],"1. Ornithine transcarbamylase (OTC) deficiency: Matches the hyperammonemia, metabolic acidosis, and early death. An X-linked urea cycle disorder that is often severe in males.

2. Propionic acidemia: The hypotonia, metabolic acidosis, hyperammonemia, and early death fit. Caused by a defect in propionyl-CoA carboxylase. Can also cause neutropenia.

3. Methylmalonic acidemia: Similar presentation to propionic acidemia with the addition of leukopenia. Due to defects in methylmalonyl-CoA mutase or related pathways.

4. Isovaleric acidemia: Another organic acidemia that can present with hypotonia, metabolic acidosis, and hyperammonemia in the neonatal period. The leukopenia is less typical.

5. Glutaric acidemia type II: Multiple acyl-CoA dehydrogenase deficiency causing hypotonia, metabolic acidosis, and hyperammonemia. Can be rapidly progressive in the neonatal form but leukopenia is not a classic finding.",Hereditary metabolic disorders
['Tyrosinemia type 2'],"1. Tyrosinemia type II: This rare genetic disorder is characterized by hypertyrosinemia, eye and skin symptoms as seen in this patient. Intellectual disability and neurological symptoms can also occur.

2. Tyrosinemia type I: Another disorder of tyrosine metabolism, type I often has more severe symptoms including liver failure and renal dysfunction, which were not reported in this patient. 

3. Richner-Hanhart syndrome (tyrosinemia type II): This is an alternate name for tyrosinemia type II and matches the patient's presentation.

4. Alkaptonuria: Another genetic disorder of tyrosine metabolism. It typically causes darkening of the urine and arthritis rather than the neurological and eye symptoms seen here.

5. Keratitis-ichthyosis-deafness (KID) syndrome: This rare condition can cause eye and skin symptoms similar to this patient. However, the hypertyrosinemia and intellectual disability would not be explained.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Phenylketonuria (PKU): Characterized by hyperphenylalaninemia and intellectual disability if untreated. Can cause failure to thrive and early death, matching patient's symptoms. 

2. Tyrosinemia type I: Causes abnormal tyrosine levels and can lead to liver and kidney failure, peripheral neuropathy, and death in untreated infants and children. Fits patient's profile.

3. Maple syrup urine disease (MSUD): Leads to poor feeding, lethargy, developmental delay, and death in early infancy if untreated. Some types allow survival into childhood or adulthood with impairments.

4. Homocystinuria: Causes intellectual disability, skeletal abnormalities, eye problems, and thromboembolism. Can present in infancy or early childhood. Some variants cause death at a young age.

5. Glutaric acidemia type I: Can cause macrocephaly, dystonia, intellectual disability, and early death. Fits general profile but some key features not reported in this patient.",Hereditary metabolic disorders
[],"1. Propionic acidemia: Consistent with hyperammonemia, 3-hydroxydicarboxylic aciduria, seizures, and potential for infant death if untreated. Other symptoms may include poor feeding, vomiting, and lethargy.

2. Methylmalonic acidemia: Also features hyperammonemia, 3-hydroxydicarboxylic aciduria, seizures, and risk of neonatal death. Patients may also exhibit metabolic acidosis, neutropenia, and developmental delays.

3. Isovaleric acidemia: Can present with hyperammonemia, acidosis, seizures, and cyanosis in severe cases. The characteristic ""sweaty feet"" odor was not mentioned here.

4. Glutaric acidemia type 2: Associated with metabolic acidosis, 3-hydroxydicarboxylic aciduria, hypoglycemia, and risk of infant death. Patients often have distinctive facial features and liver dysfunction.

5. Ornithine transcarbamylase deficiency: A urea cycle defect leading to hyperammonemia, seizures, and potential neonatal death, especially in severe cases. Cyanosis is atypical but may occur with respiratory distress.",Hereditary metabolic disorders
['Alkaptonuria'],"1. Galactosemia: vomiting, failure to thrive, dark urine; jaundice and cataracts may also occur

2. Tyrosinemia type 1: vomiting, failure to thrive, dark urine, jaundice, liver dysfunction; neurologic symptoms and rickets may develop later

3. Biliary atresia: dark urine, jaundice, pale stools, vomiting, failure to thrive; enlarged liver and spleen

4. Neonatal sepsis: vomiting, temperature instability, lethargy, poor feeding, dark urine (if kidneys involved); jaundice and rash may be present

5. Urea cycle disorder: vomiting, lethargy, failure to thrive, dark urine; seizures and respiratory alkalosis in severe cases",Hereditary metabolic disorders
['Maple syrup urine disease'],"1. Maple syrup urine disease (MSUD): Consistent with seizures, lethargy, growth delay, death in infancy, metabolic acidosis, hyperammonemia, drowsiness, sleep abnormalities, hypervalinemia, hyperleucinemia, hyperisoleucinemia, and feeding difficulties. The characteristic maple syrup odor of the urine was not mentioned.

2. Propionic acidemia: Could explain lethargy, growth delay, metabolic acidosis, hyperammonemia, and feeding difficulties. However, the elevated branched-chain amino acids are more specific for MSUD.

3. Methylmalonic acidemia: Similar to propionic acidemia, this could cause lethargy, growth delay, metabolic acidosis, hyperammonemia, and feeding issues. Again, the amino acid abnormalities favor MSUD.

4. Urea cycle disorders (e.g., ornithine transcarbamylase deficiency): The hyperammonemia, lethargy, and feeding difficulties fit, but seizures, amino acid elevations, and metabolic acidosis are less common.

5. Pyruvate dehydrogenase complex deficiency: Could explain the lactic acidosis, neurological symptoms, and developmental delay. However, the amino acid abnormalities are not typical, and hyperammonemia would be unusual.",Hereditary metabolic disorders
['Ornithine transcarbamylase deficiency'],"1. Urea cycle disorder: The combination of hyperammonemia, altered amino acid levels (glutamine, proline, arginine, citrulline), and neurological symptoms is highly suggestive of a urea cycle defect. However, the patient's skin findings and immune dysfunction are not typically associated with these disorders.

2. Organic acidemia: The patient's metabolic abnormalities, including hypoglycemia, hyperammonemia, and aciduria, could fit with an organic acid disorder such as propionic or methylmalonic acidemia. These conditions can also cause neurological symptoms and immune dysfunction. However, the specific amino acid abnormalities reported are less consistent with this diagnosis.

3. Mitochondrial disorder: The multisystemic nature of the patient's presentation, including neurological, cardiac, and metabolic abnormalities, could suggest a mitochondrial disorder. Some forms can also cause dermatologic changes and immune dysfunction. However, the specific metabolic findings are not classic for a primary mitochondrial disease.

4. Severe combined immunodeficiency (SCID): The patient's recurrent viral infections, gastrointestinal inflammation, and early mortality could fit with SCID, a group of disorders causing profound immune dysfunction. However, the metabolic abnormalities and neurological findings are not typically seen in SCID.

5. Congenital disorder of glycosylation (CDG): CDGs are a group of disorders that can cause a wide range of symptoms, including neurological, dermatologic, immunologic, and metabolic abnormalities. Some forms are associated with abnormal amino acid profiles. However, the specific pattern of findings in this patient is not classic for a known CDG.",Hereditary metabolic disorders
